Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,41758,-0.166053333912036,0.00457636289037392,-0.175023005177169,-0.157083662646903,7.61948000584469e-275
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,41911,-0.155904178021062,0.00521711850682299,-0.166129730294435,-0.145678625747689,5.67603464839766e-190
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41465,-0.377765846350789,0.0127105371604085,-0.40267849918519,-0.352853193516389,8.52560393744274e-188
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,41788,-0.15514115012798,0.00523179242694253,-0.165395463284787,-0.144886836971172,3.93597401331718e-187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,41877,-0.18402666743255,0.0064658167452017,-0.196699668253145,-0.171353666611955,5.19994612219663e-173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,41905,0.371466816687859,0.0131146769424102,0.345762049880735,0.397171583494983,1.99473186986697e-171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,41786,-0.243669457454282,0.00880431297996864,-0.26092591089502,-0.226413004013543,6.23898321015298e-164
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39633,-0.107414124135715,0.00401441788021081,-0.115282383180928,-0.0995458650905015,7.22432845000674e-153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,39625,-0.236252545935347,0.0088731356863787,-0.25364389188065,-0.218861199990045,1.97630278368888e-151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,39655,0.154421492752609,0.00598336257734997,0.142694102101003,0.166148883404215,1.13528575746465e-142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,41667,-0.185081915296662,0.00731219186331328,-0.199413811348756,-0.170750019244568,4.92099911743649e-138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,41765,0.122982573086,0.00499174892307995,0.113198745196764,0.132766400975237,4.58604027404203e-131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,41689,-0.217284929953057,0.00913753917892106,-0.235194506743743,-0.199375353162372,2.11198111800071e-122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41521,-0.197619923768481,0.00849785389084786,-0.214275717394543,-0.180964130142419,3.1602367090055e-117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,41903,0.14619490886624,0.00630447737612993,0.133838133209025,0.158551684523455,1.19003198134942e-116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,41750,0.42446493563647,0.0185364668986479,0.38813346051512,0.460796410757819,7.90644045305552e-114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,41802,-0.0783633219102852,0.0034428175454667,-0.0851112442994,-0.0716153995211705,1.59842326219708e-112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,41805,0.0675827235545671,0.00302280788016605,0.0616580201094417,0.0735074269996926,1.04714210353499e-108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39408,-0.0654083555631649,0.0029270689980684,-0.0711454107993789,-0.0596713003269508,3.63572750386004e-108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,41813,-0.0772466535987318,0.00354437165648814,-0.0841936220454486,-0.0702996851520151,1.7340912613196e-103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41836,0.0874683770684287,0.00402753779081454,0.0795744029984322,0.0953623511384252,8.63298060782473e-103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,39655,0.0575049288877424,0.00268203809944498,0.0522481342128303,0.0627617235626546,5.94844584732767e-100
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39408,0.0677421892797936,0.00320489214321113,0.0614606006790998,0.0740237778804874,3.30946609919104e-97
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,41758,0.0594645524393937,0.00282025061364051,0.0539368612366583,0.0649922436421291,4.38449682971695e-97
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,41758,-0.0866553285956528,0.00413881389818415,-0.0947674038360937,-0.0785432533552119,8.8729615244082e-96
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,41765,-0.135188478842027,0.00660385529281161,-0.148132035215938,-0.122244922468116,1.03628132347e-91
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,41848,0.0576695051791565,0.00285669136818245,0.0520703900975189,0.0632686202607941,2.760256125574e-89
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39308,-0.107140734919522,0.00529792668977324,-0.117524671231478,-0.0967567986075667,2.81325838336391e-89
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,41829,-0.128847718239837,0.00639280994507895,-0.141377625732191,-0.116317810747482,5.23629922102101e-89
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39250,-0.210614690719184,0.0104623050546107,-0.231120808626221,-0.190108572812147,1.73476052856011e-88
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,39655,0.101472430933642,0.00516525148835499,0.0913485380164659,0.111596323850817,1.73828638421057e-84
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,41712,-0.210998194425618,0.0107896669426393,-0.232145941633191,-0.189850447218045,5.78248870678065e-84
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,41740,-0.107988176139803,0.0055337721819927,-0.118834369616508,-0.097141982663097,1.25925079479864e-83
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,39655,0.094603843093844,0.0049072259673333,0.0849856801978708,0.104222005989817,1.75775976078047e-81
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41465,-0.155703075513675,0.00810051593200467,-0.171580086740404,-0.139826064286946,3.35755044022174e-81
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,39625,-0.181526059280535,0.00947843227762103,-0.200103786544672,-0.162948332016398,1.89091074137352e-80
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,41765,-0.124991842060415,0.0065432506231031,-0.137816613281698,-0.112167070839133,2.92681728287993e-80
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,39633,0.113192925032365,0.00599599730828912,0.101440770308118,0.124945079756611,2.93690626770002e-78
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,39650,0.134497567598485,0.00718559087728239,0.120413809479011,0.148581325717958,5.47698072225786e-77
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41617,-0.14099476712929,0.00756178911067357,-0.155815873786211,-0.12617366047237,1.35709644766243e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41543,-0.284230638024379,0.0152825092446265,-0.314184356143847,-0.254276919904912,3.24732772239154e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,41740,-0.165189770024666,0.00890835613982949,-0.182650148058731,-0.1477293919906,8.54848587592371e-76
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,41862,-0.233450908779845,0.0126021720653676,-0.258151166027966,-0.208750651531724,1.17318853360551e-75
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39328,-0.160587324404476,0.00870599043115585,-0.177651065649541,-0.14352358315941,8.06562885908962e-75
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39581,-0.16711299496027,0.00907139512947074,-0.184892929414033,-0.149333060506507,1.1606140332133e-74
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,41884,0.0727054625692069,0.00397293594786472,0.064918508111392,0.0804924170270217,6.65648043085394e-74
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41559,0.100729200682934,0.00569166965857257,0.0895735281521318,0.111884873213736,2.84895407894509e-69
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,41703,-0.0765462323719435,0.00438572875697594,-0.0851422607356163,-0.0679502040082706,1.87316077548613e-67
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39598,-0.140872458899913,0.00807074408565286,-0.156691117307792,-0.125053800492033,2.55132735695943e-67
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41689,-0.155874756552287,0.00894429759438537,-0.173405579837282,-0.138343933267291,2.93747275724835e-67
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,41758,-0.0972157550834302,0.00559347388584713,-0.108178963899691,-0.0862525462671698,6.50038514632278e-67
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41411,-0.0996532419583552,0.00575915014793843,-0.110941176248314,-0.0883653076683958,2.50886963902437e-66
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41877,-0.0603998719400834,0.00351366326537488,-0.0672866519402182,-0.0535130919399486,1.61228856861102e-65
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,41802,-0.0436835245908756,0.00257039811758139,-0.0487215049013352,-0.0386455442804161,4.3003755063372e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41689,-0.142790990425157,0.00840217541202008,-0.159259254232716,-0.126322726617597,4.38156730743918e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39308,-0.111713415802918,0.00657673294915447,-0.124603812383261,-0.0988230192225755,7.11164130602139e-64
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,41740,-0.0701371683965861,0.00415912170874405,-0.0782890469457245,-0.0619852898474478,3.84899177670265e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41836,-0.0758602079138138,0.00450883273425037,-0.0846975200729446,-0.0670228957546831,7.21812298505929e-63
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,39650,-0.0356400108135194,0.00212231846850053,-0.0397997550117804,-0.0314802666152583,1.63234039690976e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,41856,-0.0560663580069338,0.00334304352997067,-0.0626187233256763,-0.0495139926881913,1.7487695025694e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41586,-0.071045647916466,0.00424355672582315,-0.0793630190990793,-0.0627282767338526,2.90780685972476e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41449,-0.10421156291095,0.00623160727438984,-0.116425513168755,-0.0919976126531463,4.03282258992454e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,41740,0.0626653846371078,0.00375422960547678,0.0553070946103733,0.0700236746638423,6.50402535464528e-62
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41636,-0.063524949112304,0.00381956408291593,-0.0710112947148193,-0.0560386035097888,1.77098928917266e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,41758,0.0647443165883781,0.00391620162390309,0.0570685614055281,0.0724200717712282,8.78163018557224e-61
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,39625,-0.0597259228007141,0.00363347761067068,-0.0668475389176287,-0.0526043066837996,5.30418932663356e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,41877,-0.0556053236558933,0.00338915334383977,-0.0622480642098193,-0.0489625831019674,6.63164470602502e-60
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,41877,-0.0635081722442403,0.00388293568218641,-0.0711187261813256,-0.0558976183071549,1.51195711119169e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41534,-0.093796866444417,0.0057436808943506,-0.105054480997344,-0.0825392518914899,2.35022539135669e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41466,-0.0868497103105595,0.00532101033213724,-0.0972788905615485,-0.0764205300595705,2.70926139491387e-59
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41689,-0.0632729192455307,0.0039080816153552,-0.0709327592116269,-0.0556130792794345,2.17803863266481e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39408,-0.130197014302735,0.00804112333924105,-0.145957616047647,-0.114436412557823,2.80583757471121e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,41925,-0.0858255181678772,0.00531077618692672,-0.0962346394942536,-0.0754163968415008,3.41304800438713e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41465,-0.142616123767053,0.0088545637571902,-0.159971068731146,-0.125261178802961,8.42910678949766e-58
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41521,-0.109887462807088,0.00683968681888508,-0.123293248972103,-0.0964816766420732,1.58791686098823e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,41865,-0.244799123332805,0.0152665837286086,-0.274721627440878,-0.214876619224732,2.51574594625888e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41465,-0.101105746887453,0.00631993775399644,-0.113492824885286,-0.08871866888962,4.6872880506576e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,40881,-0.0700056489180093,0.00437755823663755,-0.0785856630618189,-0.0614256347741997,5.46312464112088e-57
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,41888,-0.085737311742599,0.00537908913651055,-0.0962803264501596,-0.0751942970350383,1.1375826976855e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41521,-0.0932347729438253,0.00585932336426305,-0.104719046737781,-0.0817504991498697,1.79125686313458e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,41689,-0.0942558066071051,0.00593118940174434,-0.105880937834524,-0.0826306753796862,2.43703801407598e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,41758,-0.0473172486669219,0.00298068897467986,-0.0531593990572945,-0.0414750982765494,3.15729821769626e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,41689,-0.109815405968965,0.00691813632292433,-0.123374953161897,-0.0962558587760337,3.22957522670316e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,41721,-0.0482201566353716,0.00304977038224181,-0.0541977065845655,-0.0422426066861776,8.53746737203338e-56
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,39600,-0.0699067541823514,0.00443247309413092,-0.078594401446848,-0.0612191069178548,1.97500093845002e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39250,-0.100170346000602,0.00637953974370545,-0.112674243898265,-0.0876664481029396,6.060413539344e-55
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,39600,-0.125063065659292,0.00799147324729144,-0.140726353223983,-0.109399778094601,1.2958668793141e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,41813,-0.0508148778387129,0.00327055060571052,-0.0572251570259055,-0.0444045986515203,5.83627721732852e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39308,-0.0940093985614813,0.00605070726008135,-0.105868784791241,-0.0821500123317218,7.53776848365788e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41750,-0.203251621531527,0.0131020792639216,-0.228931696888813,-0.17757154617424,8.49384569788471e-54
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39448,0.296460120037987,0.0191711243809592,0.258884716251307,0.334035523824668,2.253154473585e-53
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,41783,-0.0519090882735821,0.00339194486268525,-0.0585573002044452,-0.045260876342719,2.0390513609164e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,41740,-0.0447817859991973,0.00292950921627722,-0.0505236240631006,-0.0390399479352939,2.65180862651002e-52
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39625,-0.105343542052097,0.00695392745826711,-0.1189732398703,-0.0917138442338932,2.53234150588131e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,41820,-0.109257465949698,0.0072511154550159,-0.123469652241529,-0.0950452796578667,6.98609769498126e-51
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39401,-0.0770042168720458,0.00512550738406445,-0.0870502113448121,-0.0669582223992794,1.65968067105695e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41689,-0.0650608014942934,0.0043512532377642,-0.0735892578403112,-0.0565323451482755,3.90575245257896e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,41765,0.0602600055541463,0.00403585881468851,0.0523497222773568,0.0681702888309357,5.29979568652351e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,41865,-0.0721674476891825,0.00484225407944181,-0.0816582656848885,-0.0626766296934766,7.88770702269965e-50
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,41802,-0.0847336885640788,0.00572349317551439,-0.095951735188087,-0.0735156419400706,3.39447728834882e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41689,-0.132792720731468,0.00897652790954119,-0.150386715434169,-0.115198726028768,4.03033509364908e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41521,-0.0852398399938748,0.00576306899306739,-0.0965354552202869,-0.0739442247674628,4.23738504176905e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,41865,-0.0379125146406039,0.00256396353868287,-0.0429378831764224,-0.0328871461047855,4.38854424260886e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39408,-0.0776092386920627,0.00526119778789766,-0.0879211863563421,-0.0672972910277833,8.98931270567473e-49
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,41765,-0.0979304540186175,0.00667065842424432,-0.111004944530136,-0.0848559635070986,2.06521467372174e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,41925,0.0516434763124092,0.00352435715217307,0.04473573629415,0.0585512163306685,3.04395251199239e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41455,-0.0756832498073329,0.00517531448232013,-0.0858268661926803,-0.0655396334219854,4.80574588806937e-48
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,41703,-0.0480401630581513,0.0033111960642551,-0.0545301073440913,-0.0415502187722113,2.49377621015038e-47
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,41848,-0.0734470257858737,0.0051000729223055,-0.0834431687135924,-0.0634508828581549,1.14479314854894e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,41740,-0.0801057266115112,0.00556421750100122,-0.0910115929134736,-0.0691998603095488,1.23017714883778e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39308,-0.0950484973275812,0.00662966426599064,-0.108042639288923,-0.0820543553662396,3.44279840273574e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41465,-0.0987800110848111,0.00690071434627574,-0.112305411203512,-0.0852546109661107,4.01618504650661e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39490,-0.0396144601417405,0.00277166620398309,-0.0450469259015473,-0.0341819943819336,6.32204830761209e-46
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,39625,-0.0455497175548771,0.00320156373109564,-0.0518247824678246,-0.0392746526419297,1.56660930787097e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,41689,-0.116307756181651,0.00820930374798383,-0.132397991527699,-0.100217520835603,3.12917768062283e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,41911,-0.112655585704687,0.00795328711721546,-0.128244028454429,-0.0970671429549447,3.22880651432469e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39589,-0.0843177444891621,0.00595129224008885,-0.0959822772797362,-0.0726532116985879,3.60960023933107e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,39633,-0.168871323884636,0.0119528265338229,-0.192298863890929,-0.145443783878344,6.27205036429971e-45
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,41758,-0.0474936921341997,0.00338868894023266,-0.0541355224570557,-0.0408518618113437,2.61407111445169e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39476,-0.0344217326116941,0.00246600903028924,-0.039255110311061,-0.0295883549123272,6.67542288954614e-44
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,41862,-0.0616508319070993,0.00445161100103777,-0.0703759894691334,-0.0529256743450653,2.57831108140114e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41362,-0.0301934610185902,0.00218431911722838,-0.0344747264883578,-0.0259121955488225,3.79678480867099e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,41877,-0.0409798617714123,0.00297704666060349,-0.0468148732261951,-0.0351448503166295,8.11232581963077e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41622,-0.0526831159562836,0.00382996874002831,-0.0601898546867391,-0.0451763772258281,9.39175048211335e-43
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41636,-0.106146424123108,0.00772115068227915,-0.121279879460375,-0.0910129687858411,1.04667747932148e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,41689,-0.102780456935104,0.00748600861373999,-0.117453033818035,-0.0881078800521739,1.33028534978521e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39625,-0.0829833371528622,0.00604280963494973,-0.0948272440373637,-0.0711394302683608,1.45031655462983e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41689,-0.0991251536739378,0.00722362260260435,-0.113283453975042,-0.0849668533728333,1.46942620823918e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41587,-0.0707544115114097,0.00518903410649846,-0.0809249183601467,-0.0605839046626727,4.80352399303023e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,41740,-0.0581557575171055,0.00428171494509572,-0.0665479188094931,-0.0497635962247179,9.74727882757859e-42
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,41840,-0.0697236082513169,0.00514066751760439,-0.0797993165858215,-0.0596478999168123,1.25616922544096e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,41877,-0.0478936155401798,0.00355754122907627,-0.0548663963491693,-0.0409208347311904,4.82723237055119e-41
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,41911,-0.0412907211906592,0.00308517666346855,-0.0473376674510575,-0.0352437749302608,1.37962960849899e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,41911,-0.0431217893096803,0.00323061107597052,-0.0494537870185825,-0.0367897916007781,2.2153127655896e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,41734,-0.072976351568042,0.00547659009597737,-0.0837104681561577,-0.0622422349799264,3.01658417711061e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,39600,-0.156347411227594,0.0117612819267266,-0.179399523803979,-0.13329529865121,5.14333240846106e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,41720,0.090817413941753,0.00684139681248693,0.0774082761892786,0.104226551694227,5.87428791646787e-40
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41865,-0.0727052234196942,0.00549808388655025,-0.0834814678373327,-0.0619289790020557,1.14060806761844e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41617,-0.0320904283001342,0.00242917680268002,-0.036851614833387,-0.0273292417668813,1.37334684467168e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,41911,-0.0460170041945479,0.00348714143184051,-0.0528518014009553,-0.0391822069881404,1.63351622848e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41689,-0.147579081735871,0.0112593026572199,-0.169647314944022,-0.12551084852772,5.26353070763059e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41689,-0.05072280016657,0.00387958451351424,-0.0583267858130579,-0.0431188145200821,8.08391092794068e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,41802,-0.0310909507926123,0.00237824044074584,-0.0357523020564742,-0.0264295995287505,8.17158521523919e-39
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,41740,-0.0680259363018808,0.00522014176270914,-0.0782574141567908,-0.0577944584469709,1.40568118131497e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,41777,0.0264361680959477,0.00202913842410626,0.0224590567846994,0.030413279407196,1.46214763702279e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41667,-0.0357953931767917,0.00274775087772788,-0.0411809848971383,-0.030409801456445,1.49012315480562e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,41877,-0.0647369075005989,0.00496974758529563,-0.0744776127677783,-0.0549962022334194,1.49581502720892e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41534,-0.113919569106936,0.00874534335118721,-0.131060442075263,-0.096778696138609,1.51509293982849e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,41744,0.0791966287559226,0.00608358724432697,0.0672727977570418,0.0911204597548035,1.6704185659181e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",41765,0.10964031173481,0.0084468695133182,0.0930844474887062,0.126196175980914,2.72886818836399e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39385,-0.0539103548889992,0.00415723201062436,-0.062058529629823,-0.0457621801481755,3.58969791981306e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,41911,-0.0622004695937475,0.0048087807146481,-0.0716256797944577,-0.0527752593930372,4.85543291902675e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,41865,-0.0784592241272687,0.00607882496483607,-0.0903737210583474,-0.06654472719619,6.94980422075353e-38
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,39625,-0.091343648421906,0.00708999882229252,-0.105240046113599,-0.0774472507302126,1.04321345154541e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39589,-0.0722431086822338,0.00560961705006899,-0.083237958100369,-0.0612482592640986,1.11439542163402e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39633,-0.0471983497339423,0.00366612176734755,-0.0543839483979435,-0.0400127510699411,1.17356735205446e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,41911,-0.0467688865707307,0.00364494316357046,-0.0539129751713288,-0.0396247979701326,1.82866901715215e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41614,-0.0700677240100475,0.00546944384670634,-0.080787833949592,-0.0593476140705031,2.39921969815191e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41689,0.0264519367007747,0.00206560465567998,0.0224033515756419,0.0305005218259075,2.54456311901651e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39625,-0.0379252295865818,0.00296747699689517,-0.0437414845004963,-0.0321089746726672,3.87419807909732e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39509,-0.0406668808291846,0.00318608749132108,-0.0469116123121739,-0.0344221493461953,4.79878551396199e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,41689,0.104630876750404,0.00821959767772112,0.0885204653020707,0.120741288198737,6.71316100679562e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41636,-0.0407322701004535,0.00320227215483504,-0.0470087235239302,-0.0344558166769769,7.5986264269921e-37
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39408,-0.158359858657389,0.0124726417179357,-0.182806236424543,-0.133913480890235,1.128461490318e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39600,-0.0779464523324799,0.00615834758670331,-0.0900168136024184,-0.0658760910625415,1.83576804585616e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39250,-0.0914032313969328,0.00724793681906415,-0.105609187562299,-0.0771972752315671,3.33337482160665e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,41791,-0.0429582846792386,0.00341362607153513,-0.0496489917794474,-0.0362675775790297,4.14994247252498e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39408,-0.0292884646064001,0.00232855284097267,-0.0338524281747065,-0.0247245010380937,4.98809158187265e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,41925,-0.0677713206703191,0.0053958560316424,-0.0783471984923382,-0.0571954428483,5.60857306651371e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39650,0.0351315457639243,0.00280290819348553,0.0296378457046927,0.040625245823156,8.52189792028306e-36
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,41765,-0.0915706739563406,0.0073317843746596,-0.105940971330673,-0.0772003765820078,1.35445484066212e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39408,-0.0363927259376155,0.00291523390829008,-0.0421065843978641,-0.030678867477367,1.61107566546251e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39408,-0.0527772287855399,0.00422874974309072,-0.0610655782819977,-0.0444888792890821,1.67336036860852e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39474,-0.035289489200129,0.0028391179818811,-0.040854160444616,-0.029724817955642,3.12587733846302e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39308,-0.0694172276861162,0.00562208529232289,-0.0804365148590691,-0.0583979405131633,8.69058164546118e-35
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,41765,-0.0348073493734733,0.00282548891350304,-0.0403453076439392,-0.0292693911030073,1.11033252243415e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,39650,0.0354181362891899,0.00287401724446052,0.0297850624900473,0.0410512100883325,1.14211818271495e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,41715,-0.0685854085743808,0.00557648575759844,-0.0795153206592737,-0.0576554964894878,1.42115908125303e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,41805,-0.0547802083269971,0.00445611560498995,-0.0635141949127774,-0.0460462217412168,1.52066462974147e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,41899,-0.0676599809149867,0.00551413976419659,-0.078467694852812,-0.0568522669771614,2.00807806216507e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41521,-0.118695113427191,0.00967998914403868,-0.137667892149507,-0.0997223347048749,2.25172169601737e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,41636,-0.0558223320867694,0.00455647990566502,-0.0647530327018729,-0.046891631471666,2.55602994224094e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39655,-0.0280840710910207,0.00229232697072801,-0.0325770319536476,-0.0235911102283938,2.75633134948244e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,41750,-0.0490957801950913,0.00403862639788058,-0.0570114879349372,-0.0411800724552453,8.03942721729584e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41466,-0.0677517112423259,0.00557510899225551,-0.0786789248671467,-0.0568244976175051,8.51745130150212e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,41911,-0.0543397842009938,0.00447570725150033,-0.0631121704139344,-0.0455673979880531,9.64926879699767e-34
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39589,-0.0911125477962625,0.00751978884217552,-0.105851333926926,-0.0763737616655984,1.41572872186779e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41865,0.0595478560495161,0.0049242553762157,0.0498963155121333,0.0691993965868988,1.73026221824808e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,41744,0.0569487204893766,0.00472700599384695,0.0476837887414366,0.0662136522373166,2.99125321069535e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39308,-0.0757015517753003,0.00628916546885507,-0.0880283160942563,-0.0633747874563444,3.72347779292364e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,41721,-0.0254016261569278,0.00211646745257109,-0.0295499023639672,-0.0212533499498885,5.16943537169887e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,41740,0.0565460490276324,0.00471580430270642,0.0473030725943278,0.0657890254609369,5.90226548420226e-33
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39160,-0.0407282912757932,0.00341092597682179,-0.0474137061903639,-0.0340428763612225,1.18000595086567e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,41758,-0.0292546894128048,0.0024624886988292,-0.0340811672625101,-0.0244282115630996,2.19777117302667e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41466,-0.0840200979597153,0.00709327605192705,-0.0979229190214923,-0.0701172768979382,3.35601821613487e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,41802,-0.0699922695674998,0.00592881789398773,-0.0816127526397157,-0.0583717864952838,5.29975604697056e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,41925,0.0302515699336982,0.00256678378376425,0.0252206737175203,0.0352824661498761,6.65409270413636e-32
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41466,-0.0617536514228388,0.00525572574516186,-0.0720548738833561,-0.0514524289623216,1.02809311900548e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,41809,-0.04099261214487,0.0034894099566233,-0.0478318556598516,-0.0341533686298883,1.04317881725171e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39408,-0.0791684022944986,0.00682373772526662,-0.0925429282360212,-0.065793876352976,6.14425957970767e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,41877,0.0450109599609682,0.00388246338360028,0.0374013317291117,0.0526205881928248,6.27150045128319e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39153,0.0515287808445425,0.00444730048159324,0.0428120719006198,0.0602454897884653,7.41133500454549e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41465,-0.0797909045377765,0.00689118916879321,-0.0932976353086112,-0.0662841737669418,7.51515607491009e-31
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,41911,-0.0580188774255715,0.00503163731195411,-0.0678808865570016,-0.0481568682941414,1.2895473575268e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39250,-0.0824969774686161,0.00716284559755158,-0.0965361548398172,-0.068457800097415,1.63506491738257e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,41877,-0.0778687252744429,0.00676926298057346,-0.0911364807163669,-0.064600969832519,1.77085152808412e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,41765,0.0380730306634448,0.00331810487671682,0.0315695451050798,0.0445765162218097,2.47446145791825e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,41758,-0.0319849149978987,0.00279622589194339,-0.0374655177461077,-0.0265043122496896,3.72294753555852e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,39534,-0.0299084423381254,0.00261533159939709,-0.0350344922729437,-0.0247823924033071,4.10612507484139e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41404,-0.101456928575323,0.00891339932668204,-0.11892719125562,-0.0839866658950261,7.1122927038375e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,41689,-0.0648137293495313,0.00569639903262387,-0.0759786714534741,-0.0536487872455886,7.43182824678635e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39308,-0.101951075580014,0.00895706795464685,-0.119506928771122,-0.0843952223889065,7.6118099395971e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,39598,-0.0733856981193628,0.00645597161914718,-0.0860394024928912,-0.0607319937458343,8.93794035834766e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41466,-0.0616886253900029,0.00543083649873392,-0.0723330649275214,-0.0510441858524844,9.2769284912184e-30
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,41865,-0.0753758486416767,0.00664877978227388,-0.0884074570149335,-0.0623442402684199,1.1807539172246e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,41758,-0.0667669255477197,0.00590146613082294,-0.0783337991641326,-0.0552000519313067,1.5382486346608e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,41758,0.0336070571948742,0.00297776218315311,0.0277706433158941,0.0394434710738543,2.10006104181435e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,41761,-0.0467825080101309,0.0041752226142424,-0.0549659443340461,-0.0385990716862158,5.2256030214387e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39589,-0.0437416536117597,0.00392151961473053,-0.0514278320566315,-0.0360554751668879,9.73608189412964e-29
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,39633,-0.0329769033389419,0.00296214434631362,-0.0387827062577166,-0.0271711004201672,1.23420541887365e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41466,-0.0745470728866442,0.00670113828896703,-0.0876813039330196,-0.0614128418402689,1.28698271589879e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39408,0.0279890265991742,0.00251673273492484,0.0230562304387216,0.0329218227596269,1.41391514164547e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,39625,-0.107165060581553,0.00964087179965722,-0.126061169308881,-0.0882689518542244,1.49189936579883e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41689,-0.0385273334607948,0.00346885670762419,-0.0453262926077382,-0.0317283743138514,1.5619077125098e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41465,-0.0801193515590842,0.00722337607577779,-0.0942771686676087,-0.0659615344505597,1.8529456258158e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,41765,-0.0413520462874571,0.0037390302081996,-0.0486805454955283,-0.0340235470793859,2.62545520210757e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39600,-0.0722878589268225,0.00654855700352098,-0.0851230306537236,-0.0594526871999214,3.49262811643157e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,41925,-0.0676333085050908,0.00613777045523211,-0.0796633385973457,-0.0556032784128358,4.08359743903005e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39625,-0.0346206432246263,0.00314407874132582,-0.0407830375576249,-0.0284582488916276,4.71494399267519e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41465,-0.0677418402813449,0.00615752809654603,-0.0798105953505751,-0.0556730852121147,5.01224843544888e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,41911,-0.0494279916803158,0.0045124761177117,-0.0582724448710307,-0.0405835384896008,8.38949118611406e-28
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,41736,-0.10706035054452,0.00979149222627826,-0.126251675308026,-0.0878690257810149,1.0433616532507e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41832,-0.0664950608086287,0.00610563646664444,-0.0784621082832518,-0.0545280133340056,1.66878514274576e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,41819,-0.0211366686377234,0.00194287855400693,-0.024944710603577,-0.0173286266718698,1.89616150613117e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41465,-0.128361767584401,0.0118193363672126,-0.151527666864137,-0.105195868304664,2.34094384466861e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41765,-0.0718253339999761,0.00665529607106402,-0.0848697142992616,-0.0587809537006906,4.86171194284493e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41689,-0.144018432360723,0.013358744999364,-0.170201572559477,-0.11783529216197,5.50414723184477e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,41925,-0.0757626166850071,0.00703404425952153,-0.0895493434336693,-0.0619758899363449,6.1013652181849e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,41877,-0.140412035592525,0.0130725646733147,-0.166034262352222,-0.114789808832829,8.42085251655305e-27
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,41802,-0.0283500348147734,0.00264630743200287,-0.0335367973814991,-0.0231632722480478,1.13765501696942e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41466,-0.0598618876128348,0.00559524857619227,-0.0708285748221717,-0.048895200403498,1.33527818232784e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,41636,-0.0600017563464307,0.00562088459808687,-0.0710186901586809,-0.0489848225341804,1.71823529393454e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39655,0.0729826141564505,0.0068365631188,0.0595829504436025,0.0863822778692985,1.78656138719191e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,41911,-0.0295751458397158,0.00277743769352364,-0.0350189237190221,-0.0241313679604095,2.26588864292382e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41689,-0.110124821451913,0.0103527998023723,-0.130416309064563,-0.0898333338392631,2.56203811616199e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41740,-0.112702585922817,0.0106196238292703,-0.133517048628187,-0.0918881232174468,3.32179369288026e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41689,-0.0672047417293962,0.00633622054847373,-0.0796237340044047,-0.0547857494543876,3.55225355804205e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,39633,-0.084197396187126,0.0079465668403797,-0.0997726671942702,-0.0686221251799818,4.17564214329499e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,41836,0.0359140541402723,0.00339246868212575,0.0292648155233059,0.0425632927572388,4.38072241244499e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39530,-0.0307290080459098,0.00290432223178231,-0.0364214796202031,-0.0250365364716164,4.90661213099659e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,39650,-0.0770490408048318,0.00728476045681599,-0.0913271713001911,-0.0627709103094724,5.08612291909784e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39600,-0.0670447283871884,0.0063483176434886,-0.0794874309684261,-0.0546020258059508,6.01183878374131e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41465,-0.0716578872215984,0.00681741079363791,-0.0850200123771287,-0.0582957620660681,9.7723764254944e-26
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41465,-0.0817164739886481,0.00778000489622761,-0.0969652835852543,-0.066467664392042,1.05867831982181e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39589,-0.0883307313428578,0.00841382292201651,-0.10482182427001,-0.0718396384157055,1.16324151488805e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39598,-0.0537108079121535,0.00512433683366163,-0.0637545081061303,-0.0436671077181767,1.38645190082919e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41465,-0.0737453885975297,0.00703968536274523,-0.0875431719085104,-0.0599476052865491,1.41625023839571e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,41821,-0.073617700522557,0.0070373997682889,-0.0874110040684033,-0.0598243969767108,1.64229445603727e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,41740,-0.0833042887857179,0.00796408326391334,-0.0989138919829881,-0.0676946855884477,1.66062747029749e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,39625,-0.0305352746296363,0.00292423324818653,-0.0362667717960819,-0.0248037774631907,2.09076572447775e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,39633,-0.0445215336729342,0.00428113566084284,-0.0529125595681862,-0.0361305077776823,3.26002722963128e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41689,-0.125633778245078,0.0120857450949295,-0.14932183863114,-0.101945717859016,3.26813666800625e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,41911,-0.0410301562069393,0.00395020368488493,-0.0487725554293138,-0.0332877569845649,3.55161372912512e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,39598,-0.072129415627293,0.00696053047432736,-0.0857720553569746,-0.0584867758976114,4.78134223645573e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,41765,-0.0501498883195583,0.00485898976630301,-0.0596735082615122,-0.0406262683776044,7.04101157436467e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,41805,-0.0848743354308077,0.0082315629161952,-0.10100819874655,-0.0687404721150651,7.81901189512748e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39334,-0.0916135232316882,0.00888549071448191,-0.109029085032073,-0.0741979614313036,8.24858677263089e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39583,-0.119895525209442,0.0116396876016683,-0.142709312908712,-0.0970817375101723,9.07800822006735e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39408,-0.0407963954317507,0.00396264477884143,-0.0485631791982799,-0.0330296116652215,9.63053427995504e-25
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,39650,-0.0210828924115169,0.00204918756808203,-0.0250993000449577,-0.0170664847780762,1.02725504295008e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,41925,-0.0438874145996598,0.00427372767138402,-0.0522639208355725,-0.0355109083637472,1.19951956298574e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,41740,-0.0717938523628538,0.00699247037809514,-0.0854990943039203,-0.0580886104217873,1.22566817232334e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41636,-0.0571420327931803,0.00556772187112937,-0.0680547676605939,-0.0462292979257668,1.28215470113699e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39600,-0.03269862196143,0.003185001252932,-0.0389412244171768,-0.0264560195056833,1.28896025018483e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,41740,-0.115845015706409,0.0112994516185343,-0.137991940878736,-0.0936980905340812,1.43045690237015e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,41765,-0.0337281755856618,0.00329340980834096,-0.0401832588100101,-0.0272730923613135,1.6033219786706e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,41740,-0.0993398525131724,0.00970134755931982,-0.118354493729439,-0.0803252112969056,1.62568482709657e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",39650,-0.0181017010133889,0.00176730649012751,-0.0215656217340389,-0.014637780292739,1.64502332023488e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,41832,-0.0653322367890129,0.00638661947332629,-0.0778500109567324,-0.0528144626212934,1.80312862519866e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39600,-0.0305299314698209,0.00298343036634757,-0.0363774549878621,-0.0246824079517796,1.81272912106635e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39600,-0.0687672005456329,0.00672529624621163,-0.0819487811882077,-0.0555856199030581,1.96745239997771e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41465,-0.0613537273729427,0.00600293528692714,-0.0731194805353199,-0.0495879742105655,1.98749734513564e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41521,-0.0583020531694996,0.00571602721108916,-0.0695054665032343,-0.0470986398357648,2.45794231218063e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,41740,-0.0606561501202041,0.00594808723820607,-0.072314401107088,-0.0489978991333202,2.50398582837571e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39250,-0.0424624378996342,0.00417300966382347,-0.0506415368407282,-0.0342833389585402,3.29149599293285e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,41740,-0.0961588868959718,0.0094599764776737,-0.114700440792212,-0.0776173329997314,3.49772608951365e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,39655,-0.078705965989667,0.00776002777946219,-0.0939156204374129,-0.0634963115419211,4.56065101542523e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,41891,-0.0730262239546943,0.0072085672930891,-0.0871550158491489,-0.0588974320602397,4.94722686559037e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39334,-0.0552608878102525,0.00546169454695787,-0.06596580912229,-0.0445559664982151,5.89265126398309e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,41802,-0.098097616890892,0.00970264430789917,-0.117114799734374,-0.0790804340474096,6.07223329958831e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39542,-0.0345871703251124,0.00342908187804165,-0.041308170806074,-0.0278661698441507,8.06171728286527e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,41724,-0.070567943719892,0.00700271563219273,-0.0842932663589898,-0.0568426210807943,8.50278384466675e-24
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39655,0.028686895644007,0.00285574820529957,0.0230896291616199,0.0342841621263942,1.21663361917536e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39578,-0.0833020076446946,0.00829983725675107,-0.0995696886679267,-0.0670343266214626,1.33036869571196e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,41877,-0.0425262635847565,0.00425030151653241,-0.05085685455716,-0.034195672612353,1.74642804864326e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41466,-0.0405569507590904,0.00405658364743506,-0.0485078547080632,-0.0326060468101177,1.89729330148514e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39408,-0.0736254003698802,0.00738853212355778,-0.0881069233320534,-0.0591438774077069,2.73787749551974e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41764,-0.027026197664378,0.00271869870609376,-0.0323548471283218,-0.0216975482004342,3.33698098720576e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41466,0.0782634826118124,0.00789132037343077,0.0627964946798881,0.0937304705437367,4.22154799614281e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,41740,-0.0630598969792413,0.00636072718073794,-0.0755269222534877,-0.050592871704995,4.36333913025837e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,41865,-0.0601436595455776,0.00607183584901261,-0.0720444578096423,-0.0482428612815129,4.74397414116928e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41465,-0.0590895576120107,0.00597452219826728,-0.0707996211206146,-0.0473794941034068,5.54180690710228e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,41706,-0.0202864190940154,0.00205177559756746,-0.0243078992652477,-0.0162649389227832,5.68976990933732e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,41855,-0.0372966289533889,0.00377889206947477,-0.0447032574095594,-0.0298900004972183,6.75427778842496e-23
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,41899,-0.040332559871099,0.00411191586480417,-0.0483919149661151,-0.0322732047760828,1.23258048162172e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,39650,-0.0212144608616632,0.00216462098057557,-0.0254571179835913,-0.016971803739735,1.38403125806654e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39427,-0.11878388662953,0.0121200118667086,-0.142539109888278,-0.0950286633707809,1.38870893373686e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,41802,-0.0862465395767694,0.00881869283031625,-0.103531177524189,-0.0689619016293495,1.63665814051576e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,41636,-0.0909936772040513,0.00932418899627708,-0.109269087636754,-0.0727182667713482,2.01672714750074e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39598,-0.0489923565203169,0.0050188523529517,-0.0588293071321022,-0.0391554059085316,2.02758455299801e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41466,-0.0304103785481576,0.00312221577132819,-0.0365299214599608,-0.0242908356363543,2.4313574569371e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,39650,-0.0244736284412134,0.0025136462220529,-0.0294003750364371,-0.0195468818459897,2.59480585371571e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,41740,-0.0606926072106631,0.00624522043215575,-0.0729332392576883,-0.0484519751636378,2.99526353668961e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41636,-0.0749587427859229,0.00771481623065839,-0.0900797825980134,-0.0598377029738325,3.05969964534209e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,41805,0.0209683106644277,0.00215857724056259,0.016737499272925,0.0251991220559304,3.12081436348439e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,39598,-0.134417787979063,0.0138381704859174,-0.161540602131461,-0.107294973826665,3.24186346780523e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,41802,-0.0282940512007336,0.0029141819998816,-0.0340058479205015,-0.0225822544809656,3.27230037517427e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41636,-0.0592927370046517,0.00610896713157688,-0.0712663125825424,-0.047319161426761,3.38437290100142e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39308,-0.0748985819809745,0.00771722445190021,-0.0900243419066989,-0.0597728220552501,3.52954245503463e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41534,-0.0728871001345368,0.00751667153308672,-0.0876197763393868,-0.0581544239296868,3.70376741188035e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41465,-0.0507619452418587,0.00523541250640059,-0.0610233537544039,-0.0405005367293136,3.73771633818971e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41466,-0.0548446628483534,0.00566108969681482,-0.0659403986541104,-0.0437489270425963,4.03518539438447e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39625,-0.0743611401405212,0.00768262334531338,-0.0894190818973354,-0.0593031983837069,4.5267444552816e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41466,-0.0682182512254556,0.00705302344404057,-0.0820421771757751,-0.0543943252751361,4.7045334221104e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,41736,-0.0822658620475273,0.00850680796133888,-0.0989392056517515,-0.0655925184433031,4.76167270833806e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,41740,-0.100578746381263,0.0104164806576653,-0.120995048470287,-0.080162444292239,5.49927410469903e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39600,-0.111292573923545,0.011532303000661,-0.133895887804841,-0.0886892600422496,5.97556267555593e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,39630,-0.0297341754547437,0.00308132333353459,-0.0357735691884715,-0.0236947817210159,6.01290736631278e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39600,-0.143027476759642,0.0148511776830125,-0.172135785018346,-0.113919168500937,7.23457691481698e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39250,-0.0437293962562126,0.00454038774468309,-0.0526285562357914,-0.0348302362766337,7.24754953956954e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,41805,-0.0672568898398078,0.00700211820680862,-0.0809810415251527,-0.053532738154463,8.95265729418214e-22
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,39655,-0.0294800458671893,0.00308286550670622,-0.0355224622603335,-0.0234376294740451,1.39235026957213e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,41836,-0.0578456031718472,0.00605442128933168,-0.0697122688989373,-0.0459789374447571,1.46059552361313e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39408,-0.0469832027757772,0.00491893561770263,-0.0566243165864743,-0.0373420889650801,1.55456165212647e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39308,-0.0447367688484413,0.00468721319924434,-0.0539237067189602,-0.0355498309779223,1.66639334358388e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39334,-0.087687724481326,0.00921237088271984,-0.105743971411457,-0.0696314775511951,2.13426328083921e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39408,-0.0838389975545853,0.00880913516023429,-0.101104902468645,-0.0665730926405261,2.15590679609144e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,39598,-0.0546190121486249,0.00574672957209892,-0.0658826021099388,-0.043355422187311,2.43036731529795e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39334,-0.0464855412141071,0.0048950317269268,-0.0560798033988836,-0.0368912790293305,2.63214240080374e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39598,-0.041627563847555,0.00439062293552222,-0.0502331848011786,-0.0330219428939315,3.03518926408457e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,39589,-0.100934578621302,0.0106491959564548,-0.121807002695953,-0.0800621545466506,3.11974005049901e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39094,-0.0235005599269394,0.00248053822060919,-0.0283624148393334,-0.0186387050145454,3.27415792264254e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39598,-0.0887657742874419,0.00937373663726211,-0.107138298096476,-0.0703932504784082,3.38208162962491e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,41750,-0.0388940153759369,0.00410938493365478,-0.0469484098459003,-0.0308396209059735,3.43913354185415e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41636,-0.0560910519321971,0.00593652384806077,-0.0677266386743962,-0.044455465189998,4.01691130544636e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,41758,-0.0240369074063563,0.00254588146486671,-0.0290268350774951,-0.0190469797352176,4.28567924642138e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,41740,-0.0966124780535915,0.0102548538136258,-0.116711991528298,-0.076512964578885,5.19728810738728e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41522,-0.0560311104931524,0.0059530954856606,-0.0676991776450472,-0.0443630433412577,5.67612467360836e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,41786,0.0783579364735957,0.00833024549758482,0.0620306552983295,0.0946852176488619,5.96950321700301e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41547,-0.0286264360170411,0.00304982771787075,-0.0346040983440677,-0.0226487736900144,7.24248458133214e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39498,-0.0518011776743761,0.00552295787616155,-0.0626261751116527,-0.0409761802370994,7.95967861757076e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41823,0.0318329005351401,0.00340205688204432,0.0251648690463332,0.0385009320239469,9.51159621441466e-21
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41675,-0.104610418853685,0.011195357529326,-0.126553319611164,-0.0826675180962058,1.07513939914361e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39598,-0.069221555019211,0.00740949207440715,-0.083744159485049,-0.054698950553373,1.12444075851112e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39625,-0.0615876893823023,0.00662127850637136,-0.0745653952547902,-0.0486099835098144,1.64619960611612e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41465,-0.0273877737665504,0.00294700840540414,-0.0331639102411426,-0.0216116372919583,1.73185601152243e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,41744,0.0340537288620715,0.00367780980049274,0.0268452216531057,0.0412622360710373,2.37405882373558e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41614,-0.0881304126755411,0.00952199980902645,-0.106793532301233,-0.0694672930498492,2.46271732644612e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,39600,-0.102934596760457,0.0111202496676806,-0.124730286109111,-0.0811389074118029,2.50348967985663e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,39625,-0.0454616861635471,0.00491250473813014,-0.0550901954502821,-0.035833176876812,2.55472340679165e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41614,-0.0493867185456239,0.00533859897715302,-0.0598503725408438,-0.038923064550404,2.56975226470072e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39625,-0.0755370638701906,0.00817371185999376,-0.0915575391157784,-0.0595165886246028,2.87738370742488e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,41740,-0.0788108131108673,0.0085465072096352,-0.0955619672417523,-0.0620596589799823,3.37358472173966e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39328,-0.120517520675653,0.0130768145522514,-0.146148077198066,-0.0948869641532404,3.65543175487966e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,41836,0.0570384432356869,0.00620240449109923,0.0448817304331324,0.0691951560382414,4.2564017253523e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39408,-0.0225353851717253,0.00245374112650096,-0.0273447177796671,-0.0177260525637834,4.907272826904e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,39625,-0.0525339034346615,0.00572102356011097,-0.063747109612479,-0.041320697256844,4.95869603325349e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,41644,-0.070056187452522,0.00764117451007024,-0.0850328894922597,-0.0550794854127843,5.51925987144676e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41465,-0.059235093838638,0.00646179246952863,-0.0719002070789141,-0.0465699805983619,5.59506819270292e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,41865,-0.0662055699738865,0.00722421061760514,-0.0803650227843925,-0.0520461171633804,5.7053183801341e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,41925,-0.0600860613736791,0.00657235965834753,-0.0729678863040403,-0.0472042364433179,6.99202180799852e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41689,-0.0780957407057903,0.00854510597516086,-0.0948441484171056,-0.061347332994475,7.20469550066078e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39408,-0.0513314093580463,0.00562179111942964,-0.0623501199521284,-0.0403126987639642,8.01002166895019e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,41846,-0.0672074495907207,0.00736398714123233,-0.081640864387536,-0.0527740347939053,8.08529135771054e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,39598,-0.0372081221343692,0.00408278155358579,-0.0452103739793974,-0.0292058702893411,9.36489395465366e-20
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,41805,-0.0346174163885281,0.00380344870679408,-0.0420721758538445,-0.0271626569232117,1.01633231495126e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,41758,-0.0433025904249153,0.00476028181865799,-0.0526327427894849,-0.0339724380603456,1.0638401265171e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,39633,0.0363796842429655,0.00400622614796362,0.0285274809929568,0.0442318874929742,1.26119580552558e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41465,-0.0470824284132985,0.00519248031429889,-0.0572596898293243,-0.0369051669972727,1.39332437620771e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,41925,-0.0620523177820013,0.00684426534763654,-0.075467077863369,-0.0486375577006337,1.40093916830597e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39589,-0.0540500221944277,0.00596574171809708,-0.065742875961898,-0.0423571684269574,1.52414700454692e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39250,-0.0720029524626365,0.00794947005600984,-0.0875839137724158,-0.0564219911528572,1.56677496759182e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41466,-0.0589790863571929,0.00652320196033191,-0.0717645621994434,-0.0461936105149423,1.76532640153011e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41689,-0.0315848863221284,0.00349838649931547,-0.0384417238607867,-0.0247280487834701,1.98250576962554e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,41758,0.0380306637662201,0.00421731151185923,0.029764733202976,0.0462965943294642,2.18249561390977e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39167,-0.029175132232214,0.0032347405795052,-0.0355152237680442,-0.0228350406963838,2.22022272949925e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39334,-0.119731950820479,0.0132794299695119,-0.145759633560722,-0.0937042680802354,2.27501080141347e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41689,-0.0645206855604167,0.00716265642428459,-0.0785594921520145,-0.0504818789688189,2.38737376874323e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,41810,-0.0327059827841731,0.00363575981555003,-0.0398320720226511,-0.025579893545695,2.66522124111848e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,41765,0.105378120749173,0.0117310198654656,0.0823853218128603,0.128370919685485,2.99295487821368e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39598,-0.0591060846571387,0.00658855214006649,-0.0720196468516691,-0.0461925224626084,3.41348471864615e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,41740,-0.0407048937575539,0.00454410874149854,-0.049611346890891,-0.0317984406242167,3.75575843373766e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41521,-0.0534896925259169,0.00597771903680199,-0.0652060218380488,-0.041773363213785,4.10177059904029e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,41740,-0.0657928160807813,0.00736389365529937,-0.0802260476451681,-0.0513595845163946,4.62847419495959e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,41740,-0.0873169438011545,0.00980778407223675,-0.106540200582738,-0.0680936870195704,6.15116852776269e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39576,-0.1039533625596,0.0116860308990132,-0.126857983121666,-0.0810487419975344,6.72516742448924e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39600,-0.0941505787587417,0.0105982646567351,-0.114923177485943,-0.0733779800315409,7.47989273745253e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41783,-0.046708169851341,0.00526422219102374,-0.0570260453457476,-0.0363902943569345,8.04561244483524e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,41888,-0.0184439532825561,0.00208140165315088,-0.0225235005227318,-0.0143644060423803,8.90233548332662e-19
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,41765,-0.0260970938111051,0.00295281376650327,-0.0318846087934515,-0.0203095788287587,1.09648242661726e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39308,-0.0643932335071345,0.00728361334116257,-0.0786691156558131,-0.0501173513584558,1.09889988152283e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41465,-0.0597044450104091,0.00675919170230448,-0.0729524607469259,-0.0464564292738924,1.14915952087474e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39427,-0.0508281593746037,0.00575270524214739,-0.0621034616492126,-0.0395528570999949,1.1501861698233e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,41758,-0.0361392695222854,0.00409768840208735,-0.0441707387903766,-0.0281078002541942,1.29380410735729e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41466,-0.0317498701237714,0.00360006074415213,-0.0388059891823096,-0.0246937510652332,1.29918886121213e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39600,-0.0481311415386151,0.00546209806619102,-0.0588368537483495,-0.0374254293288807,1.41590149865394e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,41865,-0.0550046907236346,0.00624830939863568,-0.0672513771449605,-0.0427580043023087,1.49361037086783e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,41740,-0.075424183517529,0.00858308972072281,-0.0922470393701458,-0.0586013276649123,1.71670329418651e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39192,-0.0495070726189487,0.00564125762455732,-0.0605639375630811,-0.0384502076748164,1.95604035231285e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39334,-0.0456157135436876,0.00520372682253617,-0.0558150181158585,-0.0354164089715167,2.13090979133031e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39589,-0.0454548804061777,0.00519264176204305,-0.055632458259782,-0.0352773025525733,2.36626366626444e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41466,-0.073386722665878,0.00839965578268517,-0.0898500479999409,-0.056923397331815,2.69051632920696e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,41740,-0.0964953687331805,0.0110634855085539,-0.118179800329946,-0.0748109371364148,3.05977605205734e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39334,-0.0743647252595227,0.00854828731569371,-0.0911193683982824,-0.0576100821207631,3.82445517196534e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,41736,-0.0248000684833052,0.00285364041495949,-0.0303932036966258,-0.0192069332699846,4.02580244945837e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,39625,-0.0352793048673196,0.0040712187672214,-0.0432588936510735,-0.0272997160835656,5.12106052708061e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,41877,-0.0240182112030737,0.00277611980825014,-0.029459406027244,-0.0185770163789034,5.65087848993381e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,41758,-0.0583012019236756,0.00673872413641297,-0.0715091012310451,-0.0450933026163062,5.65895247264759e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,41765,-0.0354466386857889,0.00411176790044828,-0.0435057037706676,-0.0273875736009103,7.4032142384798e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39308,-0.0677400135083561,0.00786760365391227,-0.0831605166700242,-0.0523195103466881,8.33036967273571e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39413,-0.0419876392492651,0.00487925224075693,-0.0515509736411487,-0.0324243048573815,8.66175379825101e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39589,-0.104087980610593,0.0120989304434208,-0.127801884279698,-0.0803740769414886,8.81546953102782e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39408,-0.0495803109422272,0.00576524765871911,-0.0608801963533167,-0.0382804255311378,9.08349468734468e-18
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,41689,-0.0505945582676395,0.00589497922569454,-0.0621487175500008,-0.0390403989852782,1.03081202941298e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,41836,-0.0508336309095543,0.00592672408898928,-0.0624500101239733,-0.0392172516951353,1.0809805908061e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39408,-0.0477173858672432,0.0055628780950105,-0.0586206269334638,-0.0368141448010226,1.09891697688014e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,41836,-0.029259919830019,0.00341276962800704,-0.0359489483009128,-0.0225708913591252,1.11284383057085e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,39625,-0.0681289712222942,0.00794742773765138,-0.0837059295880909,-0.0525520128564975,1.148144143499e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,41877,0.0420416319315665,0.0049112258446342,0.0324156292760835,0.0516676345870496,1.24832494092025e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41534,-0.0777795223276688,0.00909868657072556,-0.0956129480062909,-0.0599460966490467,1.38670352944018e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41689,-0.0758785248362682,0.00888754978469032,-0.0932981224142612,-0.0584589272582752,1.52010602911478e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39427,-0.0487229976742487,0.00571540116287049,-0.0599251839534749,-0.0375208113950226,1.73318356952929e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,41702,-0.0382162990051442,0.00448573640685143,-0.047008342362573,-0.0294242556477154,1.77587327189755e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41465,-0.0480944098045027,0.00564664375734275,-0.0591618315688945,-0.0370269880401109,1.81269457654441e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39408,-0.0370536151728124,0.00434934288237602,-0.0455783272222694,-0.0285289031233554,1.8173345764134e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39600,-0.0700554352172789,0.0082464281798146,-0.0862184344497155,-0.0538924359848423,2.2294332673686e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,41718,-0.075051525924063,0.0088377335996725,-0.0923734837794211,-0.0577295680687049,2.24478182843673e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39328,-0.0439859684017054,0.00517879808206215,-0.0541364126425472,-0.0338355241608635,2.27047094164255e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39600,-0.0501774551975489,0.00591254105684662,-0.0617660356689683,-0.0385888747261296,2.40018176789483e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,41740,-0.0656359349656668,0.00773671244583036,-0.0807998913594943,-0.0504719785718393,2.41309496346643e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41636,-0.0473371422905112,0.00559194145417482,-0.0582973475406939,-0.0363769370403286,2.82742268346784e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,41862,-0.025627956860186,0.00302801105793691,-0.0315628585337424,-0.0196930551866297,2.86176803709203e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39625,-0.0653013052870171,0.00771756330241787,-0.0804277293597561,-0.050174881214278,2.97584342511289e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41689,-0.0477604192522761,0.00565412386144355,-0.0588425020207055,-0.0366783364838468,3.30164402923604e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,39650,-0.0243386720129753,0.00288600257112073,-0.0299952370523719,-0.0186821069735786,3.77650867115068e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,41679,-0.0496560783958595,0.00589102567010411,-0.0612024887092636,-0.0381096680824555,3.84501517888488e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39334,-0.0619151388058299,0.00734395257585758,-0.0763092858545107,-0.047520991757149,3.87361940770634e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,39598,-0.0613926741516616,0.0072854044129685,-0.0756720668010799,-0.0471132815022433,3.99458265810296e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41577,-0.0314066932735243,0.00373003623550175,-0.0387175642951077,-0.0240958222519408,4.15941671045853e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39271,-0.0457528741541944,0.00543608795398197,-0.056407606543999,-0.0350981417643897,4.37471984182825e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41466,-0.0524451917673418,0.00623575614007119,-0.0646672738018814,-0.0402231097328023,4.51411580593022e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41829,-0.0913863154160287,0.0108694335484799,-0.112690405171049,-0.0700822256610081,4.60825541855215e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,41802,-0.0479041147213024,0.0057016833237906,-0.059079414035932,-0.0367288154066729,4.84522728725578e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39328,-0.0624618860669037,0.00743465487922399,-0.0770338096301827,-0.0478899625036246,4.96652137793722e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39633,-0.0490273911405839,0.00583839779136802,-0.0604706508116652,-0.0375841314695026,5.12268377341319e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41636,-0.0411728376762788,0.0049063872017548,-0.0507893565917182,-0.0315563187608394,5.28285290906643e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,41765,-0.0302496662505143,0.00361517284845322,-0.0373354050334826,-0.023163927467546,6.47886685361018e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39408,-0.0685355273419032,0.00819202527416384,-0.0845918968792644,-0.0524791578045421,6.68687467723885e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,41805,-0.0346984365343024,0.00414964556300453,-0.0428317418377912,-0.0265651312308135,6.79239304052155e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41636,-0.0380809861709233,0.00455841526123636,-0.0470154800829466,-0.0291464922589,7.26204847960478e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,41786,0.039431496313231,0.00472207976920315,0.0301762199655928,0.0486867726608691,7.47411354735589e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,41737,-0.0358627232615822,0.00429547855096826,-0.04428186122148,-0.0274435853016844,7.57204186001993e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,41865,-0.0845873167531408,0.0101337612815298,-0.104449488864939,-0.0647251446413423,7.6850178461265e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41465,-0.0665449744781741,0.00797297357944398,-0.0821720026938843,-0.0509179462624639,7.75696404556667e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41689,-0.0175712419375473,0.00210645779178995,-0.0216998992094556,-0.013442584665639,8.05744048458348e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39580,-0.0509647208802256,0.00611462857993419,-0.0629493928968966,-0.0389800488635545,8.68159073972824e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41802,-0.0328652884853548,0.0039473758421273,-0.0406021451359243,-0.0251284318347853,9.19056973279772e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,41875,-0.0718966233440916,0.00863823599880799,-0.0888275659017553,-0.0549656807864279,9.4036056380211e-17
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41534,-0.0525510618879452,0.00631975698989548,-0.0649377855881403,-0.04016433818775,1.00562554598425e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41465,-0.0726850482271751,0.00874112155851984,-0.089817646481874,-0.0555524499724762,1.00665102839906e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39489,-0.0532013211383291,0.00640158722448519,-0.0657484320983201,-0.0406542101783382,1.06484621820659e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,41689,-0.0282529468702702,0.00340902437468872,-0.0349346346446601,-0.0215712590958803,1.26643191255512e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41617,-0.0553281353629499,0.00667760358053065,-0.0684162383807899,-0.0422400323451098,1.2891451993599e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39598,-0.0562213844717254,0.00678719043121021,-0.0695242777168974,-0.0429184912265534,1.33521150407665e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39598,-0.0298196052571265,0.00360237396004297,-0.0368802582188107,-0.0227589522954423,1.4001448619425e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41689,-0.0509522915609172,0.00615800342617462,-0.0630219782762195,-0.0388826048456149,1.41805188011632e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41689,0.0356953290545723,0.00432157844081183,0.0272250353105812,0.0441656227985635,1.59860057321382e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39600,-0.0356569121007526,0.00431908949206866,-0.0441223275052071,-0.027191496696298,1.68335867868194e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,41805,-0.0260544561838516,0.00316158057611766,-0.0322511541130422,-0.019857758254661,1.86843515418465e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39650,-0.0220921613208024,0.00268294458604665,-0.0273507327094539,-0.016833589932151,2.00938530587675e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39625,-0.051890322397659,0.00630422078574909,-0.0642465951377272,-0.0395340496575908,2.06485503345396e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,41728,-0.0556231054962874,0.0067778691916564,-0.0689077291119339,-0.0423384818806408,2.48673332127851e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39600,-0.0750913032329051,0.00915493539057058,-0.0930349765984234,-0.0571476298673868,2.62118812711719e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,41740,-0.0511678314212889,0.00625769010795559,-0.0634329040328819,-0.038902758809696,3.18086809379975e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41455,-0.0338764356056742,0.0041503846078187,-0.0420111894369988,-0.0257416817743495,3.59331195776165e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41689,-0.046384055849444,0.00568350276502334,-0.0575237212688897,-0.0352443904299982,3.61929026177363e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39612,0.042694025764498,0.0052340750808663,0.0324352386060001,0.052952812922996,3.80940312784862e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,39625,-0.0396382818974301,0.00486085349829095,-0.0491655547540804,-0.0301110090407799,3.88312225754798e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,39598,-0.0331892024570353,0.00410105280811125,-0.0412272659609334,-0.0251511389531373,6.44192892115093e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39259,-0.0347967651140676,0.00430646203936142,-0.043237430711216,-0.0263560995169192,7.16894848745746e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39408,-0.058163945687961,0.0072006428221455,-0.0722772056193662,-0.0440506857565558,7.30761218607638e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,41877,-0.0468369188296396,0.00580981033446482,-0.0582241470851907,-0.0354496905740886,8.1649178858609e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41508,-0.0341387988915038,0.00423619970604468,-0.0424417503153513,-0.0258358474676562,8.37727290212308e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41509,-0.0404558552444804,0.00502052248219127,-0.0502960793095753,-0.0306156311793855,8.42713279605313e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,41840,-0.0500740404292467,0.00621864090927647,-0.0622625766114285,-0.0378855042470648,8.81934891542581e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41689,0.0363597958425462,0.00451655104827129,0.0275073557879344,0.0452122358971579,8.96527993967815e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39408,-0.0460707396852128,0.00572560207041739,-0.0572929197432309,-0.0348485596271947,9.41551806947947e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,41765,-0.0525328550665949,0.00653594196637001,-0.0653433013206801,-0.0397224088125097,9.94405615320622e-16
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,41689,-0.0872282289416041,0.0108618495733661,-0.108517454105402,-0.0659390037778064,1.05162613245369e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,41865,-0.0319307927833887,0.00397663694417117,-0.0397250011939642,-0.0241365843728132,1.0599101415694e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,41744,-0.0233155737550144,0.00290553530903774,-0.0290104229607283,-0.0176207245493004,1.10512369337918e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,41791,0.0221411481432325,0.00276672320389894,0.0167183706635905,0.0275639256228744,1.31884629692618e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,41758,-0.0493486814649599,0.00617218005838821,-0.0614461543794008,-0.037251208550519,1.39949985793935e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,41925,0.0271122972679381,0.0033914915567082,0.02046497381679,0.0337596207190861,1.41092599258808e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,41862,-0.0435818340473984,0.00545522681880737,-0.0542740786122608,-0.0328895894825359,1.4720404000359e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,41707,-0.0170409733870764,0.0021334950097336,-0.0212226236061543,-0.0128593231679986,1.49321021471278e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41465,-0.0483817169471374,0.00606095602812144,-0.0602611907622554,-0.0365022431320194,1.55484270519506e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39308,-0.0445154220546798,0.00557591003916639,-0.0554442057314459,-0.0335866383779137,1.56762410777225e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39600,-0.0915601914860948,0.0114841868268073,-0.114069197666637,-0.0690511853055526,1.70577054080507e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39090,-0.041930133147047,0.00526314554731235,-0.0522458984197793,-0.0316143678743148,1.79793509833017e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,41865,-0.0545195466085695,0.00686669670214628,-0.0679782721447762,-0.0410608210723627,2.18886704343607e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,41911,-0.079781959115911,0.010054635644058,-0.0994890449782648,-0.0600748732535573,2.27531178000105e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,41758,-0.0208294739056087,0.00263803941754103,-0.0260000311639892,-0.0156589166472283,3.11184607927259e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41466,-0.0303305634170539,0.00384722530280282,-0.0378711250105475,-0.0227900018235604,3.43201998211461e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,41745,-0.0370167744384709,0.00470445580972289,-0.0462375078255277,-0.027796041051414,3.87030127019197e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,41765,-0.0725745724314193,0.00922601960175688,-0.0906575708508628,-0.0544915740119759,3.93682002715826e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,41805,-0.0207159328093842,0.00263701462470771,-0.0258844814738113,-0.0155473841449571,4.27727439902635e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39633,-0.03286906957094,0.00418371469609456,-0.0410691503752853,-0.0246689887665947,4.31922164515525e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41786,-0.0705813715814008,0.00900357989727267,-0.0882283881800552,-0.0529343549827463,4.87880771813393e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41540,-0.0695002923958063,0.00887005352791042,-0.0868855973105107,-0.0521149874811019,5.03777842490498e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,41764,-0.0517501084748302,0.00660580037773178,-0.0646974772151844,-0.0388027397344759,5.08528302447315e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,41810,-0.0377690025359369,0.00482357325024743,-0.0472232061064219,-0.028314798965452,5.24563906685828e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41689,-0.113788649696218,0.0145346687092673,-0.142276600366382,-0.0853006990260545,5.30402376514973e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,39589,-0.0304490291765952,0.00389564254467043,-0.0380844885641493,-0.0228135697890412,5.94222923366342e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41836,0.0356255303923349,0.00456487397189259,0.0266783774074254,0.0445726833772443,6.43209112337808e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41534,-0.039147061412497,0.00501608504323113,-0.04897858809723,-0.029315534727764,6.44131987710561e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41466,-0.035636757937049,0.00456942336313013,-0.0445928277287841,-0.0266806881453139,6.72128370387671e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,41774,-0.027094401220402,0.00347428783982272,-0.0339040053864545,-0.0202847970543495,6.73161845411745e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39625,-0.0890481564946773,0.0114183673403299,-0.111428156481724,-0.0666681565076308,6.81984275756813e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,39589,-0.0183615771352837,0.00235640438039599,-0.0229801297208599,-0.0137430245497076,7.17872027246355e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,41765,-0.0634557189812784,0.00814672674170402,-0.0794233033950182,-0.0474881345675385,7.25206314180566e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,41764,-0.024424586201257,0.00313649420207681,-0.0305721148373276,-0.0182770575651865,7.36034860934624e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39600,-0.0848520262447966,0.0109005440284442,-0.106217092540547,-0.0634869599490459,7.64453324170325e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,39574,-0.0601412023458329,0.00773347610620628,-0.0752988155139973,-0.0449835891776686,8.10824095090653e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41740,-0.0507375518162105,0.0065293499293107,-0.0635350776776595,-0.0379400259547616,8.38402148460489e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,39615,-0.0364320440501457,0.00468851003529877,-0.0456215237193313,-0.0272425643809602,8.51293776228194e-15
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41689,-0.0372790339510222,0.00481196037363684,-0.0467104762833504,-0.027847591618694,1.00870056406309e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,39600,-0.0877720417268317,0.0113400068239726,-0.109998455101818,-0.0655456283518454,1.08096035866902e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,41802,0.0227766172068829,0.00294509939791903,0.0170042223869616,0.0285490120268042,1.11984642193053e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,41819,0.0239193402499244,0.00309306837983545,0.017856926225447,0.0299817542744019,1.12437166521815e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41689,-0.0363983167095062,0.00470977026809191,-0.0456294664349664,-0.0271671669840461,1.16956026345006e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39328,-0.037436572923187,0.00484829663600684,-0.0469392343297604,-0.0279339115166136,1.25112913711942e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39600,0.0365585527934121,0.00473688113899062,0.0272742657609905,0.0458428398258337,1.28547278456436e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41465,-0.0369757618660022,0.00480554650240606,-0.0463946330107181,-0.0275568907212863,1.52504032468165e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41465,-0.0631134405336062,0.00820253058103623,-0.0791904004724373,-0.0470364805947752,1.52511382876664e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39600,-0.0597018272961524,0.00776341149669976,-0.0749181138296839,-0.0444855407626208,1.59494956939126e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,41819,-0.0262564264606536,0.00341622983612117,-0.0329522369394511,-0.0195606159818561,1.62756230836411e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39589,-0.0589475694083791,0.00766867718876688,-0.0739781766983622,-0.043916962118396,1.63723554883489e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41454,-0.032328462702444,0.00421711018183972,-0.0405939986588499,-0.0240629267460382,1.90129172372537e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,41765,0.0414276832065531,0.00540422869487423,0.0308353949645996,0.0520199714485066,1.90162223606003e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,41865,-0.0376800474696715,0.00492397756291083,-0.0473310434929767,-0.0280290514463663,2.10918564661736e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39598,-0.0885497496981745,0.0115691253095408,-0.111225235304874,-0.0658742640914746,2.11175145184704e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,41765,-0.0885582595384722,0.0115822307139715,-0.111259431737856,-0.065857087339088,2.21596834596774e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41534,-0.0441951612399366,0.00578362449415516,-0.0555310652484807,-0.0328592572313925,2.29924840237821e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,41728,-0.0277875443552139,0.00363958939115554,-0.0349211395618788,-0.0206539491485491,2.4177044079641e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41521,-0.0590539173091929,0.00773961775174721,-0.0742235681026174,-0.0438842665157683,2.51015450561619e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39600,-0.0536293620215755,0.00703234252241064,-0.0674127533655003,-0.0398459706776506,2.61905046489974e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39297,-0.045935581654091,0.00602987926037075,-0.0577541450044176,-0.0341170183037643,2.79418747967361e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,41740,-0.069129491975317,0.00907729398794649,-0.0869209881916921,-0.0513379957589419,2.80267749762721e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,41740,-0.0700554338202236,0.0092072315037987,-0.0881016075676691,-0.0520092600727782,2.95593505035466e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41521,-0.0303876800493671,0.00399543598881061,-0.0382187345874359,-0.0225566255112983,3.03169545346873e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41521,-0.0283199523571137,0.00372653173877301,-0.0356239545651088,-0.0210159501491186,3.17621093154432e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,41694,-0.0311599255547078,0.00410057762882477,-0.0391970577072043,-0.0231227934022112,3.18897995212881e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41534,-0.0564597868147004,0.00743736286856323,-0.0710370180370843,-0.0418825555923165,3.3820310771388e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39427,-0.0458661192018468,0.00604733612467369,-0.0577188980062072,-0.0340133403974864,3.6108023303261e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,41758,-0.0400277407008707,0.00528715302832384,-0.0503905606363854,-0.029664920765356,3.95741039482154e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39650,0.019643596038761,0.00259945500362971,0.0145486642316467,0.0247385278458752,4.45718039831193e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,41740,-0.0698210540232851,0.0092423162456313,-0.0879359938647225,-0.0517061141818478,4.48243731604191e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,41819,-0.0205695675540022,0.00272343222850694,-0.0259074947218758,-0.0152316403861286,4.538917143518e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,41865,-0.0182029882577111,0.00241221352430223,-0.0229309267653434,-0.0134750497500787,4.77401153312879e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39600,-0.0620826732965336,0.00822835016780894,-0.0782102396254391,-0.0459551069676281,4.88085240890425e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39600,-0.0393066321064378,0.0052101446216709,-0.0495185155649128,-0.0290947486479629,4.90784446516872e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41847,-0.0243149024251197,0.00323080589691994,-0.0306472819830828,-0.0179825228671567,5.57107796133261e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,41765,-0.0346540156632926,0.00460549400236437,-0.0436807839079268,-0.0256272474186585,5.6356419667101e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41465,-0.0459190065338995,0.00610611052867815,-0.0578869831701087,-0.0339510298976904,5.83278223693401e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39600,-0.0324168020279393,0.00431329302264207,-0.0408708563523177,-0.0239627477035608,6.10704530902152e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,41869,-0.0450649453348696,0.00600498276796564,-0.0568347115600823,-0.033295179109657,6.5541469928204e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,41911,-0.0269988303629624,0.00359917014334554,-0.0340532038439196,-0.0199444568820051,6.71355944424968e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,41758,-0.024034097215483,0.00321311352409416,-0.0303317997227075,-0.0177363947082584,7.90287064648775e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39308,-0.0815468913259996,0.0109027013231988,-0.102916185919469,-0.06017759673253,8.04409512006262e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,41862,-0.0441612428740022,0.00591490323514873,-0.0557544532148937,-0.0325680325331107,8.77596006904805e-14
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41836,-0.0338687896898562,0.00454687106386905,-0.0427806569750396,-0.0249569224046729,1.00014253980894e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39334,-0.0255057597820939,0.00342871892261084,-0.0322260488704111,-0.0187854706937766,1.09317312547708e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41802,-0.074940569451925,0.0100912639528849,-0.0947194467995794,-0.0551616921042707,1.1854072486322e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41740,-0.0480280042467939,0.00647951322113323,-0.060727850160215,-0.0353281583333727,1.31730536789702e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,39589,-0.0660596848553105,0.00891241941837305,-0.0835280269153217,-0.0485913427952993,1.33457167071205e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41667,-0.0593295277378727,0.00803674632615576,-0.075081550537138,-0.0435775049386074,1.65011222662418e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,41791,0.0303630865989411,0.00411778713031536,0.022292223823523,0.0384339493743591,1.75928210313081e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39408,-0.0460610050348761,0.00624700310373837,-0.0583051311182033,-0.0338168789515489,1.78641492552499e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39308,0.0442361782134215,0.00600097730537239,0.0324742626948917,0.0559980937319514,1.81178222028503e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41764,0.0257036647180015,0.00348888564471882,0.0188654488543526,0.0325418805816504,1.84486497626774e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,41693,-0.0346035634493447,0.00469838666130969,-0.0438124013055117,-0.0253947255931777,1.87755880551914e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,39600,-0.0464306347740087,0.00630513483892398,-0.0587886990582997,-0.0340725704897177,1.91325695323162e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,41636,-0.047409812498667,0.0064415515413474,-0.0600352535197079,-0.0347843714776261,1.94928114018628e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,41758,-0.0435826711169201,0.00592182856446117,-0.055189455103264,-0.0319758871305762,1.95310064406247e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39334,-0.0363996016993928,0.00494514220065057,-0.0460920804126679,-0.0267071229861176,1.96369954982713e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39598,-0.0533411845855689,0.00724747983420763,-0.0675462450606158,-0.0391361241105219,1.97086519379793e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,41840,-0.056901880108776,0.00773463348382118,-0.0720617617370655,-0.0417419984804865,1.99509147574343e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,41769,-0.0485561949991291,0.00660208070975662,-0.0614962731902521,-0.0356161168080062,2.02696303290877e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39308,-0.0401078010506498,0.0054639762879602,-0.0508171945750518,-0.0293984075262478,2.28398444351865e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39297,-0.0615577862549983,0.00838712057254117,-0.077996542577179,-0.0451190299328176,2.29852543944859e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41465,-0.076676781090771,0.0104511604427453,-0.0971610555585519,-0.0561925066229902,2.32089003088425e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39334,-0.075677274738728,0.010317152385445,-0.0958988934142002,-0.0554556560632557,2.37555898062627e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39617,-0.0305944904217512,0.0041720366255208,-0.038771682207772,-0.0224172986357304,2.40443797610571e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39334,-0.0290924289577603,0.00396976268226549,-0.0368731638150007,-0.0213116941005199,2.49466139868459e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,41765,-0.027369386765428,0.00374825586457534,-0.0347159682599957,-0.0200228052708604,3.00028880871824e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39308,-0.0361517638130738,0.00495391100005502,-0.0458614293731817,-0.026442098252966,3.13654021054505e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,41866,-0.0390733600546232,0.00535688507087491,-0.0495728547935381,-0.0285738653157084,3.17850642062895e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,39633,0.0395072521661125,0.00542141989167011,0.0288812691784391,0.0501332351537859,3.37950138239884e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39600,-0.0595809635692291,0.00818870802292414,-0.0756308312941604,-0.0435310958442978,3.67303163253766e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39600,-0.0514757130597044,0.00707705078748543,-0.0653467326031758,-0.0376046935162329,3.73804271945398e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41911,-0.0753523317561049,0.0103747811087991,-0.0956869027293512,-0.0550177607828586,3.99554713555683e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,41766,-0.0435438868250489,0.00599799546381981,-0.0552999579341357,-0.0317878157159621,4.0959362793553e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,41925,0.0193643215064319,0.00267064079838376,0.0141298655415997,0.024598777471264,4.37115880739659e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39308,-0.0477885212490293,0.00659102168522652,-0.0607069237520733,-0.0348701187459853,4.43736560537385e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39598,-0.0691150452483539,0.00953489712697817,-0.0878034436172311,-0.0504266468794767,4.49210568845475e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,39598,-0.0835148687621073,0.0115239099242747,-0.106101732213686,-0.0609280053105289,4.54341244029651e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,41769,-0.0357537719758051,0.00493882533978509,-0.0454338696417839,-0.0260736743098264,4.75922277947711e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41636,-0.0728546527696156,0.0100677574229805,-0.0925874573186573,-0.0531218482205739,4.86409368886742e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41584,-0.0367590935095501,0.00508325406044058,-0.0467222714680136,-0.0267959155510866,5.04782184232288e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,41865,-0.0265718632704748,0.00367917044950492,-0.0337830373515045,-0.0193606891894452,5.39251126714487e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,41721,-0.0187466925619528,0.00259612610445813,-0.0238350997266908,-0.0136582853972149,5.44399409604394e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41465,-0.0736626066929375,0.010201543517497,-0.0936576319872317,-0.0536675813986433,5.46153663286325e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39308,-0.0394084484750388,0.0054597288710175,-0.0501095170622331,-0.0287073798878445,5.63237307393097e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39328,-0.0512559179779938,0.00710121750217724,-0.0651743042822612,-0.0373375316737264,5.6365229266518e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39336,-0.0209775831880084,0.0029071316014956,-0.0266755611269398,-0.015279605249077,5.71937451562169e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,41636,-0.0510442401349855,0.0070756675481188,-0.0649125485292983,-0.0371759317406726,5.7311370589822e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,41802,-0.0423645071636943,0.00587536683453932,-0.0538802261593913,-0.0308487881679972,5.87684185956435e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41534,-0.0336005556022013,0.00466431701311701,-0.0427426169479106,-0.024458494256492,6.18244548566862e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41383,-0.0826648299093883,0.0114827442045371,-0.105171008550281,-0.0601586512684956,6.40238080911914e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41376,-0.0764480089985056,0.0106224201150179,-0.0972679524239407,-0.0556280655730706,6.50597792416417e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39625,-0.019420201862694,0.00270355509345454,-0.0247191698458649,-0.0141212338795231,7.24853933898854e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39600,-0.0376086772772492,0.00523601728099048,-0.0478712711479905,-0.0273460834065079,7.27715007233997e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39476,-0.0427230069266879,0.00596599278187256,-0.0544163527791581,-0.0310296610742177,8.52083380716198e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39600,-0.0574205670953536,0.00801900506906349,-0.073137817030718,-0.0417033171599892,8.54762990994685e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39250,-0.0372253766788811,0.00520002044757927,-0.0474174167561364,-0.0270333366016257,8.68152300268319e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39600,-0.050301281496685,0.00703298103335595,-0.0640859243220627,-0.0365166386713074,9.08233173065656e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39308,-0.0401190926907593,0.00561204047957721,-0.0511186920307306,-0.029119493350788,9.32772084573349e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,41740,-0.0250782053909007,0.00350935102485759,-0.0319565333996216,-0.0181998773821798,9.3981689726358e-13
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,41633,0.037304928944921,0.00523446386734358,0.0270453797649276,0.0475644781249144,1.08142295479435e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39622,0.0112134158358316,0.00157485693249622,0.00812669624813898,0.0143001354235242,1.14417108435233e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,41765,0.0296741152760483,0.00416989373880517,0.0215011235479902,0.0378471070041064,1.16622923045855e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,41740,0.0256172932628449,0.00360343695747604,0.0185545568261919,0.032680029699498,1.22812232602799e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39625,-0.0621526352488268,0.00874347599978897,-0.0792898482084132,-0.0450154222892404,1.2460112222524e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39625,-0.0572194649739312,0.00805257605808044,-0.0730025140477688,-0.0414364159000935,1.27072544034787e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39485,-0.0832273174738135,0.0117146676790465,-0.106188066124745,-0.0602665688228823,1.28270046312252e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41758,-0.0349043183957324,0.00492286450431356,-0.0445531328241869,-0.0252555039672778,1.40707871334516e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,39580,-0.0487530855806046,0.00687626135827633,-0.0622305578428262,-0.035275613318383,1.42292899572106e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41383,-0.0566865637162766,0.00799833021370389,-0.0723632909351362,-0.0410098364974169,1.43932173022955e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41422,-0.0528878001457489,0.00747440195133909,-0.0675376279703735,-0.0382379723211243,1.56249483815969e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,41786,-0.03924059925755,0.00554589689914827,-0.0501105571798806,-0.0283706413352194,1.56309706390915e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39308,-0.0235031982256827,0.00332177078394341,-0.0300138689622118,-0.0169925274891536,1.58217823689769e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,41805,-0.078091175522733,0.011042633772154,-0.0997347377161547,-0.0564476133293112,1.60646834009906e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41911,-0.0291279700733689,0.00411942434299777,-0.0372020417856445,-0.0210538983610933,1.61631525122624e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,41925,0.0212715905867224,0.00300885231459049,0.015374240050125,0.0271689411233197,1.63038609035578e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39308,-0.0239618133371367,0.00338888010490165,-0.0306040183427439,-0.0173196083315294,1.63745198245389e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,41911,-0.0567213479600236,0.00803016644291303,-0.0724604741881331,-0.0409822217319141,1.70386516342406e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39408,-0.0287859732631766,0.0040755982846384,-0.0367741459010678,-0.0207978006252853,1.72957794374379e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,41765,-0.0278281719278552,0.00394215922665002,-0.0355548040120892,-0.0201015398436211,1.75960125275634e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41465,-0.047336198061266,0.00671581737836791,-0.0604992001228671,-0.0341731959996648,1.90131004065847e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41560,-0.0179695917027452,0.00255147674229943,-0.0229704861176521,-0.0129686972878383,1.97894162940881e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,41692,0.0260970396992653,0.0037086894794883,0.0188280083194683,0.0333660710790624,2.06601469739597e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41689,-0.0209601613506419,0.00298701231299168,-0.0268147054841056,-0.0151056172171782,2.3767306340439e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41636,-0.0415219098835123,0.0059201160310858,-0.0531253373044405,-0.0299184824625841,2.43549797892099e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41521,0.0164417559785818,0.00234528790700122,0.0118449916808594,0.0210385202763042,2.49181442080482e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,41889,0.0401251199755741,0.00572574631249435,0.0289026572030851,0.051347582748063,2.53692632007214e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41465,-0.0727839916983593,0.0103911635105587,-0.0931506721790543,-0.0524173112176643,2.60361983566326e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,41689,-0.0260769637028864,0.00372477372866386,-0.0333775202110675,-0.0187764071947052,2.66628087645728e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41689,-0.0576420525095292,0.00824056948840361,-0.0737935687068003,-0.0414905363122581,2.78328111905659e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39433,-0.0182088627737048,0.00260344555630562,-0.0233116160640638,-0.0131061094833458,2.82627923129313e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39598,-0.0329447125175757,0.00471436743969598,-0.0421848726993798,-0.0237045523357716,2.94647181387244e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39408,-0.0493589549524054,0.00706727332610003,-0.0632108106715614,-0.0355070992332493,3.03409235162108e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39328,-0.0540923475315512,0.00774512028892843,-0.0692727832978509,-0.0389119117652515,3.0375983819874e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39334,-0.0708268050169873,0.0101421783189137,-0.0907054745220582,-0.0509481355119164,3.05181969920531e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,41740,-0.0297826323822378,0.00426727003831816,-0.0381464816573414,-0.0214187831071342,3.10849716951428e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,39621,0.0262233580518472,0.0037606789032633,0.0188524274014511,0.0335942887022433,3.27919717259261e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39406,-0.0490136938525995,0.00703323252743081,-0.0627988296063639,-0.0352285580988351,3.38106850470628e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39334,-0.0330146299472882,0.00474249526509767,-0.0423099206668797,-0.0237193392276968,3.56466890427012e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39373,-0.0481744911661913,0.00692069876758918,-0.0617390607506661,-0.0346099215817165,3.57701871702785e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,41740,0.0388576231295725,0.00558358656031186,0.0279137934713613,0.0498014527877837,3.58292663547211e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,41805,-0.0632698083298963,0.00909580858584316,-0.0810975931581489,-0.0454420235016437,3.66740959420234e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,39596,-0.0188540696242706,0.00271093718251265,-0.0241675065019954,-0.0135406327465458,3.73061282323824e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39250,-0.0569946424104019,0.00820198947860891,-0.0730705417884754,-0.0409187430323285,3.89719813848054e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,41740,-0.0451336768063882,0.00650360284749572,-0.0578807383874798,-0.0323866152252966,4.11083430297472e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,39589,-0.0243983976310909,0.00351957813105493,-0.0312967707679585,-0.0175000244942232,4.37593707243158e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,41708,-0.0613739363555242,0.00886105751409282,-0.0787416090831462,-0.0440062636279023,4.52289634834665e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,39600,-0.0499923287140616,0.00721664821089774,-0.0641369592074211,-0.035847698220702,4.52708145562995e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,41740,-0.0832961861681629,0.0120272332636061,-0.106869563364831,-0.0597228089714949,4.54225840749835e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39650,-0.0229126833417446,0.00330788731191696,-0.0293961424731018,-0.0164292242103874,4.5476513557208e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39250,-0.0462864178073744,0.00668208297258215,-0.0593833004336354,-0.0331895351811134,4.54846269955376e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39600,-0.077980561682379,0.0113068367643292,-0.100141961740464,-0.0558191616242938,5.61199300923769e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41452,-0.0431744348292997,0.00626371335168297,-0.0554513129985983,-0.030897556660001,5.72643970995364e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,41765,0.0514866676921425,0.00750881700215902,0.0367693863679108,0.0662039490163742,7.35470731022755e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,39600,0.0355315069659514,0.00518398116229219,0.0253709038878587,0.0456921100440441,7.56048125905371e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41679,-0.0344334881920933,0.00502666411814466,-0.0442857498636568,-0.0245812265205297,7.70636896979139e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39600,-0.045396758430126,0.00663770429360032,-0.0584066588455826,-0.0323868580146694,8.38459349015168e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41521,-0.0413195124955703,0.00605188963953511,-0.0531812161890591,-0.0294578088020815,9.02447463115976e-12
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41467,-0.0324492490616787,0.00476332328460338,-0.0417853626995013,-0.023113135423856,1.00314695115599e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39408,-0.0248100783601543,0.00364673438148189,-0.0319576777478588,-0.0176624789724498,1.07605268662437e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,41740,-0.026333605991775,0.00387266059816459,-0.0339240207641776,-0.0187431912193724,1.09236992269465e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39589,-0.0622008355695235,0.00914688467633291,-0.0801287295351359,-0.044272941603911,1.09879802796593e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39589,-0.0514919618903058,0.00757530290183045,-0.0663395555778935,-0.0366443682027181,1.1208399435931e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,41636,0.0240841675627433,0.00354494915105949,0.0171360672266667,0.0310322678988199,1.13851438985267e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,41877,-0.0281043630324997,0.00414934732411995,-0.0362370837877748,-0.0199716422772246,1.3126809297254e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39600,-0.0549464785951774,0.00811585711272125,-0.0708535585361111,-0.0390393986542438,1.35096677643443e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39598,-0.0598029088728589,0.00884741058716577,-0.0771438336237038,-0.042461984122014,1.45609160580397e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39625,-0.0195407578498079,0.00289410270198694,-0.0252131991457023,-0.0138683165539135,1.5323201989339e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39308,-0.0302901425417153,0.00449179758038723,-0.0390940657992743,-0.0214862192841564,1.62655976204561e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41466,-0.0394513491018646,0.00585254728779484,-0.0509223417859425,-0.0279803564177868,1.6413988648778e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39427,-0.0755525711015779,0.0112093019666214,-0.0975228029561558,-0.053582339247,1.66248568375313e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41689,-0.0382661810002862,0.00568660972355321,-0.0494119360584505,-0.0271204259421219,1.77732813904005e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,41740,-0.0522823687952856,0.00777803766911041,-0.067527322626742,-0.0370374149638292,1.86910314705018e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39598,-0.0595743539822671,0.00886252449228713,-0.0769449019871499,-0.0422038059773843,1.88052509843274e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39600,-0.0579876304274778,0.00862720404755953,-0.0748969503606944,-0.0410783104942611,1.8878055292003e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39165,-0.0504436767883425,0.00750657433271954,-0.0651565624804728,-0.0357307910962122,1.91173396013318e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,41805,-0.0895104124772935,0.0133244523335267,-0.115626339051006,-0.0633944859035812,1.92106960660207e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,41925,-0.0195972419529791,0.00292044097491921,-0.0253213062638207,-0.0138731776421374,2.0197767756079e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39427,-0.0916314164396065,0.0137027630279836,-0.118488831974454,-0.0647740009047586,2.38889299636845e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39598,-0.0487357913823685,0.0073124512334883,-0.0630681958000056,-0.0344033869647314,2.77763939778819e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39600,0.0267467758219792,0.0040229619801435,0.018861770340898,0.0346317813030605,3.10059270011521e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39250,-0.0254440320487135,0.00382946772591714,-0.0329497887915111,-0.0179382753059159,3.19593696641908e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,39598,-0.0508317659384865,0.00765990482732826,-0.0658451794000499,-0.0358183524769232,3.37273367343108e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39600,-0.0588943770826854,0.00887693195098985,-0.0762931637066255,-0.0414955904587453,3.40799259162869e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,41750,-0.0538612795732748,0.00812775894348099,-0.0697916871024976,-0.0379308720440521,3.56338269304595e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41598,-0.0286739750726821,0.00432727567176329,-0.0371554353893382,-0.0201925147560261,3.57692728855199e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,39625,-0.0228523334435006,0.00345089076206634,-0.0296160793371506,-0.0160885875498506,3.70462964276481e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39583,-0.0282038969991358,0.00426453744149743,-0.0365623903844707,-0.0198454036138008,3.9253575688693e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39625,-0.0583976669743417,0.00886233353890187,-0.0757678407105894,-0.0410274932380941,4.61670077487961e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41465,-0.0312476462687713,0.00474414658008152,-0.040546173565731,-0.0219491189718115,4.6761533862205e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,39625,-0.0453107106771403,0.00688163763876281,-0.0587987204491154,-0.0318227009051652,4.77833159885026e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39308,-0.0272757015041498,0.00414665902349275,-0.0354031531901956,-0.019148249818104,4.99884469158934e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,41740,-0.0545031133520836,0.00830024165483024,-0.0707715869955509,-0.0382346397086163,5.346717001055e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,39589,-0.0434217998986248,0.00661297050381861,-0.0563832220861093,-0.0304603777111404,5.39593134339172e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41287,0.0219091340748812,0.00334006124633827,0.0153626140320582,0.0284556541177042,5.60834649414522e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39407,0.0215479252856171,0.00328653185783294,0.0151063228442645,0.0279895277269697,5.7623645414056e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,41740,-0.0507086108147514,0.00773707138248953,-0.0658732707244309,-0.035543950905072,5.81144997289117e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,41865,0.0147626345126844,0.00225531238291309,0.0103422222421747,0.019183046783194,6.13888399251386e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41465,-0.0584808482521935,0.00896038143901767,-0.0760431958726681,-0.0409185006317188,6.9801516938004e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,41829,-0.0229276984558029,0.00351322273359398,-0.0298136150136471,-0.0160417818979587,6.99571088159527e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,41740,-0.0264362014883176,0.00405212647272454,-0.0343783693748577,-0.0184940336017775,7.09506361705782e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39625,-0.0237079733806807,0.00363544045934282,-0.0308334366809926,-0.0165825100803687,7.27260759311988e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39600,-0.0334816448412811,0.00513623093611028,-0.0435486574760573,-0.023414632206505,7.40144569035476e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,41740,-0.0401431202471703,0.00616915517939611,-0.0522346643987867,-0.0280515760955539,7.94106483993387e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39308,-0.0170078815047747,0.00261392175209611,-0.022131168138883,-0.0118845948706663,8.02754289227843e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,41728,-0.0632109960268784,0.00972461968695043,-0.0822712506133012,-0.0441507414404555,8.31686470221506e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41637,-0.0348028449430189,0.00535586354349418,-0.0453003374882675,-0.0243053523977703,8.43081375008437e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39328,-0.054861222005726,0.00844857608445359,-0.071420431131255,-0.038302012880197,8.75459088738138e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41617,-0.0769385759208021,0.0118518348832741,-0.100168172292019,-0.0537089795495848,8.79511824968415e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39334,-0.0626391312665346,0.00966146868928289,-0.0815756098975291,-0.0437026526355401,9.3618902354595e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41751,-0.0397689458591992,0.00613634365638135,-0.0517961794257066,-0.0277417122926917,9.44374664499216e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,41888,-0.0229205218300576,0.00353769693293765,-0.0298544078186154,-0.0159866358414998,9.56259735217775e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39600,-0.0329272016857892,0.00508160293713358,-0.042887143442571,-0.0229672599290074,9.58405270754442e-11
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,41911,-0.0293261717706699,0.0045321735606755,-0.0382092319495939,-0.0204431115917459,1.00989248152968e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,41751,-0.0390548135147903,0.00604205813277518,-0.0508972474550297,-0.027212379574551,1.05691165876701e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,41783,-0.048210216881168,0.00746237304610342,-0.0628364680515307,-0.0335839657108053,1.08066502269291e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41521,-0.0652868275299091,0.0101069222357531,-0.0850963951119851,-0.0454772599478331,1.08731561427446e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39308,-0.0507710122700038,0.00786186104890212,-0.0661802599258519,-0.0353617646141556,1.10776193615051e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,39600,-0.045416939639865,0.0070614490105135,-0.0592573797004714,-0.0315764995792585,1.31442111326279e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39600,-0.0247492816104875,0.0038495362646888,-0.0322943726892775,-0.0172041905316974,1.33626842463007e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39334,-0.0380682618858939,0.00593219457205327,-0.0496953632471183,-0.0264411605246695,1.44625669146511e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39598,-0.0591289490236866,0.00923266930257289,-0.0772249808567295,-0.0410329171906438,1.57205338608026e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,41765,-0.0371637232256385,0.00581462990501635,-0.0485603978394706,-0.0257670486118065,1.69896560383514e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,39576,-0.0220594991277379,0.00345221947622095,-0.028825849301131,-0.0152931489543448,1.72666868085242e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39600,-0.0429753698201963,0.00672647065745483,-0.0561592523088077,-0.0297914873315848,1.7372893085405e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,39598,-0.0515391640918191,0.00807475453251737,-0.0673656829755531,-0.0357126452080851,1.80933648374503e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39320,-0.0188804484010264,0.00295911200619545,-0.0246803079331695,-0.0130805888688833,1.83860172283126e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41466,-0.0577740254663015,0.00905690792290134,-0.0755255649951881,-0.0400224859374149,1.84350362391545e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41465,-0.0321808791419383,0.00507024553383731,-0.0421185603882594,-0.0222431978956172,2.26915275348584e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41636,0.0756163046640628,0.0119191359382078,0.0522547982251755,0.09897781110295,2.3111198334926e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39598,-0.0224981769632524,0.00354883013657999,-0.0294538840309492,-0.0155424698955557,2.39382512075441e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39598,-0.0208409685922238,0.00328774950467027,-0.0272849576213776,-0.0143969795630701,2.40354654233491e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,39600,-0.0297810735633463,0.0047061733553231,-0.0390051733397795,-0.020556973786913,2.57873220320059e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39308,-0.0587918902795685,0.00929457349659418,-0.0770092543328931,-0.0405745262262439,2.62656999773074e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39600,-0.0567424813295161,0.00897432482380182,-0.0743321579841676,-0.0391528046748645,2.6689535451381e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,41855,-0.0433454920433517,0.00686336345961491,-0.0567976844241969,-0.0298932996625065,2.77908801638737e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39600,-0.0524620149900671,0.00831694875772679,-0.0687632345552116,-0.0361607954249226,2.93814408367279e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,41689,-0.0262240327115751,0.00416031982376366,-0.0343782595661518,-0.0180698058569983,3.00591254676375e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,39600,-0.0478601549162212,0.00759210616731744,-0.0627406830041634,-0.032979626828279,3.01294857087651e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39408,-0.0461059650720556,0.00733329036964359,-0.0604792141965571,-0.0317327159475542,3.3568592164783e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,41903,0.0293545180243927,0.0046730801481447,0.0201952809340291,0.0385137551147563,3.45495792371878e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41657,-0.0192324836106065,0.0030617206995154,-0.0252334561816567,-0.0132315110395564,3.45756780580731e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,41802,-0.0268634139067125,0.00427865076523856,-0.0352495694065801,-0.0184772584068449,3.52612966918145e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,41758,0.0330681481957347,0.00527090349625897,0.0227371773430671,0.0433991190484022,3.63579000946009e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39633,-0.0316007599079598,0.00504429091785464,-0.0414875701069549,-0.0217139497089647,3.87562339660168e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39542,-0.0416400935469253,0.00665100356953034,-0.0546760605432047,-0.0286041265506458,3.97555294833098e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39600,-0.0317609018683772,0.00507714292441758,-0.0417121020002356,-0.0218097017365187,4.10533459735895e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39655,-0.0439714077335636,0.00702967282208508,-0.0577495664648504,-0.0301932490022769,4.11902963297347e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,41855,0.0167103292550528,0.00267305510591751,0.0114711412474545,0.0219495172626511,4.1927148780704e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,41862,0.0203274903078134,0.00325300726168691,0.013951596074907,0.0267033845407197,4.26192010248364e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39334,-0.0248510815874315,0.00397662753588567,-0.0326452715577674,-0.0170568916170955,4.27975817857829e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,41803,-0.019042439058757,0.00304899762240874,-0.0250184743986781,-0.0130664037188359,4.35473208367779e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41604,0.0181857348737562,0.00291320754437421,0.0124758480867828,0.0238956216607297,4.43984257380732e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39625,-0.0320514139757613,0.00513715322547176,-0.042120234297686,-0.0219825936538367,4.56124084974382e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,39600,-0.0223393586292947,0.00358805126601128,-0.0293719391106768,-0.0153067781479126,4.95806127057911e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41465,-0.0255658598583432,0.00410720246756987,-0.0336159766947802,-0.0175157430219063,4.97659627039917e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,41865,0.0246875625843202,0.00397179365543015,0.0169028470196771,0.0324722781489633,5.26198277433983e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39600,-0.0674457919439362,0.0108612355505889,-0.0887338136230904,-0.0461577702647819,5.49762770116458e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,39627,-0.024643411275794,0.00397181701643434,-0.0324281726280053,-0.0168586499235827,5.68146899859885e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39408,-0.0492383930972848,0.00794176608994515,-0.0648042546335773,-0.0336725315609923,5.85503197761775e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,41865,-0.0410069527945542,0.0066168691221145,-0.0539760162738986,-0.0280378893152098,5.91275255674354e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39328,-0.0284945668979532,0.00460340009920219,-0.0375172310923895,-0.0194719027035169,6.24041033050181e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,39633,-0.0550068898140613,0.00889540614761361,-0.0724418858633839,-0.0375718937647386,6.48146493355097e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40174,0.0203892622200073,0.00329856798748989,0.0139240689645271,0.0268544554754875,6.57372441476977e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39334,-0.036500651088524,0.00590822860737684,-0.0480807791589826,-0.0249205230180654,6.72994180237283e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,41805,-0.0700296701322008,0.0113537932355025,-0.0922831048737858,-0.0477762353906159,7.11987150699972e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,39588,-0.0637117598738742,0.0103295260024601,-0.0839576308386961,-0.0434658889090523,7.16244048584423e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,41765,-0.0751354893046159,0.0121873012541931,-0.0990225997628344,-0.0512483788463975,7.25137674913079e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39600,-0.0500526816050526,0.00814179109661547,-0.066010592154419,-0.0340947710556863,8.13785031384692e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39408,-0.0375758542202445,0.0061230819671426,-0.049577094875844,-0.025574613564645,8.71761602113586e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39328,-0.0447191700854076,0.00729164838214753,-0.0590108009144168,-0.0304275392563985,8.93143655914817e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,41877,-0.0206344823629399,0.00336731706245284,-0.0272344238053475,-0.0140345409205324,9.15827372298118e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39250,-0.0433177078971673,0.00707001017392871,-0.0571749278380676,-0.0294604879562671,9.27375774797515e-10
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,41726,0.0405087046931164,0.00663784290218091,0.0274985326048418,0.053518876781391,1.07234093742648e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39328,-0.0282407925587187,0.00463019455428131,-0.03731597388511,-0.0191656112323273,1.10228790665122e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39308,-0.0278593070336685,0.0045704667398145,-0.0368174218437049,-0.018901192223632,1.12850012337237e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,41758,-0.0327382861162376,0.00537597535903375,-0.0432751978199438,-0.0222013744125315,1.16245130764353e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",41805,-0.0706674410717111,0.0116084025931817,-0.0934199101543473,-0.0479149719890749,1.17784189456287e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,41758,0.0128479125735671,0.00211621375408486,0.00870013361556073,0.0169956915315734,1.30468882858949e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39408,-0.0327958279276001,0.00540134584467885,-0.0433824657831706,-0.0222091900720295,1.30744274285285e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39427,-0.0461654752158538,0.00760501490516334,-0.061071304429974,-0.0312596460017337,1.3186880334557e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,41765,-0.0793982026287824,0.0130848683100981,-0.105044544516575,-0.0537518607409902,1.33116974620651e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39600,-0.0940052644569076,0.0155024399460574,-0.12439004675118,-0.0636204821626351,1.37221704792081e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,41765,-0.0185083854352567,0.00305769375849985,-0.0245014652019164,-0.012515305668597,1.4598851904066e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39589,-0.0225277699113476,0.00372249450296641,-0.0298238591371618,-0.0152316806855335,1.47913138252788e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,39598,-0.0598575969664026,0.00989251060309177,-0.0792469177484625,-0.0404682761843427,1.48822406020792e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,41836,0.0309868855489144,0.00512900427439404,0.0209340371711021,0.0410397339267267,1.56783746141061e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,41706,-0.0210084046913987,0.00347960380497742,-0.0278284281491545,-0.014188381233643,1.60666304516679e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39600,-0.0555689799109088,0.00921832507699631,-0.0736368970618216,-0.037501062759996,1.71220790363356e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39308,-0.0616635725257119,0.010260779831805,-0.0817747009960498,-0.0415524440553741,1.91993628835264e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41465,-0.0341869933567033,0.00569191190433977,-0.0453431406892092,-0.0230308460241973,1.94997774467372e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,41871,-0.0155901109792757,0.00259822397441426,-0.0206826299691276,-0.0104975919894237,2.02089368462454e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41617,-0.0440447334968633,0.00736130709964314,-0.0584728954121639,-0.0296165715815628,2.2443760776009e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,41614,-0.0329401288550901,0.00550895022163951,-0.0437376712895035,-0.0221425864206766,2.29852346640135e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,41758,0.0284064369971815,0.00475483287516495,0.0190869645618582,0.0377259094325048,2.37158647272628e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,41899,-0.0328214278836006,0.00549985039738602,-0.0436011346624772,-0.022041721104724,2.46750681611441e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41466,-0.0326101192961859,0.00546605593315614,-0.0433235889251719,-0.0218966496671998,2.49632377705426e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41465,-0.0384132282002689,0.0064412796833096,-0.0510381363795558,-0.0257883200209821,2.53210900261554e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39328,-0.0315816516174778,0.00529525566620507,-0.0419603527232397,-0.0212029505117159,2.53681743041874e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,41689,-0.0487516408707354,0.00818311069957146,-0.0647905378418955,-0.0327127438995754,2.62554140905822e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,41802,-0.0441501785221351,0.00741763852135173,-0.0586887500239845,-0.0296116070202857,2.71516038560982e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41447,-0.0460949242369714,0.00777668646616123,-0.0613372297106474,-0.0308526187632953,3.15812779954042e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,41689,-0.0559750429271584,0.0094526379254805,-0.0745022132611002,-0.0374478725932166,3.26755328605137e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,41911,-0.0346859685017689,0.00586633037807452,-0.0461839760427949,-0.0231879609607428,3.44750687119783e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41521,0.0216637304449425,0.0036686427943245,0.0144731905680665,0.0288542703218185,3.61271640889996e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,39633,0.0252641934341858,0.00428083946177514,0.0168737480891065,0.0336546387792651,3.70376193785942e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",41802,-0.0381690469545831,0.00646895780742756,-0.0508482042571411,-0.025489889652025,3.71644842734044e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39625,-0.0571363566907831,0.00970657482103889,-0.0761612433400193,-0.0381114700415468,4.06305060651924e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39633,-0.0144860539083845,0.00246462770701672,-0.0193167242141373,-0.00965538360263177,4.28348352023014e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,41877,-0.0153108811013452,0.00260678968599385,-0.0204201888858932,-0.0102015733167973,4.37000707489791e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41521,-0.0593423477439383,0.0101063282126721,-0.0791507510407757,-0.0395339444471009,4.41679211674764e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,41689,-0.0367574264533396,0.00627272765921114,-0.0490519726653934,-0.0244628802412858,4.74349175397534e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41865,-0.0348172573860745,0.00595144425522615,-0.0464820881263178,-0.0231524266458313,5.02502147205528e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39625,-0.0550601392392517,0.00941086591871439,-0.0735054364399319,-0.0366148420385715,5.03436457241785e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41521,-0.0261721601248099,0.00447452868913314,-0.0349422363555109,-0.0174020838941089,5.06069307809476e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39562,-0.0281426022812559,0.00481316568365138,-0.0375764070212126,-0.0187087975412992,5.14786868605528e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39600,-0.0362250511778788,0.00620017261498995,-0.0483773895032591,-0.0240727128524985,5.285344198624e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39308,-0.0303043255182239,0.00519317231323585,-0.0404829432521661,-0.0201257077842816,5.52120334636677e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,41774,-0.0193316021150045,0.00331932403023287,-0.0258374772142609,-0.0128257270157481,5.88111497555196e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39589,-0.0341858750488229,0.00587547677440343,-0.0457018095266536,-0.0226699405709921,6.10724846130666e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,39600,-0.0181301386760247,0.00311918755198986,-0.0242437462779249,-0.0120165310741246,6.32734070763303e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,39655,-0.0431665464686296,0.00743436971682164,-0.0577379111136,-0.0285951818236592,6.56073776574743e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41466,-0.0440804503987794,0.00759353036785041,-0.0589637699197662,-0.0291971308777926,6.58842379705674e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41465,-0.0241887375458338,0.00417166457102086,-0.0323652001050347,-0.0160122749866329,6.85469043640301e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,41858,-0.056251569542516,0.00970704256031108,-0.0752773729607258,-0.0372257661243063,6.990614480304e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39334,-0.0279568089463655,0.00482554863308515,-0.0374148842672124,-0.0184987336255186,7.08731496682119e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39535,-0.0586412626797523,0.0101263945599382,-0.0784889960172311,-0.0387935293422734,7.1924852902104e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,41764,-0.0648203381506616,0.0112012691717435,-0.0867748257272789,-0.0428658505740443,7.33410705375856e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39308,-0.0141634122252107,0.00245420739000246,-0.0189736587096155,-0.00935316574080587,8.09542084277593e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,41865,0.0177722816865644,0.00308580520111288,0.0117241034923832,0.0238204598807457,8.63029088027107e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,41689,-0.0580661290639987,0.0100957759704753,-0.0778538499661302,-0.0382784081618671,9.04183358722527e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39600,-0.0576529760894639,0.0100420994097708,-0.0773354909326147,-0.0379704612463131,9.65369157399672e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,41925,0.0179304269471789,0.00312384235989557,0.0118076959217836,0.0240531579725742,9.68173930227131e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,39600,-0.0337793764990295,0.0058854478864095,-0.0453148543563921,-0.0222438986416668,9.74813429391158e-09
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41465,-0.0552525458675684,0.00963757076878803,-0.0741421845743929,-0.0363629071607438,1.00864561953169e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39619,-0.0289589614271536,0.00505150635497484,-0.0388599138829043,-0.0190580089714029,1.01417983098334e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39334,-0.0271759691099055,0.0047455358459857,-0.0364772193680375,-0.0178747188517736,1.05191392701626e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39308,-0.0470516001708547,0.00821989118969687,-0.0631625869026606,-0.0309406134390488,1.06769057429183e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41465,-0.0315764005569219,0.00551890173842794,-0.0423934479642406,-0.0207593531496031,1.07940596542133e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,41812,-0.0143680586365089,0.0025122932385434,-0.0192921533840539,-0.00944396388896378,1.09408973250076e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41458,-0.04827658268563,0.00844204899846614,-0.0648229987226236,-0.0317301666486363,1.09804855256458e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,39589,-0.0245188463537989,0.00428710369492844,-0.0329215695958587,-0.0161161231117392,1.098131113758e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39427,-0.0405720425833974,0.00710294265283377,-0.0544938101829516,-0.0266502749838432,1.14595918611369e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39308,-0.0369902247364147,0.0064828605982723,-0.0496966315090284,-0.0242838179638009,1.18837068770196e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39328,-0.0284683013488106,0.00499856325877506,-0.0382654853360098,-0.0186711173616115,1.2639646410113e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39308,-0.0310540315280459,0.00548038362244774,-0.0417955834280434,-0.0203124796280483,1.49597511631818e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,41846,-0.02260580401246,0.00399030604534573,-0.0304268038613376,-0.0147848041635824,1.4992737303912e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,39643,-0.0335137255550654,0.00592110641222781,-0.0451190941230319,-0.0219083569870989,1.55105855486565e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39259,-0.0509719125244494,0.00900644819189282,-0.0686245509805593,-0.0333192740683395,1.55743162302378e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,41720,-0.0289122849506609,0.00511068298148339,-0.0389292235943683,-0.0188953463069534,1.57055664000062e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,41750,-0.0304117921480056,0.0053810156916778,-0.0409585829036941,-0.0198650013923171,1.6218587080277e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,41805,-0.0285131415704529,0.00504728440922158,-0.0384058190125272,-0.0186204641283786,1.64521174028503e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",41755,0.0319674178566916,0.00566156686385035,0.0208707468035449,0.0430640889098383,1.67241747878608e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41636,0.0348698943209163,0.00617814693952082,0.0227607263194555,0.0469790623223771,1.69538904289419e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39338,-0.0236256914352798,0.00418797420106457,-0.0318341208693663,-0.0154172620011932,1.73025064553618e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",41925,-0.0301314397779827,0.00534618786387444,-0.0406099679911766,-0.0196529115647888,1.7751229756938e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,41911,-0.032815709107293,0.00582961492606634,-0.044241754362383,-0.0213896638522029,1.84771146730009e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39600,-0.0393127733070432,0.00698772373863429,-0.0530087118347664,-0.02561683477932,1.88968651161092e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,41765,-0.0404927058867894,0.00719865422845631,-0.0546020681745638,-0.026383343599015,1.89244972763004e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41465,-0.0265887262469183,0.00473235606797563,-0.0358641441401505,-0.017313308353686,1.96624282099412e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41534,-0.0368112021611231,0.00657417004627785,-0.0496965754518277,-0.0239258288704185,2.19515975210355e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,41728,0.0181166215021038,0.00323553709615613,0.0117749687936378,0.0244582742105699,2.19584865754443e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,39589,-0.0241309101488764,0.00431214084698263,-0.0325827062089623,-0.0156791140887904,2.24557321902858e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41840,-0.0405398380392749,0.00725172434238647,-0.0547532177503524,-0.0263264583281974,2.31062986832699e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,39600,-0.0414207373824846,0.00742549236862005,-0.0559747024249799,-0.0268667723399893,2.48791119718055e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39595,-0.0362650397006885,0.00650634336620983,-0.0490174726984597,-0.0235126067029172,2.55120486625471e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,41865,-0.0181067963257278,0.00324927855457181,-0.0244753822926885,-0.011738210358767,2.55916296378897e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39308,-0.0186327950367365,0.00334424722434464,-0.0251875195964519,-0.012078070477021,2.58517190651938e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41740,-0.0601822875217059,0.0108329924383707,-0.0814149527009124,-0.0389496223424994,2.82259230596485e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39600,-0.0342546489865566,0.00617308019819821,-0.046353886175025,-0.0221554117980881,2.9389813816834e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,39625,-0.0315207613491398,0.00568069833874953,-0.0426549300930888,-0.0203865926051907,2.94367938541133e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39600,-0.031239221931258,0.00563662357800143,-0.0422870041441408,-0.0201914397183752,3.05599527870331e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,41758,0.0166908639459445,0.0030138662446722,0.010783686106387,0.022598041785502,3.11768746774466e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,41765,-0.0396079233373476,0.00715539852490879,-0.0536325044461688,-0.0255833422285264,3.16476283982709e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,41703,-0.064086430054907,0.0115950236630599,-0.0868126764345043,-0.0413601836753096,3.31857393306182e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39633,-0.0300891574445207,0.00544886372298276,-0.0407689303415669,-0.0194093845474745,3.42562099651164e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,41758,0.0157879860173492,0.0028596627863009,0.0101830469561995,0.021392925078499,3.43606471465193e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,41636,0.0201877560105954,0.00366029290041972,0.0130135819257727,0.027361930095418,3.54738858499104e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41614,-0.023639363448074,0.00428641014795141,-0.0320407273380588,-0.0152379995580892,3.55521625197028e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,41805,-0.0542780491023939,0.00984666849675872,-0.073577519356041,-0.0349785788487468,3.60765530586057e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,41848,0.0112497982070719,0.00204162642453931,0.00724821041497481,0.0152513859991689,3.650899800894e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39600,-0.052997081475933,0.00962031686373446,-0.0718529025288525,-0.0341412604230135,3.69269528467885e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39522,-0.0576230639380129,0.0104726502303922,-0.0781494583895816,-0.0370966694864441,3.83448970596035e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,39600,-0.0336444305941965,0.0061215836879627,-0.0456427346226034,-0.0216461265657896,3.97089057583707e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39314,-0.0497532569069818,0.00905660775279451,-0.067504208102459,-0.0320023057115046,4.02855085701795e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39334,-0.0248905570090634,0.00453188454021753,-0.0337730507078898,-0.016008063310237,4.0573166187496e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39334,-0.0296396387467556,0.00540034875553181,-0.040224322307598,-0.0190549551859133,4.14652151945327e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39334,-0.0497836501759131,0.00907166418651787,-0.0675641119814882,-0.0320031883703381,4.16172904999166e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,41925,-0.0418583762632251,0.00763720639685164,-0.0568273008010543,-0.0268894517253959,4.30984358851394e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39334,-0.0322530727619694,0.00589127202543135,-0.0437999659318148,-0.0207061795921239,4.48064355718894e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39250,-0.0385165193118183,0.00703647983513993,-0.0523080197886925,-0.024725018834944,4.50388706985924e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,41759,-0.0237572862169086,0.00434355202594043,-0.0322706481877518,-0.0152439242460653,4.59412575778032e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,41765,-0.0205750194913729,0.00376216434838624,-0.0279488616142099,-0.0132011773685359,4.61017393133283e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,41636,-0.0559610552018744,0.0102429560548669,-0.0760372490694135,-0.0358848613343352,4.75755332328582e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,41855,-0.0117136042481256,0.00214508806947111,-0.015917976864289,-0.00750923163196222,4.82903472745287e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41465,-0.0296750796576251,0.00544458346471255,-0.0403464632484617,-0.0190036960667885,5.11869296338118e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39600,-0.0602062556450985,0.0110483420031626,-0.0818610059712972,-0.0385515053188998,5.16451283013975e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,41877,-0.0641193959488033,0.0117709479111131,-0.0871904538545849,-0.0410483380430217,5.20632351300997e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41625,-0.0590777001051434,0.0108488066087853,-0.0803413610583625,-0.0378140391519242,5.25827696719862e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,39600,-0.0209655275617627,0.0038580316668709,-0.0285272696288297,-0.0134037854946957,5.61996693122918e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41689,-0.048872516631997,0.00900292385018112,-0.066518247378352,-0.031226785885642,5.78376205128105e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,41723,-0.0649759942992507,0.011982786856789,-0.0884622565385572,-0.0414897320599443,5.98303570793818e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41689,0.0138140494994995,0.00255801678245389,0.00880033660588985,0.0188277623931091,6.76930086267137e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39334,-0.0209537985158846,0.00387995911157185,-0.0285585183745654,-0.0133490786572038,6.7865755386597e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39427,-0.0286375110473145,0.00530572582346599,-0.0390367336613078,-0.0182382884333211,6.90126580453902e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41465,-0.0410948926111261,0.00762044430511806,-0.0560309634491575,-0.0261588217730947,7.06274348356992e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,41758,0.0179876813663106,0.00334016218618974,0.0114409634813787,0.0245343992512425,7.35785901118094e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,41805,-0.0225800028050918,0.00419373279687357,-0.030799719086964,-0.0143602865232196,7.40024462364909e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41465,-0.0487055842145205,0.00904940648414587,-0.0664424209234464,-0.0309687475055946,7.48778673845574e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39328,0.0179284887026583,0.00333526651986399,0.0113913663237249,0.0244656110815917,7.80022871889056e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41598,-0.0168933801817935,0.00314537911229948,-0.0230583232419005,-0.0107284371216865,7.9712977741307e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,39625,-0.0154435987979417,0.00287518711531393,-0.021078965543957,-0.00980823205192642,7.97443245041022e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,41740,-0.0416344485663394,0.00775362908138609,-0.0568315615658562,-0.0264373355668227,8.02221970745133e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39308,-0.0293635133631233,0.00547523112782017,-0.0400949663736508,-0.0186320603525957,8.35675393852847e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39427,-0.029764260250869,0.00555492932152564,-0.0406519217210593,-0.0188765987806788,8.57932067889565e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,41740,-0.0492095663080977,0.00919392417293746,-0.0672296576870551,-0.0311894749291403,8.82536033407564e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39250,-0.0160781623822563,0.00300383467667601,-0.0219656783485413,-0.0101906464159713,8.85267667989098e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39250,-0.0205745378662002,0.00384588441796566,-0.0281124713254129,-0.0130366044069875,8.98992288679632e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,41758,0.0208023697016714,0.00389013431779218,0.0131777064387987,0.028427032964544,9.06845959299193e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39328,-0.0467877357965457,0.00875013368949564,-0.0639379978279571,-0.0296374737651342,9.1216092673898e-08
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41689,-0.0492477903710313,0.00924454076002752,-0.0673670902606853,-0.0311284904813774,1.01373969605688e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39250,-0.0370893991310976,0.00696974006801094,-0.050750089664399,-0.0234287085977961,1.0501072180248e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,41911,-0.0378308169315986,0.00711044614643094,-0.0517672913786033,-0.023894342484594,1.05184813702389e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39317,-0.0151587423687437,0.00284942540008291,-0.0207436161529062,-0.00957386858458124,1.05899473365561e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,41805,-0.0722517428351177,0.0135869097575141,-0.0988820859598453,-0.0456213997103901,1.0677319364878e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39600,-0.0670964452541719,0.0126258210262096,-0.0918430544655427,-0.0423498360428011,1.09206462347991e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39373,-0.0306543517507934,0.00577158968005167,-0.0419666675236946,-0.0193420359778921,1.11045062369992e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41689,-0.01950078164082,0.00367426630604112,-0.0267023436006606,-0.0122992196809794,1.13018610031259e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,41739,0.0272328634640295,0.00513848956145597,0.0171614239235758,0.0373043030044832,1.17817408550095e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,41865,-0.0343251630468926,0.00647795446288144,-0.0470219537941402,-0.021628372299645,1.18454151128087e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,41836,-0.0259756475028482,0.00490657653492939,-0.0355925375113098,-0.0163587574943866,1.21550998914239e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39250,-0.0677454909947627,0.012803997176585,-0.0928413254608693,-0.0426496565286561,1.24088739128315e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39633,-0.0159095677214527,0.00301066170528695,-0.0218104646638151,-0.0100086707790903,1.28515661617871e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,41836,-0.0567003304309063,0.0107309749158309,-0.0777330412659348,-0.0356676195958779,1.28538447004194e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41375,0.0515037355576671,0.00976118759172734,0.0323718078778815,0.0706356632374527,1.33915149545121e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41447,-0.0374082270840439,0.00709555504412026,-0.0513155149705196,-0.0235009391975682,1.37083643722008e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39328,-0.0187704174562865,0.00356287945831467,-0.0257536611945833,-0.0117871737179898,1.40340120707733e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,41612,0.0195979896241991,0.00372063206961844,0.0123055507677469,0.0268904284806512,1.40589754844095e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,41911,-0.0196518323791338,0.00373459081028355,-0.0269716303672895,-0.012332034390978,1.44621325144905e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,41877,0.0348384111039857,0.00662245429012142,0.0218584006953477,0.0478184215126236,1.45779170643517e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,39580,-0.0478521144669038,0.00909683068936424,-0.0656819026180577,-0.0300223263157499,1.46522346027376e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39600,-0.0241293028429939,0.00458891764654801,-0.033123581430228,-0.0151350242557598,1.48225964573238e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,41740,-0.0216380509758112,0.0041203524682005,-0.0297139418134842,-0.0135621601381382,1.53215641380918e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39589,-0.0467849477592841,0.00891878853091556,-0.0642657732798786,-0.0293041222386896,1.58618972931454e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39600,-0.0494723662845887,0.00943266159922987,-0.0679603830190792,-0.0309843495500981,1.5936254959006e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,39598,-0.0125039839934293,0.00239083632164403,-0.0171900231838516,-0.00781794480300701,1.72659031139196e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41740,0.0219781748561253,0.00420685962158686,0.0137327299978151,0.0302236197144356,1.77425131933348e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,41774,-0.0224481305953945,0.00429874069882587,-0.0308736623650932,-0.0140225988256958,1.79671947926011e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41465,-0.0313797289307481,0.00602735528330154,-0.0431933452860192,-0.0195661125754771,1.95697826142605e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39600,-0.0327723298290422,0.00629717954385414,-0.0451148017349963,-0.0204298579230881,1.98251564554858e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39308,-0.0418420726925915,0.00804531661868223,-0.0576108932652086,-0.0260732521199743,2.02097763320857e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,41728,-0.0369209668851752,0.00710331002377444,-0.0508434545317731,-0.0229984792385773,2.04782613820293e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39381,-0.0284733406739584,0.00547822035544103,-0.0392106525706228,-0.017736028777294,2.05622969488741e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39598,-0.0126432878801416,0.00243569823422768,-0.0174172564192278,-0.00786931934105534,2.13097178903492e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39308,-0.0381656034586393,0.00736766822384726,-0.0526062331773799,-0.0237249737398986,2.25741980272227e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39334,-0.0434048404182074,0.00838238236459849,-0.0598343098528205,-0.0269753709835944,2.28212223200806e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39598,-0.0216032708709775,0.00417551393110571,-0.0297872781759447,-0.0134192635660103,2.33421322898309e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39589,-0.0317734031088802,0.00614221529005577,-0.0438121450773896,-0.0197346611403709,2.34479688132911e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39600,-0.0430953515526049,0.00833596476845067,-0.0594338424987683,-0.0267568606064416,2.38446615313563e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,39598,-0.0258278299760696,0.00499671483327694,-0.0356213910492924,-0.0160342689028468,2.39528473578945e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,41758,-0.014470931911211,0.00280043197281953,-0.0199597785779373,-0.00898208524448469,2.40855833271975e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,38964,0.0608382454318432,0.011777763452226,0.0377538290654802,0.0839226617982061,2.44229864030551e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,41802,-0.0121360849947586,0.00235240615307412,-0.0167468010547839,-0.00752536893473337,2.51858071738093e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,39598,-0.0752103545286348,0.0145963648515217,-0.103819229637617,-0.0466014794196523,2.61245339773515e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39035,-0.0677853174359918,0.0131823995319809,-0.0936228205186743,-0.0419478143533092,2.76599106608094e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39250,-0.0241933174939773,0.00471060283280784,-0.0334260990462807,-0.014960535941674,2.85718575806787e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41521,-0.0277817235474013,0.00542023476166483,-0.0384053836802644,-0.0171580634145383,3.00942737310702e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39534,-0.0158605820127852,0.00309540647720175,-0.0219275787081007,-0.00979358531746979,3.04370689285965e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,41758,0.0283720685707943,0.00553795068811304,0.0175176852220928,0.0392264519194959,3.04633351227798e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39308,-0.0428811654279773,0.00836905008435267,-0.0592845035933086,-0.0264778272626461,3.04688821518474e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,41865,0.0698445696430121,0.0136549296994383,0.0430809074321131,0.0966082318539111,3.18166730891407e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41614,-0.0201357961315481,0.00393690002675043,-0.027852120183979,-0.0124194720791173,3.18822037489775e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,41925,-0.0236518715680969,0.00462766033858554,-0.0327220858317245,-0.0145816573044692,3.24932216500211e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39600,-0.0349026419596945,0.00682846890705522,-0.0482864410175227,-0.0215188429018663,3.25250604152938e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39625,-0.0539381764277085,0.0105629079159136,-0.0746414759428992,-0.0332348769125178,3.33878970442599e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41740,-0.0520384551442491,0.0101994902525216,-0.0720294560391915,-0.0320474542493067,3.40654181312729e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41466,-0.0390566074967284,0.00766284446693184,-0.0540757826519148,-0.024037432341542,3.50194428862268e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39600,0.0194319859092971,0.00381733102355937,0.0119500171031208,0.0269139547154735,3.63093250394897e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,41689,0.0150667227014015,0.00296103244702108,0.00926309910524017,0.0208703462975628,3.66227284697291e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39241,-0.0271048271095171,0.00532689275072264,-0.0375455369009335,-0.0166641173181007,3.67453178588285e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,41750,-0.0164585285091887,0.00323567768636021,-0.0228004567744547,-0.0101166002439227,3.69602033080129e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,39567,-0.0474742472612854,0.00933885666190779,-0.0657784063186247,-0.0291700882039461,3.76618113367715e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,41706,0.0189941885225841,0.00373831025071685,0.011667100431179,0.0263212766139891,3.8070814347753e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39250,-0.0360440744334049,0.00709355677668861,-0.0499474457157145,-0.0221407031510952,3.81335122971856e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,41748,-0.0157143031685997,0.00309696564870947,-0.0217843558400703,-0.00964425049712916,3.94653096121536e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,41740,0.0335190442924098,0.00660876781116662,0.0205658593825232,0.0464722292022963,3.99220325825622e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39328,-0.0356818032006799,0.00703961698230836,-0.0494794524860043,-0.0218841539153556,4.07190934804114e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41716,-0.0367450455002168,0.00725504345797292,-0.0509649306778438,-0.0225251603225899,4.14470654976273e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,39598,-0.0162899733762262,0.00321650199991343,-0.0225943172960565,-0.00998562945639585,4.16111367259504e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,41877,0.0319794128110963,0.0063245988645986,0.0195831990364831,0.0443756265857096,4.33042682932644e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41617,-0.0429834195168515,0.00852073588461196,-0.0596840618506909,-0.026282777183012,4.60674682466978e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39334,-0.0485039890753652,0.00963735417391927,-0.0673932032562469,-0.0296147748944834,4.90907309303687e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41689,-0.0111067482797429,0.00220919908101274,-0.0154367784785279,-0.00677671808095792,5.03486536237372e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41367,-0.0443773474863007,0.00883655955189732,-0.0616970042080194,-0.0270576907645819,5.18221557433526e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41636,-0.0421184074961854,0.00838861924642264,-0.0585601012191738,-0.025676713773197,5.21096709171772e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39276,-0.0221850486435998,0.00442754500740257,-0.0308630368581089,-0.0135070604290908,5.51046134487355e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,41911,-0.0310951991126332,0.00622232578120512,-0.0432909576437952,-0.0188994405814711,5.88588937422194e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,41740,-0.0351919554119434,0.00704625896912004,-0.0490026229914186,-0.0213812878324681,5.97714394034214e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39334,-0.0310670111939998,0.00622352490234462,-0.0432651200025952,-0.0188689023854044,6.07373463859459e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39334,-0.0306021454621138,0.00613531883267795,-0.0426273703741625,-0.018576920550065,6.20057535755759e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39427,-0.0390613504169964,0.00785568282888518,-0.0544584887616113,-0.0236642120723814,6.71539413339674e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,41655,-0.0357755736193129,0.00720221155670852,-0.0498919082704616,-0.0216592389681642,6.87491652161467e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39554,-0.0256920320253495,0.00517329221402088,-0.0358316847648304,-0.0155523792858686,6.92777748305497e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39308,0.01771205365025,0.00356717120427598,0.0107203980898691,0.0247037092106309,6.96547967447222e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,41789,0.0144390575743799,0.00290888419710565,0.00873764454805286,0.020140470600707,6.99981473211724e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,41836,-0.0351635006713148,0.00709176152158872,-0.0490633532536287,-0.0212636480890009,7.19720284515887e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41636,-0.0192698788838544,0.00388791418803857,-0.02689019069241,-0.0116495670752988,7.27307357635654e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41840,0.018573982489759,0.00374785088339844,0.0112281947582981,0.02591977022122,7.28856253820025e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,41703,-0.0548026685522655,0.0110627097054899,-0.0764855795750257,-0.0331197575295053,7.36784299114459e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39334,-0.0463783519759891,0.00937432493752969,-0.0647520288535473,-0.0280046750984309,7.63597486939497e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,41911,-0.0144279705723195,0.00292665100488092,-0.0201642065418861,-0.00869173460275289,8.32814754226803e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39522,-0.0225822844675802,0.00458067587448214,-0.0315604091815652,-0.0136041597535952,8.34802741948175e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,39572,-0.0237802536086781,0.00482911246136901,-0.0332453140329614,-0.0143151931843949,8.5873250682367e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39334,-0.0181699975283517,0.00369211770754396,-0.0254065482351378,-0.0109334468215655,8.72513110651197e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41534,-0.0211374318885566,0.00429860732865569,-0.0295627022527217,-0.0127121615243914,8.88352220789694e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39334,-0.023131449945846,0.00470598598043706,-0.0323551824675026,-0.0139077174241893,8.99462625691247e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,41733,-0.0345333521704148,0.0070275105032456,-0.0483072727567762,-0.0207594315840535,9.03023467236481e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,41899,-0.0108969755706544,0.00221852264429498,-0.0152452799534726,-0.00654867118783623,9.13095961406125e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39650,-0.0169276621079042,0.00345116090485588,-0.0236919374814217,-0.0101633867343866,9.47978776294215e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39408,-0.0405745271516212,0.00828215622648625,-0.0568075533555343,-0.0243415009477082,9.7707752555351e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39600,-0.0227572206814995,0.00464881234070819,-0.0318688928692876,-0.0136455484937114,9.95620482910087e-07
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41465,-0.0201624450698833,0.00412159948434912,-0.0282407800592076,-0.0120841100805591,1.01076721055159e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39589,-0.0224367520046991,0.00458925273443042,-0.0314316873641827,-0.0134418166452154,1.02795192168834e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41521,0.0726214708634802,0.0148564286890702,0.0435028706329026,0.101740071094058,1.0297501285078e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,41877,0.0216239248271561,0.00442576177349842,0.0129494317510992,0.030298417903213,1.04147519212991e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41521,-0.0267127827335611,0.0054693550945125,-0.0374327187188056,-0.0159928467483166,1.05155797241866e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41466,-0.0322984761512378,0.00661720064718199,-0.0452681894197144,-0.0193287628827611,1.06822092453534e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,41865,-0.0117347207903154,0.00240565327224565,-0.0164498012039169,-0.00701964037671396,1.08423554991858e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41521,-0.0251892810105819,0.00516515602442254,-0.0353129868184501,-0.0150655752027138,1.09120617441373e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41689,-0.0538737007724134,0.0110775489551593,-0.0755856967245257,-0.0321617048203012,1.16773311253984e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41636,-0.0174928700674319,0.00360112424883278,-0.0245510735951441,-0.0104346665397196,1.2018979099319e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39408,-0.0373698967036314,0.00769395360996114,-0.0524500457791552,-0.0222897476281075,1.20820180125629e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,41740,0.0256390597780721,0.00529059228116414,0.0152694989069904,0.0360086206491538,1.2731173771887e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39250,-0.0640113780794665,0.0132107415519044,-0.0899044315211991,-0.0381183246377339,1.28136291765515e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41521,0.017530561311256,0.00361900325797243,0.01043731492563,0.0246238076968819,1.28707384856479e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41534,-0.0157803356534221,0.00326327227370311,-0.0221763493098802,-0.00938432199696399,1.34178354074907e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41786,-0.0390730556300255,0.00808251260885362,-0.0549147803433786,-0.0232313309166724,1.35141523287799e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",41758,0.0123734251895027,0.00255987080989121,0.00735607840211595,0.0173907719768895,1.35591473814884e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39598,-0.0213763176776544,0.00442455145694043,-0.0300484385332577,-0.0127041968220512,1.37478488536274e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41534,-0.0281976112782982,0.00584213210811464,-0.0396481902102029,-0.0167470323463935,1.40473615851675e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,41750,-0.0161108603576723,0.00334426485967913,-0.0226656194826434,-0.00955610123270116,1.47019829426855e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41466,-0.0370269609883146,0.00769036708025797,-0.0521000804656203,-0.021953841511009,1.49084128617248e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41333,-0.0206700701707262,0.00429361850118419,-0.0290855624330472,-0.0122545779084052,1.49536083323027e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39314,-0.0294067236977532,0.00610884891958753,-0.0413800675801447,-0.0174333798153616,1.50117487823271e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39633,-0.0427795106199882,0.00890513878881097,-0.0602335826460577,-0.0253254385939187,1.57642961136572e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39308,-0.0292333207289669,0.00609146765972556,-0.041172597342029,-0.0172940441159048,1.61566018852221e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,41758,-0.0454901324748179,0.00948807930394284,-0.0640867679105458,-0.0268934970390899,1.64906324069142e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,41911,-0.0238568705341692,0.00501452676067691,-0.0336853429850959,-0.0140283980832424,1.98012859707641e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41689,-0.0454400729667232,0.00957018288486966,-0.0641976314210677,-0.0266825145123786,2.0752483614065e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39328,-0.0664188150689973,0.0140307369050442,-0.093919059402884,-0.0389185707351106,2.23165076419748e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39250,-0.0338611152024884,0.00716608504592774,-0.0479066418925068,-0.01981558851247,2.32842048851142e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,41740,-0.0523707049561038,0.0110882918783421,-0.0741037570376543,-0.0306376528745533,2.34721597914678e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39063,-0.0122158572099058,0.0025862018021822,-0.0172848127421829,-0.00714690167762871,2.34865550567328e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,39633,-0.0427303058410725,0.009051997526384,-0.0604722209927851,-0.0249883906893599,2.38114793634806e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39600,-0.0573109363187018,0.0121524713508099,-0.0811297801662892,-0.0334920924711145,2.43495378571033e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39470,0.00409031685625343,0.000867383096496281,0.00239024598712072,0.00579038772538614,2.43879879107452e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41636,-0.0402935055479112,0.00854586436328471,-0.0570433996999492,-0.0235436113958732,2.44248847831556e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39385,-0.0432635451287833,0.00917788169640205,-0.0612521932537313,-0.0252748970038353,2.46071918904337e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,41740,0.0285190660294308,0.00605732686525086,0.0166467053735392,0.0403914266853225,2.52475988467748e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,41903,0.0151054741029682,0.00321134626667393,0.00881123542028731,0.0213997127856491,2.57953838454048e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39625,-0.0363123456034827,0.00771913266572443,-0.0514418456283026,-0.0211828455786628,2.57959383934526e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39308,-0.0201361841312574,0.00428255323019789,-0.0285299884624452,-0.0117423798000695,2.60956215913737e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,41855,-0.0302294167866284,0.00643182503171996,-0.0428357938487995,-0.0176230397244573,2.62811459176674e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39573,-0.0225783565247106,0.00481781467811485,-0.0320212732938158,-0.0131354397556055,2.81354803722655e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39308,-0.0161007741543456,0.00343936842145096,-0.0228419362603895,-0.00935961204830173,2.8853713680222e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,41865,-0.0117851582108731,0.00252203392197296,-0.0167283446979401,-0.00684197172380611,2.99927868633285e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41689,-0.0186476229078913,0.00399175443138309,-0.0264714615934021,-0.0108237842223804,3.01932280384307e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39408,-0.0369161960842171,0.00790188211862878,-0.0524038850367295,-0.0214285071317047,3.02140732323872e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,41914,-0.0168572054475761,0.00361121532205505,-0.023935187478804,-0.00977922341634822,3.07091914359999e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,41689,-0.0211670768050433,0.00453524171989876,-0.0300561505760449,-0.0122780030340417,3.0829576790253e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,41738,-0.0460567856172404,0.00987006730098752,-0.0654021175271759,-0.0267114537073048,3.09686320814322e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39308,-0.0185986392408523,0.00400409450255758,-0.0264466644658652,-0.0107506140158394,3.44285914451388e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,41740,-0.0416648673556358,0.00897394394594463,-0.0592537974896873,-0.0240759372215844,3.46927548967135e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39408,-0.0214412532657911,0.0046230203125241,-0.0305023730783383,-0.0123801334532438,3.56042134221463e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,41728,-0.0197888412853447,0.00427207068367831,-0.0281620998253541,-0.0114155827453352,3.65377027219199e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39589,-0.0256881367358466,0.0055458565959853,-0.0365580156639778,-0.0148182578077154,3.66395141858788e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,41877,-0.0199338111572805,0.00430642595292926,-0.0283744060250218,-0.0114932162895391,3.71180219279729e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39308,-0.0449447702888323,0.00971066968847956,-0.0639776828782522,-0.0259118576994124,3.72849146005742e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39250,0.0152796881664354,0.00330322948833719,0.00880535836929451,0.0217540179635763,3.77769705404408e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39600,-0.0246402600496813,0.00532738065117425,-0.0350819261259829,-0.0141985939733798,3.78485816065364e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41601,0.028081984750149,0.00607481599062859,0.0161753454085169,0.039988624091781,3.8244329005894e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39565,-0.0222994216053789,0.00482562293257864,-0.0317576425532331,-0.0128412006575248,3.86165775085286e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,41819,0.0136170780846179,0.00294856654859654,0.00783788764936866,0.0193962685198671,3.90728141367711e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39655,-0.0130854712362241,0.00284039550674656,-0.0186526464294474,-0.00751829604300087,4.13247924883156e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39241,-0.0272827627218692,0.00592318779302621,-0.0388922107962006,-0.0156733146475378,4.15064348243575e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41466,-0.0204057985063197,0.00443510917173926,-0.0290986124829286,-0.0117129845297107,4.24547210166548e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,41802,-0.0166004379696757,0.00361207667821182,-0.0236801082589709,-0.00952076768038054,4.35054756138903e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39250,-0.0307671746831818,0.00670651395026126,-0.0439119420256939,-0.0176224073406697,4.53370564749713e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39259,-0.0367336014364381,0.00801489412450445,-0.0524427939204668,-0.0210244089524094,4.63190909567901e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,41877,-0.0298380419279008,0.00651471913762707,-0.0426068914376498,-0.0170691924181517,4.68988154105571e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39408,-0.0327876261712768,0.007168582811896,-0.046838048482593,-0.0187372038599606,4.84295948388672e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39625,-0.0129599091113833,0.00283969518609027,-0.0185257116761202,-0.00739410654664639,5.07697935446457e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39427,-0.0215558467390014,0.00472423131230746,-0.030815340111124,-0.0122963533668788,5.10247243642426e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39408,-0.05275935143609,0.0115803140824268,-0.0754567670376466,-0.0300619358345334,5.2720233195202e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41447,-0.0230995364680761,0.00507680130278363,-0.033050067021532,-0.0131490059146201,5.41329603544669e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,41758,-0.0217031306732636,0.00477043855179404,-0.0310531902347799,-0.0123530711117473,5.42533332439125e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39625,-0.0432647532990851,0.00950902988960737,-0.0619024518827156,-0.0246270547154547,5.42551765673985e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41534,-0.0209252150315733,0.00460433020078546,-0.0299497022251128,-0.0119007278380338,5.55168930152026e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39598,-0.0219113831897118,0.00482811484103541,-0.0313744882781412,-0.0124482781012824,5.7313823325073e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39408,-0.0149934668527243,0.00330631388704404,-0.0214738420713306,-0.00851309163411797,5.82790000752308e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39625,-0.0138462021590011,0.00305387881579026,-0.01983180463795,-0.00786059968005224,5.8494763234836e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39334,-0.0426350973765245,0.00940697873067639,-0.0610727756886502,-0.0241974190643987,5.89802778058445e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,41740,0.0131221249066941,0.00289567947402129,0.00744659313761234,0.0187976566757758,5.90488202483982e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,39589,-0.0215559599176968,0.00476155655953704,-0.0308886107743894,-0.0122233090610042,6.04323361901634e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,39650,-0.0197722986624083,0.00437182953595784,-0.0283410845528857,-0.0112035127719309,6.17033910019413e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39308,-0.0300719403130179,0.0066514517983937,-0.0431087858378696,-0.0170350947881663,6.21768868182631e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41465,-0.0274374696680513,0.00608388045068447,-0.0393618753513929,-0.0155130639847097,6.54431631368038e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41521,-0.0547945777077187,0.0121606533540836,-0.0786294582817227,-0.0309596971337148,6.66751386261245e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,41925,0.014493046708176,0.00322248448038437,0.00817697712662261,0.0208091162897294,6.93459079883541e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41465,-0.0275869524432551,0.00614662169966256,-0.0396343309745937,-0.0155395739119165,7.2468566255572e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41636,-0.0377063531506219,0.00842364677878387,-0.0542167008370383,-0.0211960054642055,7.66096498107321e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39334,0.0154624022948763,0.00345480384542608,0.00869098675784113,0.0222338178319114,7.6973436666269e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39308,-0.0206466278175664,0.00461629514173533,-0.0296945662953677,-0.0115986893397652,7.80870862074843e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39600,-0.0360079714996919,0.00805598399660976,-0.0517977001330471,-0.0202182428663368,7.91063487916166e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,41689,-0.0264185021407076,0.00591975564578381,-0.0380212232064439,-0.0148157810749714,8.15828170612519e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,39598,-0.0298365565400982,0.00668613837195682,-0.0429413877491336,-0.0167317253310628,8.1833403270208e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,39598,-0.0180709914562849,0.00404980800566937,-0.0260086151473968,-0.0101333677651729,8.19345222373056e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39408,-0.0398453287568056,0.00894546326208172,-0.0573784367504857,-0.0223122207631254,8.50326534154297e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,41911,0.011646111779735,0.00261623302706939,0.00651829504667905,0.016773928512791,8.59734505038029e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39655,-0.0226714590011612,0.00509672170244188,-0.0326610335379473,-0.0126818844643751,8.74211146500729e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39244,-0.0480728219917924,0.0108252957080656,-0.069290401579601,-0.0268552424039838,9.05345781208126e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,41805,0.019360132698171,0.00436036765157849,0.0108138121010771,0.0279064532952648,9.06792593359912e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41877,-0.0158136196821982,0.00356212470609399,-0.0227953841061424,-0.00883185525825394,9.09468477283638e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,41876,-0.0126259670415791,0.00285364868212964,-0.0182191184585532,-0.00703281562460501,9.74360423839442e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,41636,-0.0264615662119353,0.00598578935784009,-0.0381937133533019,-0.0147294190705687,9.91627528134547e-06
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41521,-0.0360778344293968,0.00818349712446903,-0.0521174887933561,-0.0200381800654375,1.04876702790046e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39250,-0.0176667260931974,0.00401187332939405,-0.0255299978188098,-0.00980345436758509,1.07502956193226e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39589,-0.0208879882441174,0.00474354843376225,-0.0301853431742914,-0.0115906333139434,1.07549024348392e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41877,-0.0123956142444502,0.00281677592357909,-0.0179164950546652,-0.00687473343423517,1.08774447317929e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41636,0.0170173890377607,0.00387037476764757,0.00943145449317147,0.0246033235823499,1.10711939541985e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39250,0.0123697974242366,0.0028138774635086,0.00685459759575976,0.0178849972527135,1.11334098441345e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,39630,-0.0104888313621852,0.00238770814525153,-0.0151687393268782,-0.00580892339749217,1.12920979672889e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39241,-0.0312497498514517,0.0071160621422819,-0.0451972316503242,-0.0173022680525791,1.13691131897806e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39427,-0.0160729468448693,0.00366517995111061,-0.0232566995490461,-0.00888919414069254,1.16915130869254e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,39630,-0.017804883967419,0.00406115069381766,-0.0257647393273016,-0.00984502860753638,1.17492649213396e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,41810,0.01396744222983,0.00318665124324932,0.00772160579306129,0.0202132786665986,1.17900485035255e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39633,-0.0109353821509623,0.00249708724886582,-0.0158296731587393,-0.00604109114318524,1.20183494248738e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41521,-0.0248373421804048,0.00568786843569547,-0.0359855643143679,-0.0136891200464417,1.27106402513754e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41465,-0.0201719873784437,0.00462103217003703,-0.0292292104317163,-0.0111147643251711,1.27965252748943e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39427,-0.0219185585633898,0.00502502121082911,-0.0317676001366149,-0.0120695169901648,1.30140510065631e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39334,-0.0298544810879721,0.00684645239334713,-0.0432735277789325,-0.0164354343970117,1.30929421497884e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39625,-0.0186266347290548,0.00427254286010682,-0.0270008187348642,-0.0102524507232455,1.31473987338026e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,41802,0.0142229921256459,0.00326722702971788,0.00781922714739881,0.0206267571038929,1.35155638457717e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,41925,0.0293087426039442,0.00673375621564361,0.0161105804212827,0.0425069047866057,1.35590540060109e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,41740,-0.0413544748741592,0.00954265156523551,-0.0600580719420208,-0.0226508778062976,1.47749918029103e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39600,-0.0297079931510829,0.00685483145935572,-0.0431434628114201,-0.0162725234907457,1.47808091414598e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39308,-0.0417973906177826,0.00964500720583379,-0.0607016047412168,-0.0228931764943483,1.48044102654591e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39488,-0.0152483632348178,0.00352169229827174,-0.0221508801394304,-0.00834584633020522,1.50552632092597e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,41836,0.0165281559546603,0.00382070060538714,0.00903958276810151,0.0240167291412191,1.52989588167455e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39408,-0.0273922324629935,0.00633914431679015,-0.0398169553239023,-0.0149675096020848,1.56624105608215e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",41765,-0.0337855291213853,0.00782310644954472,-0.0491188177624929,-0.0184522404802776,1.5811102846088e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41521,-0.0408140580473863,0.00945457794212276,-0.0593450308139469,-0.0222830852808257,1.59445526336565e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41392,0.0320575276967615,0.00744636788793424,0.0174626466364104,0.0466524087571126,1.68135682444499e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39328,-0.0269507071835474,0.00626226024029426,-0.0392247372545242,-0.0146766771125707,1.69481317491791e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41317,-0.0413616874785111,0.0096138515847939,-0.0602048365847071,-0.0225185383723151,1.70295840889118e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41251,-0.017395805487833,0.00404723435432071,-0.0253283848223016,-0.00946322615336443,1.73482401057016e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41636,-0.0186556772161143,0.004344987297815,-0.0271718523198317,-0.0101395021123969,1.77062941111963e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39308,-0.0537602774363658,0.0125379966370764,-0.0783347508450355,-0.029185804027696,1.82042079719228e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,41925,-0.0142046309818496,0.00331323209446006,-0.0206985658869913,-0.00771069607670787,1.82176793433432e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,41758,-0.0137493140300391,0.00321347629192472,-0.0200477275622116,-0.00745090049786668,1.89366330692127e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,39600,-0.0350389156764764,0.00818994575921025,-0.0510912093645285,-0.0189866219884244,1.89932226084277e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39250,-0.032001094807403,0.00748716468136169,-0.0466759375828719,-0.0173262520319341,1.93557474616184e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39334,-0.0147086015001365,0.00344194148463268,-0.0214548068100165,-0.00796239619025639,1.94224271477676e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,39650,-0.015445845117003,0.00361701387553044,-0.0225351923130427,-0.00835649792096336,1.96814926774055e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39250,-0.0314296997973341,0.00736034500991387,-0.0458559760167653,-0.017003423577903,1.97044919793638e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",41758,-0.0348578051894827,0.0081669203167763,-0.0508649690103642,-0.0188506413686012,1.98463135842701e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,41915,0.02005143181263,0.00470388951154166,0.0108318083700084,0.0292710552552517,2.03331091229878e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,41703,-0.0397026121585251,0.00932167514452931,-0.0579730954418026,-0.0214321288752477,2.06617423229488e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,41865,-0.0310683389330365,0.00732736948320116,-0.0454299831201107,-0.0167066947459622,2.24993679831158e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,41925,-0.0161788542490593,0.00382033849950581,-0.0236667177080907,-0.00869099079002792,2.30160470756224e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,41877,-0.0240670036240389,0.00569833980371346,-0.0352357496393173,-0.0128982576087606,2.4212860961895e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,41844,-0.0224954027106079,0.00533003208762424,-0.0329422656023514,-0.0120485398188644,2.45385301436316e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,41911,-0.0104370999484517,0.00247614559967607,-0.0152903453238168,-0.00558385457308664,2.5136068288648e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39334,-0.0207771130577905,0.00493276434657537,-0.0304453311770782,-0.0111088949385027,2.55115555244935e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,41865,-0.0504036457092427,0.0119686613803618,-0.0738622220147518,-0.0269450694037336,2.5557883926213e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41689,-0.0521963102227297,0.0124081439146088,-0.0765162722953629,-0.0278763481500965,2.60948240641336e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,41698,-0.0158432420261616,0.0037664929564687,-0.0232255682208403,-0.00846091583148295,2.61238408923233e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,39650,-0.00957474883492449,0.00227792196175613,-0.0140394758799665,-0.00511002178988248,2.65142317714974e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41802,-0.0320706233266296,0.00764447912453612,-0.0470538024107204,-0.0170874442425388,2.74332733211039e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39259,-0.0287292714471409,0.00685288588068567,-0.0421609277732848,-0.015297615120997,2.78385604255579e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39334,-0.0196463986815141,0.00469712213003064,-0.0288527580563741,-0.010440039306654,2.90426759609736e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,39566,-0.041003542921753,0.00983368182194622,-0.0602775592927676,-0.0217295265507384,3.07340938275933e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39328,-0.0217525677114064,0.00522619643808896,-0.0319959127300607,-0.011509222692752,3.17632320133371e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,41802,0.0126405657247422,0.00303951139469291,0.00668312339114414,0.0185980080583403,3.22017655582141e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,41911,-0.0157037931096141,0.00378031285132562,-0.0231132062982124,-0.00829437992101593,3.28610688271236e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,41877,0.0146733626796065,0.00353586173208303,0.00774307368472378,0.0216036516744893,3.34739684135008e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39600,-0.0137971392106609,0.00332484454731199,-0.0203138345233924,-0.00728044389792941,3.35403204398478e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39600,-0.0209718354381303,0.00506492539992345,-0.0308990892219803,-0.0110445816542803,3.48982651765832e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41465,-0.0286896369277496,0.00693153930123343,-0.0422754539581671,-0.0151038198973321,3.5104606708179e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39250,-0.024596628136302,0.00594883304292629,-0.0362563409004375,-0.0129369153721664,3.58147326121725e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41925,-0.0102409251093718,0.00247769699355849,-0.0150972112167464,-0.00538463900199715,3.59867498370611e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,41802,0.0102996567413188,0.00249192939075898,0.00541547513543122,0.0151838383472064,3.59947158427886e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39408,-0.0164550378037452,0.00398408399154674,-0.0242638424271768,-0.00864623318031355,3.65185528439061e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41466,-0.0299439447454455,0.00725697797259572,-0.0441676215717331,-0.0157202679191579,3.7108344204142e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,39600,-0.0416663811730927,0.0101034982189632,-0.0614692376822606,-0.0218635246639249,3.75157829147409e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41466,0.0148097654640095,0.00359271627384453,0.00776804156727418,0.0218514893607448,3.77683979114316e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,41786,-0.036078343212485,0.00875830510212348,-0.053244621212647,-0.018912065212323,3.82295870621237e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,41925,0.0135719166795117,0.00329721338160763,0.00710937845156074,0.0200344549074626,3.87526839124634e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41534,-0.0350291832089328,0.0085111106951565,-0.0517109601714395,-0.018347406246426,3.88399052245609e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39589,-0.0472034151802718,0.0114696879380386,-0.0696840035388274,-0.0247228268217161,3.89174223987249e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39554,0.0119170907400372,0.0028988516320041,0.00623534154130917,0.0175988399387653,3.96874923968552e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41466,-0.0281507391299171,0.00685844856357022,-0.0415932983145147,-0.0147081799453194,4.07629561520809e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,41636,-0.0142524455979852,0.0034761222607447,-0.0210656452290448,-0.00743924596692555,4.15477957235789e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41466,-0.0207471952278958,0.00506655666075831,-0.030677646282982,-0.0108167441728095,4.24878482942158e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41911,-0.0153565645280658,0.00375071772040262,-0.0227079712600549,-0.00800515779607666,4.25946736821309e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,39589,-0.0209514470350573,0.0051219711201069,-0.0309905104304669,-0.0109123836396478,4.33506026828688e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,39600,-0.0341811109517928,0.00836797180070969,-0.0505823356811838,-0.0177798862224018,4.44361982467782e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41521,-0.0402259489256918,0.00985930982442931,-0.0595501961815732,-0.0209017016698104,4.53068639809068e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39308,-0.0227030516677356,0.00557125452815601,-0.0336227105429214,-0.0117833927925498,4.6339639987753e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,41911,-0.0274647234507122,0.00674310152425689,-0.0406812024382557,-0.0142482444631687,4.66781049757024e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,41736,-0.0103560896131538,0.00254390550600422,-0.015342144404922,-0.0053700348213855,4.70978448978581e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41617,0.0198174908941666,0.00487032447985315,0.0102716549136544,0.0293633268746787,4.74880617913321e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41576,-0.03027350341406,0.00744595423721884,-0.044867573719009,-0.0156794331091111,4.81575904541771e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39600,-0.0173811354969803,0.00427666357401538,-0.0257633961020505,-0.00899887489191016,4.85365549768691e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39600,-0.0210523482856995,0.00519969591705523,-0.0312437522831277,-0.0108609442882712,5.18414490907772e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,39633,0.0212867955830602,0.00526346166170661,0.0109704107261153,0.0316031804400052,5.28463131605795e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,39600,-0.0150338552358818,0.00372033826183248,-0.0223257182290735,-0.00774199224269015,5.35878412691025e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,41865,-0.02030396552178,0.00502681652353437,-0.0301565259079074,-0.0104514051356527,5.39518727408484e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41521,-0.0153085187287832,0.00379002354873556,-0.0227369648843049,-0.00788007257326147,5.39526066404274e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39334,-0.0127003324585218,0.00314489125644842,-0.0188643193211607,-0.00653634559588289,5.41911187806099e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39598,-0.0230901515264059,0.00572184373016584,-0.0343049652375309,-0.0118753378152809,5.48692483865209e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39633,0.014079865354364,0.0034892915232292,0.00724085396883476,0.0209188767398932,5.49321705444258e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41636,-0.0400500373129214,0.0099275213743809,-0.059507979206708,-0.0205920954191348,5.50909158338338e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,39600,-0.0443126041636936,0.0109920462686994,-0.0658570148503444,-0.0227681934770429,5.5835230158881e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41764,-0.0135544396226454,0.00336514952655646,-0.020150132694696,-0.00695874655059471,5.65964883708749e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39408,-0.0183116488761345,0.00456248334352263,-0.0272541162294389,-0.00936918152283016,6.02218851960134e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,41805,0.0284374710632888,0.00708774945902217,0.0145454821236053,0.0423294600029722,6.04870938900742e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41465,-0.01847832265384,0.00462594559519688,-0.0275451760204259,-0.00941146928725411,6.51927648000565e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39328,-0.020863303872228,0.00523221245582134,-0.0311184402856378,-0.0106081674588182,6.72238403051891e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39633,-0.0183189022967448,0.00459426673565121,-0.0273236650986212,-0.00931413949486847,6.72491560511348e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,41802,-0.0260111198267603,0.00652470965641114,-0.0387995507533261,-0.0132226889001945,6.74001823728874e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39334,-0.0342644548864676,0.00860297244592411,-0.0511262808804789,-0.0174026288924564,6.8539586253164e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,41740,-0.0238216117103624,0.00599017426644777,-0.0355623532726,-0.0120808701481247,7.02286935939997e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39598,-0.0418399829483353,0.0105359913457654,-0.0624905259860355,-0.0211894399106352,7.19826595305312e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41617,-0.0409466958592781,0.0103389381450552,-0.0612110146235864,-0.0206823770949698,7.5211625478886e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39328,-0.0257576008376795,0.00650443513446149,-0.038506293701224,-0.0130089079741349,7.54321800474394e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41465,-0.0220191378285114,0.00556139112007285,-0.0329194644238542,-0.0111188112331686,7.55787670759142e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39625,-0.0136196760467529,0.00344069478554758,-0.0203634378264262,-0.00687591426707969,7.59243819512045e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39259,-0.0175936164017693,0.00445375607681776,-0.0263229783123321,-0.00886425449120647,7.85603070821735e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39408,-0.0293908638392836,0.0074491191603119,-0.0439911373934949,-0.0147905902850723,8.01209435737959e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,39589,-0.0143366325734434,0.00363706613344029,-0.0214652821949864,-0.00720798295190044,8.13694258827713e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41521,-0.0187882578978175,0.00476910914633015,-0.0281357118246246,-0.00944080397101043,8.20556702575408e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41466,0.0134761617012048,0.00342154881428749,0.00676992602520132,0.0201823973772083,8.23858684448766e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,41740,-0.020029320010504,0.00509198376067976,-0.0300096081814363,-0.0100490318395717,8.41480470640739e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39408,-0.0348584200910969,0.00886173981798216,-0.052227430134342,-0.0174894100478519,8.42109522105743e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39408,-0.0164929723924526,0.00419490847649919,-0.024714993006391,-0.00827095177851419,8.48862453557776e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,41905,-0.0245008367882004,0.00623646383315604,-0.0367243059011862,-0.0122773676752145,8.58583714395777e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41384,0.0163894393936441,0.00417182175423957,0.00821266875533453,0.0245662100319537,8.58893993625933e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,41925,-0.0165306647520375,0.00420944402418271,-0.0247811750394356,-0.00828015446463941,8.64300618732205e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,41716,-0.0373139896090846,0.0095110011424326,-0.0559555518482524,-0.0186724273699167,8.78096338389317e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41676,-0.0262901392753925,0.00670391443582631,-0.0394298115696121,-0.013150466981173,8.84083811692292e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41466,-0.0256313486569332,0.00653789095298897,-0.0384456149247916,-0.0128170823890748,8.88490802751576e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39308,-0.030579646616716,0.00780225320936473,-0.0458720629070709,-0.0152872303263612,8.93462226825202e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,41888,-0.0119077123451873,0.003041169961152,-0.0178684054690452,-0.00594701922132937,9.06663206073126e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41581,-0.0180243065096503,0.00461149755507142,-0.0270628417175903,-0.00898577130171036,9.33202228833913e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39600,-0.0274229359718897,0.0070180480025796,-0.0411783100569458,-0.0136675618868337,9.38194452457705e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39250,-0.0362060346801763,0.00926817198174761,-0.0543716517644016,-0.018040417595951,9.42248174042514e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41689,-0.0253200113076465,0.00648338442441916,-0.0380274447795081,-0.012612577835785,9.45540351288262e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,41740,0.0279152542517608,0.00714946435959599,0.0139023041069526,0.0419282043965689,9.48829854286807e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,41765,-0.0334961853818746,0.00858540573957378,-0.0503235806314392,-0.01666879013231,9.60636181202002e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39616,0.0302934322572079,0.00776653914796523,0.0150710155271961,0.0455158489872198,9.6562153467311e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,41740,-0.0202952086266779,0.00520497652234698,-0.030496962610478,-0.0100934546428779,9.69937116503914e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41802,-0.0113555872556296,0.0029155598305269,-0.0170700845234623,-0.00564108998779689,9.87550866163822e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39530,0.01726936378936,0.00443548681997512,0.00857580962220872,0.0259629179565112,9.94146856762934e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41534,-0.0384539521531598,0.00987715221590224,-0.0578131704963282,-0.0190947338099914,9.94181749377997e-05
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41466,0.0188287461935513,0.00484527904446445,0.00933199926640102,0.0283254931207017,0.0001024212017338
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39158,-0.0163350673284835,0.00421437451936397,-0.0245952413864368,-0.00807489327053009,0.000106814692235287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39625,-0.0122473832639155,0.00316008075896346,-0.0184411415514839,-0.00605362497634711,0.00010695436061418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39408,0.0133248341510689,0.00343842978662598,0.00658551176928202,0.0200641565328559,0.000107137088910512
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,39598,-0.0348920383996293,0.00900829031764009,-0.0525482874222039,-0.0172357893770548,0.000107982592313943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39308,0.0176029262157823,0.00454816885311857,0.0086885152636699,0.0265173371678947,0.000109332058402033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41488,-0.0306099614929054,0.00791903316681075,-0.0461312664998545,-0.0150886564859564,0.000111466903911766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39334,-0.0170167090378768,0.00440350020594783,-0.0256475694415345,-0.00838584863421903,0.000112036594632829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41622,-0.0192169067111519,0.00497537363972355,-0.02896863904501,-0.00946517437729372,0.000112819903580161
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,41911,-0.0163896420544292,0.00425048699256399,-0.0247205965598547,-0.00805868754900382,0.000115826161258499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,41689,0.0185994454545303,0.00482433614278168,0.00914374661467818,0.0280551442943823,0.000116122728434579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39600,-0.0191924929834478,0.00498247480995397,-0.0289581436109576,-0.00942684235593802,0.000117821852124684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,41708,-0.0271178028466598,0.00704369794298607,-0.0409234508149125,-0.0133121548784071,0.000118708876401273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39250,0.0171395678446432,0.00446085886486269,0.00839628446951236,0.0258828512197741,0.000122638045388598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41466,-0.0434143139023499,0.0113020582582568,-0.0655663480885332,-0.0212622797161666,0.000122984336783428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41465,-0.0191516166089347,0.00499508053710933,-0.0289419744616689,-0.00936125875620037,0.000126627747275517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39589,-0.0291892255562956,0.00762060643112679,-0.0441256141613041,-0.0142528369512871,0.000128697641119674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41465,-0.0188311346975004,0.004916920253899,-0.0284682983951425,-0.00919397099985838,0.0001288227597634
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39600,-0.0358057067063728,0.00936058195183513,-0.0541524473319696,-0.0174589660807759,0.000131410425896768
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39598,-0.0405835571660271,0.0106119002479511,-0.0613828816520113,-0.0197842326800429,0.000131844952706316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,41740,-0.0278193988794654,0.00728677152752725,-0.0421014710734188,-0.013537326685512,0.000135268087715042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,41840,-0.028168994372973,0.00738554171713812,-0.0426446561385637,-0.0136933326073822,0.000137315757116512
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39308,-0.0127438320189155,0.00334525225291436,-0.0193005264346276,-0.00618713760320331,0.000140010759620119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39598,-0.0433790267441716,0.0113883491531495,-0.0657001910843447,-0.0210578624039985,0.000140248986659572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39408,-0.035286383771766,0.00926688030068217,-0.053449469161103,-0.0171232983824289,0.000140986504127041
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41534,-0.0194647141543008,0.00511243309945334,-0.0294850830292293,-0.00944434527937221,0.000141124443990079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39600,-0.0344800551852866,0.00906538736960097,-0.0522482144297045,-0.0167118959408687,0.000143447051793378
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39334,-0.0197875723677975,0.00520502136596085,-0.0299894142450807,-0.00958573049051418,0.000144541939640156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39650,-0.00665185808644753,0.00175257738997647,-0.0100869097708014,-0.00321680640209365,0.000148150191918241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41465,-0.0127699971163712,0.00336657611831815,-0.0193684863082748,-0.00617150792446767,0.000149416727412287
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41689,-0.0292063683653842,0.00770057835839095,-0.0442995019478305,-0.014113234782938,0.000149658089329827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41521,-0.0149081577588591,0.00393139275519792,-0.022613687559047,-0.00720262795867119,0.000150070520908584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,39613,-0.0191572169436685,0.00505191295547548,-0.0290589663364004,-0.00925546755093654,0.000150193767302606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41689,0.0107551699660511,0.00283726339038381,0.00519413372089886,0.0163162062112034,0.000150906922939933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39625,-0.0247728489623773,0.00654735251250855,-0.0376056598868941,-0.0119400380378606,0.000155366873575166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,39636,-0.0142487044910286,0.00377178838689449,-0.0216414097293418,-0.0068559992527154,0.000159111899437085
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39427,-0.0297570408634316,0.00789151268686023,-0.0452244057296777,-0.0142896759971855,0.000163613590283435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,41707,-0.0127049136623154,0.00337303659412801,-0.0193160653868063,-0.00609376193782453,0.000166203084701523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39462,-0.00535900123057848,0.00142681063009507,-0.00815555006556482,-0.00256245239559214,0.000173601044742183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39427,0.01343777019775,0.00358295404678949,0.0064151802660426,0.0204603601294574,0.000177421811377822
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41614,-0.012896232869795,0.0034392212579274,-0.0196371065353327,-0.00615535920425727,0.000177775156601797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41533,-0.0292271859177952,0.00779700933885976,-0.0445093242219604,-0.0139450476136301,0.000178661106474611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,41802,-0.0136637108059197,0.00365045654723978,-0.0208186056385097,-0.00650881597332971,0.000182597188087358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41354,-0.0493070601825917,0.0131775662774994,-0.0751350900864906,-0.0234790302786928,0.000183550113155724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,41877,0.0133188584720958,0.00357014327595784,0.0063213776512184,0.0203163392929731,0.000191802522649236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,41925,0.0293227328938947,0.00787119005667448,0.0138952003828128,0.0447502654049767,0.000195869825956356
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41466,-0.0163774295707367,0.00440366146231526,-0.0250086060368747,-0.00774625310459884,0.000200824470782618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41521,-0.0288220973492291,0.00775707331896089,-0.0440259610543924,-0.0136182336440657,0.00020358545861232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39595,-0.00785802167423266,0.00211538089729348,-0.0120041682329279,-0.00371187511553744,0.000204445978071659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,41911,-0.0240764087878844,0.00648754562296192,-0.0367919982088898,-0.0113608193668791,0.00020714090618587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41408,-0.0130360200774365,0.00351441768202107,-0.0199242787341978,-0.00614776142067522,0.000208713578916245
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39385,0.0193146518608553,0.00521555592260805,0.00909216225254356,0.0295371414691671,0.000213893621949679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39334,-0.017159947974146,0.00463433930133351,-0.0262432530047597,-0.00807664294353228,0.000214316674469926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,41802,-0.00971682744264055,0.00262462418122325,-0.0148610908378381,-0.00457256404744297,0.000214626106100061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41689,-0.0177018507522291,0.00478154403020591,-0.0270736770514327,-0.00833002445302554,0.000214682985951975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39308,-0.0117179193528401,0.00316708221232998,-0.0179254004890068,-0.00551043821667332,0.000216756049423826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41465,-0.0299018735826715,0.00809005540665683,-0.0457583821797188,-0.0140453649856241,0.000219822147274625
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39308,-0.0400101482840694,0.0108307322018036,-0.0612383833996044,-0.0187819131685343,0.000221738209977364
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41534,0.0154941325899891,0.00420115057583375,0.00725987746135493,0.0237283877186232,0.000226887937572797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39589,-0.0242736327779704,0.00658285634320069,-0.0371760312106438,-0.0113712343452971,0.000227647562048673
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,41765,-0.0506808812246004,0.0137460849105945,-0.0776232076493656,-0.0237385547998352,0.000227886096832978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39308,-0.00997298207568367,0.00270902726595758,-0.0152826755169605,-0.00466328863440682,0.000233107183620085
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39308,-0.0343168941452704,0.00933179578654742,-0.0526072138869033,-0.0160265744036375,0.000236761970470127
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,41865,-0.0137519412399117,0.00374515729737986,-0.0210924495427762,-0.00641143293704716,0.000241674752550614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,41765,-0.00683751127330289,0.00186643362946005,-0.0104957211870446,-0.00317930135956118,0.000249856323401355
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41617,-0.0290304313492808,0.00792795618077812,-0.0445692254636059,-0.0134916372349557,0.000251461129827475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39598,-0.0221256202003876,0.00604627969211295,-0.033976328396929,-0.0102749120038462,0.000254011406588619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,39650,0.00873614923516671,0.00239043089683164,0.0040509046773767,0.0134213937929567,0.000258742829088375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,41740,0.0305494480512107,0.00836812173671488,0.0141479294472495,0.0469509666551719,0.000262547855513814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,41765,-0.0264361862383246,0.00725319731769089,-0.0406524529809987,-0.0122199194956504,0.000268668299478891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,41836,-0.0180184141542383,0.00495538444432081,-0.0277309676651071,-0.00830586064336948,0.000277816555427788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,41810,-0.013916140019037,0.00382861620548679,-0.0214202277817911,-0.00641205225628285,0.000279284839930504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39308,-0.0283680022998477,0.00780957810607481,-0.0436747753877543,-0.0130612292119411,0.000282041078674575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39545,-0.0182305971971686,0.00501978771905314,-0.0280693811265127,-0.00839181326782445,0.000282795661736848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,41802,0.014715769661979,0.0040531669172642,0.00677156250414118,0.0226599768198169,0.000283740017412225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39169,-0.0320822947011428,0.00884195088597167,-0.0494125184376473,-0.0147520709646384,0.000286507891566353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41465,-0.0259045924232054,0.00715448659961216,-0.0399273861584452,-0.0118817986879655,0.000294881319136328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,41877,0.00639558165647325,0.00176641814253469,0.00293340209710525,0.00985776121584125,0.000294957876052509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39308,-0.0297009977995388,0.008217381717972,-0.0458070659667639,-0.0135949296323136,0.000302411692591435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,41802,0.0105804202074251,0.00292777259771912,0.00484198591589566,0.0163188544989546,0.000302849311784185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41534,-0.0253326532886955,0.00701940307196689,-0.0390906833097506,-0.0115746232676404,0.000308603161529201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,41765,-0.0253614394727306,0.00703062855119673,-0.0391414714330762,-0.011581407512385,0.000310570432509365
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41617,-0.0276137689321011,0.00765955412959563,-0.0426264950261085,-0.0126010428380937,0.000313149774916293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39600,-0.0138032729692739,0.00383383840598181,-0.0213175962449982,-0.0062889496935495,0.000319151461902227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,41827,0.0161691751876484,0.00449406399203135,0.00736080976326695,0.0249775406120298,0.000321972481998005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41706,-0.0731797095632346,0.020417899423836,-0.113198792433953,-0.0331606266925162,0.000339475807775241
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,41802,-0.0261817507735015,0.00730811621873914,-0.0405056585622302,-0.0118578429847728,0.000341470239145612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39250,-0.0225153688788971,0.00628528015959458,-0.0348345179917025,-0.0101962197660917,0.000342182772230812
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,41765,-0.00956261073311466,0.00267417915162182,-0.0148040018702934,-0.00432121959593589,0.000350268982252106
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39576,-0.0145588957925054,0.0040752251290137,-0.0225463370453722,-0.00657145453963851,0.000355052953548376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39600,-0.0191458646395784,0.00536771399270864,-0.0296665840652873,-0.00862514521386947,0.000362824584919592
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39328,-0.00846596458811463,0.00237675801203694,-0.013124410291707,-0.00380751888452222,0.000369663860561182
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41765,-0.031235368951127,0.00877500296036108,-0.0484343747534347,-0.0140363631488193,0.000372749708197649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39334,0.00985862591361061,0.00278250342111847,0.00440491920821842,0.0153123326190028,0.000397165702400052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41636,-0.0127327563280872,0.00359579773104092,-0.0197805198809274,-0.00568499277524697,0.000399988721914982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41465,-0.0279072783550788,0.0078896868936128,-0.0433710646665599,-0.0124434920435977,0.000405840824805316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39399,-0.00789757639944099,0.00223310146860936,-0.0122744552779153,-0.00352069752096665,0.000407019373704958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39259,-0.0205290067300333,0.00580969323375209,-0.0319160054681874,-0.00914200799187918,0.000411710293952575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39334,-0.0117033818209251,0.00331360316752218,-0.0181980440292686,-0.00520871961258165,0.000414285428633017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,41740,-0.0232268933395362,0.00657989125609141,-0.0361234802014754,-0.0103303064775971,0.000417010593062259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,41750,0.0146498419229039,0.00415405983523284,0.00650788464584751,0.0227917991999602,0.000422314226687878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,41911,-0.0323820928586263,0.00919802215518654,-0.050410216282792,-0.0143539694344607,0.000432093235247486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39334,-0.020710695493246,0.00588943853862741,-0.0322539950289558,-0.00916739595753631,0.0004389461825493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,41745,0.0349539077608418,0.00995424963678779,0.0154435784727377,0.0544642370489459,0.000447153767051462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,41758,0.00915505659921521,0.00260924036000776,0.00404094549359999,0.0142691677048304,0.000451796684676273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41534,-0.017904516198469,0.005103755534476,-0.027907877046042,-0.00790115535089606,0.000452841333620696
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39250,-0.0136472179181032,0.00389002329554962,-0.0212716635773804,-0.00602277225882592,0.000452906611512749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41431,-0.0108653893388174,0.00309838725145099,-0.0169382283516614,-0.00479255032597349,0.000455099389688618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39427,-0.0107970606036745,0.00308041853928303,-0.0168346809406693,-0.00475944026667979,0.000458345562548935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39334,-0.0156367191797799,0.00446552881794778,-0.0243891556629575,-0.00688428269660222,0.000464265778400278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41636,-0.0371418962024929,0.0106122216037182,-0.0579418505457805,-0.0163419418592052,0.000466957072485642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41465,-0.0296653103328379,0.00849024260009115,-0.0463061858290166,-0.0130244348366593,0.000477356407859491
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39615,-0.00852343919116047,0.00244261447157858,-0.0133109635554545,-0.00373591482686646,0.000485864472091154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41689,-0.00866300627483662,0.00248555992450421,-0.0135347037268649,-0.00379130882280837,0.00049313282362763
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39308,-0.0226170255579715,0.00650434778123305,-0.0353655472091882,-0.00986850390675468,0.000508659375993675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39250,-0.0362026604710245,0.0104268693277752,-0.0566393243534639,-0.0157659965885851,0.000518540852335099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,41846,0.00826466532591365,0.00238238058302951,0.00359519938317581,0.0129341312686515,0.0005239074351729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39250,-0.0206554442635136,0.00595946824182769,-0.0323360020174959,-0.00897488650953135,0.000530370147628576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41534,-0.0241200701760069,0.00696499989881104,-0.0377714699776765,-0.0104686703743372,0.00053583798734724
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39600,-0.0107266864212403,0.00309844151366571,-0.0167996317880251,-0.00465374105445549,0.00053829120446311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,41879,-0.00755546298461874,0.00218472613901475,-0.0118375262170877,-0.00327339975214982,0.0005452773061594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39589,-0.0164727411279579,0.00476726465752806,-0.0258165798567129,-0.00712890239920285,0.000551580640028414
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41689,-0.0208859995383693,0.00604529680577301,-0.0327347812776844,-0.00903721779905422,0.000552206548701295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39598,-0.0175460574770454,0.00508929159006758,-0.0275210689935778,-0.00757104596051292,0.000567618917262331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41863,-0.0103541454102517,0.00300404448316009,-0.0162420725972455,-0.00446621822325791,0.000569163791133256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,41814,-0.0128252933975351,0.00373341207763171,-0.0201427810696932,-0.00550780572537693,0.000593774259161581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41504,-0.0189010294762039,0.00552097396770268,-0.0297221384529012,-0.0080799204995067,0.00062013369024478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41465,-0.0141603077203718,0.00413945025618976,-0.0222736302225037,-0.00604698521823987,0.000626270144349728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39250,-0.0161966775838308,0.00473613531395208,-0.0254795027991769,-0.00691385236848476,0.000629001727153207
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39250,0.013438615857821,0.003930259356606,0.00573530751887329,0.0211419241967688,0.000630248643603291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39633,0.0147828791574543,0.00433514820104416,0.00628598868340775,0.0232797696315009,0.000651942444328849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41911,-0.00921119408600277,0.00270623090197441,-0.0145154066538726,-0.00390698151813292,0.000666760569968647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39250,-0.0157994333128146,0.00464314096212504,-0.0248999895985796,-0.00669887702704948,0.000669576487801016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39334,-0.012017561845916,0.003533806496055,-0.0189438225781838,-0.00509130111364818,0.000674483060235728
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,41765,-0.00886822307461216,0.00261042397969919,-0.0139846540748226,-0.00375179207440176,0.000682719988040238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,41802,0.0119856373663251,0.0035330588588961,0.00506084200288874,0.0189104327297615,0.000694802591557231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39308,-0.0130324053783068,0.0038430326808477,-0.0205647494327683,-0.0055000613238453,0.000698446497567296
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41689,-0.0147803496755315,0.00436127972750302,-0.0233284579414374,-0.00623224140962555,0.000703565511157963
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39598,0.025471551773366,0.00752159704533731,0.0107292215645048,0.0402138819822271,0.000710497467920999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39408,-0.0377401945726855,0.0111541126464989,-0.0596022553598233,-0.0158781337855477,0.000718164384316359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39600,-0.0140834878017355,0.00416399629634972,-0.0222449205425809,-0.00592205506089,0.000721571164517415
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41799,0.0175229085121096,0.00518465505232347,0.00736098460955558,0.0276848324146636,0.000727582843695907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41465,-0.0220902926254617,0.00654223583541261,-0.0349130748628705,-0.00926751038805302,0.000736140001835273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41443,0.0163796080124746,0.00485189420032169,0.00686989537984409,0.0258893206451051,0.000737872651946044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,39650,0.0108231773148876,0.0032070087894886,0.00453744008748996,0.0171089145422853,0.000741097593099619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41534,0.0218304157941831,0.00649763587953199,0.00909504947030045,0.0345657821180658,0.00078239258893949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39600,-0.017532642015006,0.00521915115539107,-0.0277621782795725,-0.00730310575043946,0.000784085438748879
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,41750,-0.0110709033374177,0.00329937496989883,-0.0175376782784194,-0.00460412839641599,0.000794588372830848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,41765,-0.0163534179648853,0.00487906475655586,-0.0259163848877348,-0.00679045104203582,0.000805277904497984
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39308,-0.0190306597116895,0.00567857511190823,-0.0301606669310297,-0.00790065249234941,0.000807087849789631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,41925,0.00949833563434726,0.00283606772815676,0.00393964288716002,0.0150570283815345,0.000812930168585751
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39250,-0.0208910082198112,0.00624285701712706,-0.0331270079733802,-0.00865500846624213,0.000821556473458055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39600,-0.0155087427634373,0.00465452546842673,-0.0246316126815536,-0.00638587284532087,0.000865175685766604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39625,-0.0251041010695468,0.00754925905482211,-0.0399006488169981,-0.0103075533220955,0.000885886444639763
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39250,-0.0136741054108557,0.00411539603806656,-0.0217402816454661,-0.00560792917624522,0.000894605710099771
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,41764,-0.0115035831033742,0.00346534383579186,-0.0182956570215262,-0.00471150918522213,0.00090388787707195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,41650,-0.0163770602410908,0.00493402070073909,-0.0260477408145394,-0.00670637966764218,0.000905191381572018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41562,-0.0119902883561911,0.00361378428340596,-0.0190733055516668,-0.00490727116071541,0.000909364587157404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,41689,0.0115379635252586,0.00347790482296462,0.00472127007224796,0.0183546569782693,0.00091073122150996
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41466,-0.0124601723949489,0.00375773762559433,-0.0198253381411138,-0.005095006648784,0.000916109101371131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,41758,0.00826087144517636,0.00249317296237988,0.0033742524389118,0.0131474904514409,0.000924188394812448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39408,0.018386980687469,0.005550321563804,0.00750835042241314,0.0292656109525248,0.000926777597657903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41466,-0.0130118843277774,0.00393087201945078,-0.020716393485901,-0.0053073751696539,0.000934932181520129
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,41805,-0.0127651327436012,0.0038636274120963,-0.0203378424713099,-0.00519242301589243,0.000955952297265606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39600,-0.0339105307976593,0.010263490438898,-0.0540269720578993,-0.0137940895374193,0.00095621735955594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41466,-0.0239930288161066,0.00726752886373967,-0.0382373853890363,-0.0097486722431768,0.000964651747686201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,41764,-0.00841116460961826,0.00255115847608229,-0.0134114352227395,-0.00341089399649698,0.000979829766011072
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41521,0.0109965499656901,0.00333734312576001,0.00445535743920049,0.0175377424921797,0.000986861874130682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41636,-0.0202742838387114,0.00615648277104371,-0.0323409900699571,-0.00820757760746573,0.000993318269558529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,41636,0.00911826452690726,0.00277546407313154,0.00367835494356944,0.0145581741102451,0.00102138496320453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39259,-0.0346283554924786,0.0105410209821157,-0.0552887566174254,-0.0139679543675317,0.00102273616733995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41612,-0.0159900606039501,0.00487575074375186,-0.0255465320617037,-0.00643358914619642,0.00104261671271181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39589,-0.0153137286784808,0.00467117214591819,-0.0244692260844805,-0.00615823127248115,0.00104740947085276
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,41744,-0.0138775145098378,0.00423509368615666,-0.0221782981347049,-0.00557673088497077,0.00105266483349697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,41865,-0.0177099930106144,0.0054063123829503,-0.0283063652811969,-0.00711362074003177,0.00105633876732195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39408,-0.0440354206510507,0.0134491998208383,-0.0703958522998937,-0.0176749890022077,0.00106293356076048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39600,-0.00945460915288472,0.00289208899877538,-0.0151231035904845,-0.00378611471528498,0.00108210865729942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,41698,-0.00874453812696964,0.0026758686336471,-0.013989240648918,-0.00349983560502132,0.00108618120211424
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39427,-0.0237615221463049,0.00727297250011304,-0.0380165482465265,-0.00950649604608335,0.00108993951617153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39625,-0.0342015194054331,0.0104707512319053,-0.0547241918199675,-0.0136788469908987,0.0010926231691888
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39241,0.0118741191170695,0.00363993542292184,0.00473984568814265,0.0190083925459963,0.00110907827936868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41534,-0.0281202190697367,0.00862823656499114,-0.0450315627371193,-0.011208875402354,0.00112057963293739
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39408,0.00910380599903006,0.00279670787826062,0.00362225855763925,0.0145853534404209,0.00113666607670884
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,41773,0.0174785444999186,0.00537372287091176,0.0069460476729316,0.0280110413269057,0.00114644174466225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",41728,-0.0378984195819813,0.011667108204803,-0.0607659516633952,-0.0150308875005674,0.0011638326250557
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39427,-0.0257104303885166,0.0079181324537239,-0.0412299699978155,-0.0101908907792178,0.00116970159432938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39250,0.00719637541740346,0.00221709304932985,0.00285087304071696,0.01154187779409,0.00117457919418985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41465,-0.0199471956618822,0.00614783690074685,-0.031996955987346,-0.00789743533641834,0.00117921213785749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,39608,0.00654274002789668,0.00202151251711984,0.0025805754943418,0.0105049045614516,0.00121339018057544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39408,-0.0412585679157216,0.0127616499265755,-0.0662714017718095,-0.0162457340596337,0.00122859947491079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39589,-0.0178199478829034,0.0055212247162922,-0.0286415483268362,-0.00699834743897072,0.00125227798717466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39250,0.0220704513180815,0.00684835646294479,0.00864767265070968,0.0354932299854532,0.00127354234730479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41689,-0.00732988292024749,0.00227673408935842,-0.01179228173539,-0.00286748410510499,0.00128739912101623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39600,-0.0183813257811083,0.00571480043190663,-0.0295823346276453,-0.00718031693457134,0.00130166087280222
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,41734,0.0100674602374467,0.00313047271386311,0.00393173371827501,0.0162031867566184,0.00130325856587697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39328,-0.0222243437779246,0.00691299200871057,-0.0357738081149973,-0.00867487944085186,0.00130891774347247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,41705,-0.0115422613524207,0.00359570049517775,-0.0185898343229691,-0.00449468838187227,0.00133046774375638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,41739,-0.0113911740102416,0.00354873893191968,-0.0183467023168042,-0.00443564570367908,0.00133090251494626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",41758,-0.013186830488122,0.00411139976744959,-0.0212451740323232,-0.00512848694392085,0.00134269433206015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39241,0.0159445447229531,0.0049751703822953,0.00619321077365428,0.0256958786722519,0.00135543939650242
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,41836,0.0111391042179618,0.00348791101654714,0.00430279862552936,0.0179754098103942,0.00140824053475122
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39334,-0.0418677115234229,0.0131097454484229,-0.0675628126023318,-0.016172610444514,0.0014090045997388
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41597,-0.0189680058793274,0.00594097016907353,-0.0306123074107116,-0.00732370434794333,0.00141262785194096
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39328,-0.0133545530308532,0.00419581773465212,-0.0215783557907714,-0.00513075027093509,0.00146261956649674
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41534,-0.0181077251760545,0.00569464634376714,-0.0292692320098381,-0.00694621834227093,0.00147734215437452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41581,-0.00940683036725649,0.00296961661230446,-0.0152272789273732,-0.00358638180713975,0.00154010270848047
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39250,-0.0254010556401236,0.00802717212859068,-0.0411343130121614,-0.0096677982680859,0.00155848800243474
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39633,-0.0212057378295149,0.0067085156090515,-0.0343544284232558,-0.00805704723577393,0.00157644132043322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,41744,-0.0181479903792706,0.00574767190074344,-0.0294134273047278,-0.00688255345381349,0.00159515011002305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39334,-0.0215502010245653,0.00682804592427199,-0.0349331710361384,-0.00816723101299222,0.0016031956135781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41534,0.0114145064809703,0.00362162240019683,0.00431612657658451,0.0185128863853561,0.00162656663466398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41466,-0.0212367747140689,0.00674551177145298,-0.0344579777861168,-0.00801557164202106,0.00164608362101907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39600,-0.0091054955338843,0.0028948116399334,-0.0147793263481538,-0.00343166471961484,0.00166271355742648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39650,0.00514389134649339,0.00163759602147155,0.00193420314440916,0.00835357954857762,0.00168745171003092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,41802,-0.0279806808262502,0.00890874615549932,-0.0454418232910288,-0.0105195383614715,0.00168853124788102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41744,-0.00985018255103437,0.00313695108917936,-0.0159986066858259,-0.00370175841624283,0.00169293359483626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,39650,-0.00495181717297308,0.00157825612812473,-0.00804519918409755,-0.0018584351618486,0.00170828791233688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39250,-0.0153825714224046,0.00490777966811532,-0.0250018195719106,-0.00576332327289858,0.00172718458902478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41740,-0.0137440015661748,0.00438540849346762,-0.0223394022133714,-0.0051486009189783,0.00172802674433836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,41925,0.00530642699618488,0.0016987503418573,0.00197687632614458,0.00863597766622518,0.0017896079684842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41636,-0.0190816736731948,0.00612858346515547,-0.0310936972648995,-0.00706965008149005,0.00185249123333111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39308,-0.0110401128977155,0.00356339785817334,-0.0180243726997352,-0.00405585309569571,0.00195205224465578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41521,-0.0276753028806429,0.00894394834255428,-0.0452054416320493,-0.0101451641292365,0.00197695915780579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,39650,-0.00690932164958569,0.00223810934764558,-0.011296015970971,-0.00252262732820036,0.00202603507472714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,41740,-0.0113609932241288,0.00368108569182621,-0.0185759211801081,-0.00414606526814939,0.00203074920313965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39334,-0.016743546917374,0.00542817898725263,-0.0273827777323892,-0.00610431610235888,0.00204371120942358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39328,-0.0204707493094487,0.00663761532599311,-0.0334804753483952,-0.00746102327050216,0.00204720949902425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,41740,-0.0227420030335434,0.00738100367690776,-0.0372087702402826,-0.0082752358268042,0.00206626793974174
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41465,-0.0152633409241968,0.0049545806240581,-0.0249743189473507,-0.00555236290104293,0.00206983442282097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39600,-0.0122608646115259,0.00397996573515285,-0.0200615974524255,-0.00446013177062635,0.00207062027386836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41556,-0.0149590642954846,0.00485971281756341,-0.0244841014179089,-0.00543402717306031,0.00208705125194692
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,41865,-0.0255972564029055,0.00831576875169192,-0.0418961631562217,-0.00929834964958938,0.0020870891426596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,41689,-0.0245682013862456,0.00798921386563352,-0.0402270605628873,-0.00890934220960391,0.00210815167662145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,41925,-0.0106573759892124,0.00346759104354086,-0.0174538544345525,-0.00386089754387235,0.00212045328682926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,41865,0.00927691815324986,0.00302328921882607,0.00335127128435076,0.0152025650221489,0.0021558096152446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41521,-0.0152483844795402,0.00497283352854663,-0.0249951381954916,-0.0055016307635888,0.00217146356412111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39408,-0.00942736745543903,0.00308002570134768,-0.0154642178300805,-0.00339051708079758,0.00221282094018523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39334,-0.0107164301405765,0.00350167066634782,-0.0175797046466183,-0.00385315563453482,0.00221604783179902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,41925,-0.0285690624431884,0.00936843350030252,-0.0469311921037814,-0.0102069327825955,0.00229670558224008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,41740,-0.0112266083757964,0.00368238700715191,-0.0184440869098142,-0.0040091298417787,0.00230266966212138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,41740,-0.0295862187210904,0.00974374498826497,-0.0486839588980898,-0.0104884785440911,0.00239865208180314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,41786,-0.0188419730174385,0.00620715373198305,-0.0310079943321252,-0.00667595170275169,0.00240585308722658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,39625,-0.0232275596250669,0.00765460004118546,-0.0382305757057904,-0.00822454354434339,0.00241530043982788
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41470,-0.0180967083445529,0.00596566508029061,-0.0297894119019225,-0.00640400478718331,0.00242234987426466
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39655,-0.0131673911192618,0.00434640377816849,-0.021686342524472,-0.00464843971405153,0.0024553202421298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41570,0.0123804754243445,0.00408802178657409,0.0043679527226593,0.0203929981260297,0.00246273951711921
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39408,-0.00983642725858606,0.00325067709588838,-0.0162077543665273,-0.00346510015064483,0.00248426036995621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39600,-0.00843669157169591,0.00279113354679848,-0.0139073133234209,-0.00296606981997088,0.0025112742430749
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,41765,-0.0185915420011316,0.00615499246674481,-0.0306553272359514,-0.00652775676631174,0.00252789350357111
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39633,-0.0117993072050058,0.00391084499190759,-0.0194645633891447,-0.00413405102086697,0.00255809721840267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,41925,-0.00732307221931707,0.00243431020570172,-0.0120943202224925,-0.0025518242161417,0.00263226754293581
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39427,-0.0126986847039475,0.00422174588559088,-0.0209733066397056,-0.00442406276818933,0.0026364452822512
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41466,-0.0159042705862615,0.0052916415075263,-0.0262758879410131,-0.00553265323150996,0.0026561577845493
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,39650,-0.0059661581670921,0.00198542385832436,-0.00985758892940784,-0.00207472740477636,0.00266194468724049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,41740,-0.0206603295427552,0.00688540401548052,-0.034155721413097,-0.00716493767241338,0.00269955575193522
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,41636,0.0133005096056527,0.00443432586686484,0.00460923090659762,0.0219917883047078,0.0027098413961857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39598,-0.0123130282730213,0.00410746440838402,-0.020363658513454,-0.00426239803258861,0.00272615106318223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39308,-0.00999703660733123,0.00333808576771555,-0.0165396847120537,-0.00345438850260875,0.00275215652208121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41836,-0.0137401978841669,0.00458826475887476,-0.0227331968115614,-0.00474719895677235,0.00275277658849776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,41758,-0.0231983411040955,0.00775179117071885,-0.0383918517987045,-0.00800483040948661,0.00277086555264018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,41740,-0.0155262623335214,0.00519410937073831,-0.0257067167001685,-0.00534580796687435,0.00280221128486121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,39600,-0.00807280184425256,0.00271121893652577,-0.0133867909598431,-0.00275881272866205,0.00291191283789384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41465,-0.0117789548285965,0.00396213106734955,-0.0195447317206016,-0.00401317793659141,0.00295562749416539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39308,-0.0201412693706353,0.0067824161637817,-0.0334348050516474,-0.00684773368962315,0.00298819250626186
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,41786,-0.0275281567121995,0.00927851070884196,-0.0457140377015297,-0.00934227572286922,0.00301385606750619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41783,-0.0207540153749599,0.00699586602964639,-0.0344659127930668,-0.007042117956853,0.0030164149891406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39630,0.0058305620063672,0.00196699598185726,0.00197524988192697,0.00968587413080742,0.00304123553770062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39598,-0.00959046495212645,0.00324536550067065,-0.0159513813334409,-0.00322954857081197,0.0031320377933462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41557,0.0129407398993814,0.0043794649546145,0.00435698858833694,0.0215244912104258,0.0031336582919964
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39585,-0.0275478585424071,0.00932868305551156,-0.0458320773312097,-0.00926363975360441,0.00315340118256178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,41805,-0.0120512250497027,0.00408159202142849,-0.0200511454117025,-0.00405130468770282,0.00315685606117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41534,-0.0358209961800676,0.0121501109025156,-0.0596352135489981,-0.0120067788111371,0.00320198202764264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39633,-0.0192048673994343,0.00651807456752016,-0.0319802935517738,-0.00642944124709477,0.00322166609792445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39408,0.0303810139887702,0.0103129959857034,0.0101675418567916,0.0505944861207488,0.00322707559967303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39598,0.009585370541504,0.00325387862574425,0.00320776843504527,0.0159629726479627,0.00322765402697957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,41865,0.00936842281571122,0.0031903882728924,0.0031152618008421,0.0156215838305803,0.00332560199067098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39600,-0.0368037438432579,0.01253722885595,-0.0613767124009198,-0.0122307752855959,0.00333638935480657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,41727,0.0155971728431869,0.00531501351858404,0.00517974634676215,0.0260145993396116,0.00334610193351437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39600,-0.0399092262506732,0.0136180909932477,-0.0666006845974388,-0.0132177679039076,0.003389999575509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39598,-0.0197587641743641,0.00677541364573283,-0.0330385749200005,-0.0064789534287278,0.00354988363070361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41465,-0.0203368222368787,0.00697558393433122,-0.0340089667481679,-0.00666467772558955,0.00355812391329479
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39476,-0.0173660895126532,0.00596526480670193,-0.029058008533789,-0.00567417049151741,0.00360772474368995
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,41764,0.0102890908429314,0.00353970903926268,0.0033512611259765,0.0172269205598862,0.00365800410053054
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,41908,-0.0185638185764661,0.00639386112075196,-0.03109578637314,-0.00603185077979229,0.00369763119349755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41511,-0.0273518370402983,0.00943458417910753,-0.0458436220313491,-0.00886005204924754,0.00374861641005291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39250,-0.0201559501998599,0.00695594126737405,-0.033789595083913,-0.00652230531580673,0.00376724842681167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41740,-0.0306386783604117,0.0105786822965535,-0.0513728956616567,-0.00990446105916678,0.00378254951782919
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,41758,0.00989086380561277,0.00341729891313728,0.0031929579358637,0.0165887696753618,0.00380567035283702
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39427,-0.0161239329721422,0.00559206872476203,-0.0270843876726758,-0.00516347827160865,0.00394235694028253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39600,-0.0238932140976787,0.00829511975698548,-0.0401516488213702,-0.00763477937398712,0.0039794548833723
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39328,-0.0261783061800883,0.00910028021432498,-0.0440148554001652,-0.00834175696001132,0.00402715458205787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39385,-0.0317976867250339,0.0110540513788465,-0.0534636274275729,-0.0101317460224948,0.00402818796353717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41780,-0.00691559621725879,0.00240456647508748,-0.0116285465084303,-0.00220264592608733,0.00403361834606742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39308,-0.0117862941745153,0.00410117992420185,-0.0198246068259509,-0.00374798152307967,0.00406262420168247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41459,-0.0330334226568582,0.0115182790210021,-0.0556092495380222,-0.0104575957756941,0.00413861058633379
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,39589,-0.0259974046748491,0.00906596055493345,-0.0437666873625187,-0.00822812198717953,0.00414405687923719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41689,-0.00743638640042531,0.0025941824234867,-0.0125209839504592,-0.00235178885039137,0.0041561790055324
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,39600,-0.0367021390610484,0.0128065646443231,-0.0618030057639218,-0.0116012723581751,0.00416634156494789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,41689,-0.00946107894285905,0.00330793459183937,-0.0159446307428642,-0.0029775271428539,0.00424155126678911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39250,0.00953089875559295,0.00333257776400653,0.00299904633814015,0.0160627511730458,0.00424574508055623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39589,-0.00864988001275177,0.00302486196995392,-0.0145786094738615,-0.00272115055164208,0.00424981269979614
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,41673,-0.0209289924908312,0.00733583559253584,-0.0353072302522015,-0.00655075472946099,0.00433793293175006
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39259,0.0113358899563129,0.00397544419287625,0.00354401933827548,0.0191277605743504,0.00436001829261073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,41765,-0.0113828915997839,0.00399361220533342,-0.0192103715222374,-0.0035554116773304,0.00437493478531003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41447,-0.0123413011399711,0.00434210181822523,-0.0208518207036926,-0.00383078157624966,0.00448681576928796
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41466,-0.0336640381186697,0.0118579187924559,-0.0569055589518832,-0.0104225172854563,0.00453331697575916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39250,-0.011894864435612,0.00419113062204739,-0.0201094804548249,-0.00368024841639915,0.00454682115581398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41646,-0.0212054390437264,0.00747715729208247,-0.035860667336208,-0.00655021075124473,0.00457485366721341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41465,-0.0107538335114468,0.00379945219647804,-0.0182007598165438,-0.00330690720634985,0.00465671022751052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,41758,-0.00738435899479359,0.00261249640197554,-0.0125048519426657,-0.00226386604692154,0.00471229391967537
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39655,0.0434840348165033,0.0153953156563558,0.013309216130046,0.0736588535029606,0.00474395517074168
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39633,0.0065722043489355,0.00232769274046063,0.00200992657763266,0.0111344821202383,0.00475898266981121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,41805,-0.00868788130397902,0.00308083185895462,-0.0147263117475301,-0.00264945086042797,0.00480983432471057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39259,0.0174164740024222,0.00618212383537855,0.00529951128508026,0.0295334367197642,0.00485287034961058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,41705,0.00690031924109919,0.00245594369293371,0.00208666960294913,0.0117139688792493,0.00496703227092684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39241,-0.0182047847800459,0.00648598663796168,-0.0309173185904508,-0.00549225096964104,0.00501292468250729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,41911,-0.0109513944753194,0.00390441389316296,-0.0186040457059188,-0.00329874324471995,0.00504090065751183
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41465,-0.0113155659051728,0.00403655371359509,-0.0192272111838191,-0.00340392062652638,0.00506624015400667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,41787,0.00628937795782128,0.00224538488542998,0.00188842358237851,0.010690332333264,0.00510148344823847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39250,-0.0206923176751255,0.00739915435174958,-0.0351946602045547,-0.00618997514569635,0.00517394189446162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39250,-0.0128385744915126,0.00459085846952163,-0.0218366570917749,-0.00384049189125017,0.0051743693787606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39440,-0.0116513158639985,0.00416852114097956,-0.0198216173003185,-0.00348101442767859,0.00519794073347513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,41802,-0.00878623756417911,0.00315484002280252,-0.0149697240088721,-0.00260275111948617,0.00536035569802934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,41925,-0.00915306816116908,0.00329380004119242,-0.0156089162419062,-0.00269722008043194,0.00546234074939167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39589,-0.0102522641235489,0.00369045718486022,-0.0174855602058749,-0.00301896804122288,0.0054779444799074
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,41740,-0.00865746670231675,0.00312899571665778,-0.014790298306966,-0.0025246350976675,0.00566796491103809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,41865,-0.0149379472868802,0.0054089915882537,-0.0255395707998574,-0.00433632377390292,0.00575824961746966
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39241,-0.00865285406105702,0.00313816700453729,-0.0148036613899501,-0.00250204673216393,0.00583810159888319
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39308,-0.0182831469472391,0.00665575792734822,-0.0313284324848416,-0.00523786140963662,0.00602497505173433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,39589,-0.0130885314893176,0.00477430671280828,-0.0224461726464218,-0.00373089033221336,0.00612672664492629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,41765,-0.0198754881542888,0.00725625055022034,-0.0340977392327206,-0.00565323707585689,0.00616933192667101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39598,-0.00797460713455786,0.0029126166007059,-0.0136833356719414,-0.0022658785971743,0.00619223666261106
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,41877,0.0174522364976837,0.00638407441555557,0.0049394506431948,0.0299650223521726,0.00627072990208652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,41802,0.00979465570124094,0.00358528504462976,0.00276749701376661,0.0168218143887153,0.00630531282351104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,39600,0.0101007320714869,0.00369832499178129,0.00285201508759552,0.0173494490553782,0.00632116511598025
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,41802,-0.0205793926871364,0.00755574035308161,-0.0353886437791764,-0.00577014159509647,0.00646445949702798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,41744,-0.00680438222423059,0.00249950018818691,-0.0117034025930769,-0.00190536185538425,0.00649152894177121
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41466,-0.0213130568148152,0.00783095464627618,-0.0366617279215165,-0.0059643857081139,0.00650458397536077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39600,0.0125964928631151,0.00463969656780748,0.00350268759021241,0.0216902981360177,0.00663914116096905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39372,-0.0127998188694765,0.00473383115070648,-0.0220781279248612,-0.00352150981409184,0.00686379489317813
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39250,0.0100057821919929,0.00370779013700763,0.00273851352345798,0.0172730508605279,0.00697450222516224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39259,0.0144158612757276,0.00534289821413899,0.00394378077601517,0.02488794177544,0.00698389302172191
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39427,-0.0151797887725987,0.00562689433003143,-0.0262085016594603,-0.00415107588573714,0.00699241768264489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41534,-0.0106407151276253,0.00394538872233242,-0.0183736770233968,-0.00290775323185374,0.0070057828303145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39600,0.0207249652341098,0.00768666070202603,0.00565911025813877,0.0357908202100808,0.00702370523226932
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41534,-0.00974230378548404,0.00361402632108008,-0.016825795374801,-0.00265881219616709,0.00703333190711882
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41595,-0.00704005774756946,0.00261246863297115,-0.0121604962681929,-0.00191961922694599,0.00705232898415077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39328,-0.0104827021113625,0.0038921059063952,-0.0181112296878971,-0.00285417453482788,0.00708534635576743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39625,-0.0213454798656393,0.007936161194852,-0.0369003558075492,-0.00579060392372942,0.00716350935051334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",41758,0.0108650145222431,0.00405178405286652,0.00292351777862468,0.0188065112658614,0.00733759321281175
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39589,-0.0270146607032381,0.0100837873013984,-0.0467788838139789,-0.00725043759249735,0.00739480771523487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39427,-0.0202697620732964,0.00757354171315148,-0.0351139038310733,-0.00542562031551948,0.00745317418756828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41465,-0.0149031365753174,0.00558591853861784,-0.0258515369110083,-0.00395473623962638,0.00764037028198346
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39600,-0.0113160077397354,0.00424330995162421,-0.0196328952449188,-0.00299912023455191,0.00766920337706297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39589,-0.0184537419367275,0.00692424220593437,-0.0320252566603588,-0.00488222721309612,0.00770797605332227
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41534,-0.0168961260340952,0.00634159948500618,-0.0293256610247073,-0.0044665910434831,0.00772370797717367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,41877,-0.0114452404868315,0.00431665887020655,-0.0199058918724364,-0.00298458910122669,0.00802512122422531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,39655,-0.0261022138927165,0.00985734187804422,-0.0454226039736832,-0.00678182381174984,0.00810851371601987
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39241,-0.0213312659916885,0.00806164919970181,-0.037132098423104,-0.00553043356027295,0.00815653694222734
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39308,0.0269808889610485,0.0102203547458113,0.00694899365925835,0.0470127842628386,0.00830465361644809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41786,0.0252149755060269,0.0095522641553682,0.00649253776150524,0.0439374132505486,0.00830805935013368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39589,-0.017410837091122,0.00659585002050295,-0.0303387031313078,-0.00448297105093622,0.00831051081468069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39241,-0.0265507773629751,0.0100583750123881,-0.0462651923872558,-0.00683636233869441,0.00831081416729576
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,41740,-0.0102555076535557,0.00389719278294864,-0.017894005508135,-0.00261700979897637,0.00851052718503007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39598,-0.0153603138220092,0.00585641738842195,-0.0268388919033163,-0.0038817357407022,0.00873262473932668
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,41758,-0.0119025786850007,0.00454261882160441,-0.0208061115753453,-0.00299904579465604,0.00879786443667686
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,41877,-0.0167072992402039,0.00637780205736612,-0.0292077912726415,-0.00420680720776635,0.00881327189335848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39250,-0.0169492118383076,0.00647523641991506,-0.0296406752213411,-0.00425774845527411,0.0088690478207764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39600,0.0116044514581002,0.00443953715804384,0.00290295862833425,0.0203059442878661,0.00896404040716741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39250,0.0117860508235609,0.0045337352132268,0.00289992980563634,0.0206721718414854,0.00934520898885253
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41614,-0.0130225886376002,0.00501005348008316,-0.0228422934585632,-0.0032028838166372,0.009352188183781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39408,-0.00987169896298844,0.0037997282451856,-0.0173191663235522,-0.00242423160242467,0.0093895344689302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41466,-0.0184481468452124,0.00710283760445143,-0.0323697085499372,-0.00452658514048762,0.00940688449433886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41758,0.0102190746878712,0.00394146284509348,0.00249380751148795,0.0179443418642544,0.00953280451261854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39250,0.0127363518144817,0.00491524385832516,0.00310247385216443,0.0223702297767991,0.00957739319215261
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39598,-0.0129918455370074,0.00502072373219684,-0.0228324640521132,-0.00315122702190163,0.00967618149383858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39250,-0.01318562030119,0.00510947024048732,-0.0232001819725452,-0.0031710586298349,0.00987545754578852
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,39598,-0.0268749346435351,0.0104222117778942,-0.0473024697282077,-0.00644739955886243,0.00993243095601824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41534,-0.0103024713564343,0.00400060199505579,-0.0181436512667437,-0.00246129144612496,0.0100283425836318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,41692,0.0182300720188261,0.0070932880159638,0.00432722750753702,0.0321329165301151,0.0101794776650339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41414,-0.0158853410715309,0.00618355829951928,-0.0280051153385887,-0.0037655668044731,0.0102115078614505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41521,-0.0214811070581319,0.00836296020847713,-0.037872509066747,-0.00508970504951669,0.0102221254720398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39600,-0.0145786112736334,0.00568153697382756,-0.0257144237423354,-0.00344279880493136,0.0103021154623836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41465,-0.0142199193858066,0.00555459600811019,-0.0251069275617026,-0.00333291120991067,0.0104777034047401
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41465,-0.0129126471591337,0.00505155586529595,-0.0228136966551137,-0.00301159766315359,0.0105944553241663
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,41925,0.00736938930324156,0.00288483562686845,0.00171511147457939,0.0130236671319037,0.0106442498108475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,41836,-0.00853025108468492,0.00334154258073035,-0.0150796745429164,-0.00198082762645344,0.0106975617900933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39589,-0.0124491062308488,0.00487666971879011,-0.0220073788796774,-0.0028908335820202,0.0106998338317661
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39600,-0.0179566104697235,0.0070587805829798,-0.0317918204123639,-0.00412140052708312,0.0109767910821745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41666,0.0110188556093967,0.00433556280595489,0.00252115250972513,0.0195165587090683,0.0110490842823254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41534,-0.00978001849776495,0.00384852880926385,-0.0173231349639221,-0.00223690203160781,0.0110577218541569
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41744,-0.0158831727912049,0.00625369031401246,-0.0281404058066693,-0.00362593977574051,0.0111027489337163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39334,0.00589246093454283,0.00232625916896836,0.00133299296336484,0.0104519289057208,0.0113225693909199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39328,-0.0218249648890492,0.00861788545089343,-0.0387160203728003,-0.00493390940529807,0.0113387364287535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39600,0.00976280044972583,0.0038563620282947,0.00220433087426821,0.0173212700251834,0.0113678605116681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39295,-0.0100903386194954,0.00398952804542308,-0.0179098135885246,-0.00227086365046615,0.0114463364357515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,41689,-0.00764279097051479,0.00304718799967956,-0.0136152794498867,-0.00167030249114285,0.0121486661878064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39328,-0.00842220650842795,0.00335793754863475,-0.0150037641037521,-0.00184064891310384,0.0121512006759945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39250,0.00902870525890087,0.0036072642857215,0.00195846725888673,0.016098943258915,0.0123320864026904
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39328,-0.0173906850049185,0.00695287480340057,-0.0310183196195836,-0.00376305039025334,0.0123913338300604
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,41802,-0.029143432849721,0.0116819799374349,-0.0520401135270935,-0.00624675217234859,0.0126172813970954
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39250,0.0123352693378536,0.00494441313530302,0.00264421959265965,0.0220263190830475,0.0126182203409199
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39328,-0.0241785890199725,0.00970147167248214,-0.0431934734980375,-0.00516370454190751,0.0127082833670189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41855,-0.0080355584377024,0.00323259229275373,-0.0143714393314997,-0.00169967754390509,0.0129385048255885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39259,0.00756573586403248,0.00304474957762067,0.00159802669189597,0.013533445036169,0.0129759501731051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,41722,-0.0126345704170906,0.0050924875149994,-0.0226158459464895,-0.00265329488769181,0.0131130845948683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39308,-0.0165822989741649,0.0066843423946936,-0.0296836100677644,-0.00348098788056547,0.013125229672586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39408,-0.0298399132487841,0.0120300321574452,-0.0534187762773767,-0.00626105022019154,0.0131367130398675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39308,-0.00768497321987303,0.00311955819957724,-0.0137993072910444,-0.00157063914870164,0.0137751159911747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41587,-0.00796461191632487,0.00323619267750893,-0.0143075495642424,-0.00162167426840736,0.0138638692717764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39408,-0.022934572941069,0.00932162811509856,-0.0412049640466622,-0.0046641818354758,0.0138952505471462
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39241,-0.0195171374700732,0.00795764536423712,-0.035114122383978,-0.00392015255616848,0.0141976613712819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41465,-0.0193035067421928,0.00787099772840661,-0.0347306622898697,-0.00387635119451582,0.0142005002006322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39334,-0.0272634501548346,0.0111250875435427,-0.0490686217401783,-0.00545827856949091,0.0142765708878922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39259,-0.00827929208953788,0.00337934000256462,-0.0149027984945645,-0.00165578568451123,0.0143026572612707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39650,0.00503208382881568,0.00205432455946799,0.00100560769225843,0.00905855996537293,0.0143205779042377
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39241,-0.0149069003859866,0.00610635739517571,-0.026875360880531,-0.00293843989144224,0.0146543258584273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41637,-0.0152706812848088,0.0062595417177537,-0.027539383051606,-0.00300197951801153,0.01471739861281
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39241,0.0138505752879835,0.00567853539441985,0.00272064591492059,0.0249805046610464,0.0147396943135545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41590,-0.0111233440076777,0.00456881994532658,-0.0200782311005178,-0.00216845691483759,0.0149207764824827
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38213,-0.0276472194457298,0.0113733586612116,-0.0499390024217046,-0.00535543646975509,0.0150805485898688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39308,-0.00801943615380213,0.00329963034089791,-0.014486711621962,-0.00155216068564222,0.0150982973781273
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,41689,-0.00771680477687853,0.00318752734667355,-0.0139643583763587,-0.00146925117739837,0.015494046770065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41274,-0.01577207019457,0.00651630085055949,-0.0285440198616666,-0.00300012052747336,0.0155173048752439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,39600,-0.00790438957964423,0.00327024585054661,-0.0143140714467156,-0.00149470771257288,0.0156624772805894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,41925,0.00651158903045763,0.00269890158659672,0.00122174192072807,0.0118014361401872,0.0158490807592208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,41832,-0.0150442059623513,0.00623659364997877,-0.0272679295163097,-0.0028204824083929,0.0158680425855438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41299,-0.00939599411488388,0.00389891550869923,-0.0170378685119344,-0.00175411971783339,0.015971047549588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39393,-0.00935459204726848,0.00388930367992356,-0.0169776272599187,-0.0017315568346183,0.0161798984645448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,41758,-0.0106382986025762,0.0044398738112785,-0.019340451272682,-0.00193614593247029,0.0165852916308116
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,41866,-0.00793743398309712,0.0033135184710513,-0.0144319301863577,-0.00144293777983658,0.0166128489840927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,41715,-0.0104481245227852,0.00436757272330892,-0.0190085670604706,-0.00188768198509968,0.0167615264442092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,41925,0.0106270629478783,0.0044424653208435,0.00191983091902501,0.0193342949767315,0.0167635661520404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39241,-0.0110509082213583,0.00464780767096208,-0.020160611256444,-0.00194120518627262,0.0174404254186858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,41740,-0.0140220974771304,0.00589847575057184,-0.0255831099482512,-0.0024610850060096,0.0174569236330283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,41877,0.00711878149876934,0.00299640129929671,0.0012458349521478,0.0129917280453909,0.0175261468085664
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39241,-0.00919030982329407,0.00387335813553114,-0.0167820917689351,-0.00159852787765303,0.0176763566051024
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39625,-0.00705523638939754,0.0029786412490719,-0.0128933732375785,-0.00121709954121662,0.0178722600577003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39241,-0.0368898597051967,0.015584807557194,-0.067436082517297,-0.00634363689309639,0.0179487979807288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41534,-0.011913363912105,0.00504013532612385,-0.0217920291513077,-0.00203469867290227,0.0181081943977504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39308,-0.00695409049888012,0.0029469802327287,-0.0127301717550284,-0.00117800924273188,0.0183058661013431
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39600,-0.00616895256920915,0.00262101754018877,-0.0113061469479791,-0.00103175819043916,0.0186077036911903
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39408,-0.0073110663081956,0.00310645448739595,-0.0133997171034917,-0.00122241551289954,0.0186150039386699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39600,-0.0250976521093035,0.0106663643834181,-0.046003726300803,-0.00419157791780389,0.0186415680580086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,41911,0.0148950429890334,0.00633663912362274,0.00247523030673285,0.027314855671334,0.0187565758179989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41840,-0.00759248872237827,0.00323043103271644,-0.0139241335465025,-0.00126084389825404,0.0187727754941409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39259,0.00733046948564869,0.00311997488269527,0.00121531871556596,0.0134456202557314,0.0188153571422347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,41891,0.00963175111403543,0.0041053227192059,0.00158531858439185,0.017678183643679,0.018982484716328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,41862,-0.0168844689625734,0.00720827933217115,-0.0310126964536289,-0.00275624147151796,0.0191763337145277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41740,-0.00945715112398999,0.004039648616348,-0.0173748624120321,-0.00153943983594792,0.0192427804705721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41696,-0.00671331464659848,0.00287177465875316,-0.0123419929777547,-0.00108463631544228,0.019418390862214
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39334,-0.00984675647745407,0.00421438241550369,-0.0181069460118413,-0.00158656694306684,0.0194853279567084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41447,0.0150110984931362,0.0064517521790833,0.00236566422213292,0.0276565327641395,0.0199983022487028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41925,-0.00678513783500538,0.0029193041667121,-0.0125069740017611,-0.00106330166824968,0.0201280620088842
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41636,-0.0059193198856074,0.00254688861877218,-0.0109112215784009,-0.000927418192813921,0.0201334039171353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,41694,-0.0108340780158223,0.00466191176032936,-0.0199714250660679,-0.00169673096557674,0.0201430749680978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,41877,-0.0113606027065373,0.00489614685239864,-0.0209570505372387,-0.00176415487583598,0.0203389252360044
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39328,-0.0112169174036777,0.00484747989284911,-0.0207179779936619,-0.00171585681369339,0.0206882314858305
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,41805,-0.00670580472045649,0.00289846410295795,-0.0123867943622541,-0.0010248150786589,0.0207065037053138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39427,-0.0102408117409412,0.00442868832273957,-0.0189210408535107,-0.00156058262837163,0.0207753956706709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39408,-0.010070036672144,0.00436769943249908,-0.0186307275598422,-0.0015093457844458,0.0211535138934818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,39650,0.00567896658003645,0.00246572623575565,0.000846143157955369,0.0105117900021175,0.0212882181150195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39397,0.00817872329224107,0.00355187106159387,0.00121705601151709,0.0151403905729651,0.0213173496388494
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,41747,-0.0188094699208094,0.0081759058224076,-0.0348342453327283,-0.00278469450889048,0.0214299593570787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41466,-0.0124071620737133,0.00539561490027506,-0.0229825672782524,-0.00183175686917419,0.021493072108967
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,41750,-0.0233385225227712,0.0101509224034378,-0.0432343304335091,-0.00344271461203316,0.0215118580806839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41534,-0.0121190590472862,0.0052767757493177,-0.0224615395159489,-0.00177657857862349,0.0216530028010603
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41534,0.00883455355303671,0.00385861950018773,0.00127165933266877,0.0163974477734047,0.0220626765179239
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,41815,-0.00973909816723888,0.00425544043575637,-0.0180797614213214,-0.00139843491315639,0.0221169827257901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41447,-0.00886362618519338,0.00387477341254159,-0.0164581820737749,-0.00126907029661186,0.0221815983924835
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39334,-0.0109781196270528,0.0048049436651867,-0.0203958092108187,-0.00156043004328688,0.0223466121538747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,41708,-0.0189223361638683,0.00828381938267482,-0.035158622153911,-0.00268605017382567,0.0223726009182313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41534,0.0112996337229564,0.00494814136211349,0.00160127665321398,0.0209979907926988,0.0224104970632234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39633,-0.0155138174977242,0.00679724759392031,-0.028836422781808,-0.00219121221364039,0.0224865932563593
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,41877,0.012866310560105,0.00565838016937802,0.00177588542812406,0.0239567356920859,0.0229908683071679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41373,0.0162918852181273,0.00717324877507733,0.00223231761897571,0.0303514528172789,0.0231514179944556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39427,-0.010495109397172,0.00462200512430402,-0.0195542394408079,-0.00143597935353615,0.023185718105473
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41534,-0.0130067319607204,0.00573201269828935,-0.0242414768493675,-0.00177198707207325,0.023276288463585
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,41805,-0.0156356094581792,0.00689985236445862,-0.029159320092518,-0.00211189882384026,0.023462670534003
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41424,0.0114275078126293,0.00504607633464425,0.0015371981967266,0.021317817428532,0.0235518677225271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41465,-0.00753874422219906,0.00333253099355798,-0.0140705049695727,-0.00100698347482542,0.0237036497320358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41466,-0.00671495501399625,0.00296866923212853,-0.0125335467089682,-0.000896363319024318,0.0237176542604372
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39250,-0.0221557943103362,0.00980340337255816,-0.0413704649205502,-0.00294112370012224,0.0238407127647463
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,41752,-0.00749415898732206,0.00333377759133958,-0.0140283630663476,-0.000959954908296485,0.0245959967046679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39334,0.00525901320832345,0.0023400692789245,0.000672477421631431,0.00984554899501548,0.0246362967692394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39258,-0.0133579375112899,0.00594960717285846,-0.0250191675700925,-0.00169670745248729,0.0247770132597638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,41836,0.00705625162917129,0.00314328642824518,0.000895410229810745,0.0132170930285318,0.0247932882225708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41466,-0.00917051147091924,0.00408747048180151,-0.0171819536152502,-0.00115906932658828,0.0248772544705079
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41466,-0.0125034010454585,0.00557436646709004,-0.023429159320955,-0.00157764276996207,0.0249126434269193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39327,0.0169411204828225,0.00755665094165092,0.00213008463718673,0.0317521563284583,0.02498934983195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41750,0.00780269334985556,0.00348113759874388,0.00097966365631755,0.0146257230433936,0.0250154600931229
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39328,-0.0196099778001301,0.00875802257926479,-0.0367757020554891,-0.00244425354477109,0.0251706459800217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39241,0.0116221554383127,0.00519977498243063,0.00143059647274863,0.0218137144038767,0.0254297045146375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39334,-0.0152393117663674,0.00682612123682238,-0.0286185093905392,-0.0018601141421955,0.0256025166399057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39122,-0.0108530246453346,0.00486898306121189,-0.0203962314453099,-0.00130981784535931,0.025834099245859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,39600,-0.0147764873868105,0.00662963345744175,-0.0277705689633963,-0.00178240581022463,0.0258437198791683
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,41621,0.00649416956595676,0.00291512346756335,0.000780527569532601,0.0122078115623809,0.0259141346587706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39328,-0.0174791122597067,0.00787034202941657,-0.0329049826373632,-0.00205324188205019,0.0263796599087954
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41689,0.0162314894638956,0.00731363971309237,0.00189675562623452,0.0305662233015566,0.0264803414956102
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,41865,-0.00710420488491019,0.00320150796577613,-0.0133791604978314,-0.000829249271988981,0.0265023326856074
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,41786,-0.00724719458471313,0.00327441100214754,-0.0136650401489223,-0.000829349020503948,0.0268952727937444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39023,0.0122182339069785,0.00552257224922988,0.00139399229848795,0.0230424755154691,0.0269594468576871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,41840,-0.0143353996435009,0.00650637205616233,-0.027087888873579,-0.00158291041342272,0.0275917416910597
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39250,0.0135826151936004,0.00617131736159624,0.00148683316487177,0.025678397222329,0.0277626163882113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39589,-0.00873169135411877,0.00397924772512527,-0.0165310168953643,-0.000932365812873251,0.0282341995031443
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39600,0.00809958234289592,0.0036920385645591,0.000863186756360087,0.0153359779294318,0.0282708683132125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,39589,-0.0261190749064646,0.0119190240446729,-0.0494803620340235,-0.00275778777890566,0.0284454405040332
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39633,0.00795859995830223,0.00363960585161445,0.000824972489137907,0.0150922274274666,0.028787893288185
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39259,0.0143593889070819,0.0065834225574207,0.0014558806945373,0.0272628971196264,0.0291945890112945
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,39633,0.0196355535357647,0.00900736878289999,0.00198111072128076,0.0372899963502487,0.0292827283262115
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39427,-0.0131090249071154,0.00603267800846111,-0.0249330738036992,-0.00128497601053164,0.0298017328901651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,41925,0.00692705786534869,0.00318826340839129,0.000678061584901757,0.0131760541457956,0.0298224060014021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,41736,0.00999792812323662,0.00461037289072902,0.000961597257407742,0.0190342589890655,0.0301330370475649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39334,-0.0081888865432548,0.00378543501611899,-0.015608339174848,-0.000769433911661589,0.0305430571946894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,41689,0.00691971154341365,0.00319900569305843,0.000649660385019115,0.0131897627018082,0.0305529192370388
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39546,0.0167993092080293,0.00776661375516991,0.00157674624789629,0.0320218721681623,0.0305615331246791
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41591,-0.0129270598944239,0.00597730153136304,-0.0246425708958955,-0.00121154889295238,0.0305830931520289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41437,-0.0173672636103576,0.00803886552193892,-0.0331234400333579,-0.00161108718735733,0.0307592135108389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39427,-0.0162826148049236,0.00754636921604286,-0.0310734984683676,-0.00149173114147957,0.0309750065337994
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39334,-0.0130253114446581,0.00603781877012535,-0.0248594362341037,-0.00119118665521238,0.0310053864777295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,41805,-0.0202347770086531,0.00938945318892584,-0.0386381052589478,-0.00183144875835847,0.0311756422398825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,41805,-0.00951898350051269,0.00442041748840836,-0.0181830017777931,-0.000854965223232293,0.0313042994552774
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41689,-0.0158139010969309,0.00736261859208392,-0.0302446335374154,-0.00138316865644644,0.0317428864332819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,39589,-0.0160853784223288,0.00749088341041553,-0.0307675099067433,-0.00140324693791441,0.0317890427603334
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39408,0.0119841437329967,0.00558105779996967,0.00104527044505616,0.0229230170209372,0.0317924597480761
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,41911,-0.0112197115155612,0.00522726663502613,-0.0214651541202124,-0.000974268910909975,0.0318605261528511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39589,-0.00800470931143498,0.00373174528411411,-0.0153189300682986,-0.000690488554571324,0.0319722230667399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41521,-0.025425815758322,0.0118860156629665,-0.0487224064577363,-0.00212922505890767,0.0324432617086105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41521,-0.0137869721991361,0.0064530150818169,-0.0264348817594972,-0.00113906263877499,0.0326560805733748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39250,-0.0225623564839823,0.0105943205436175,-0.0433272247494726,-0.00179748821849203,0.0332221231642853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,41689,-0.0186474435796018,0.0087616228740753,-0.0358202244127894,-0.00147466274641422,0.0333300725223538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39259,0.0129514864868004,0.00609095633652295,0.00101321206721547,0.0248897609063854,0.0334972934366106
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39368,0.00779427608677537,0.00366656738541709,0.000607804011357876,0.0149807481621929,0.0335451726091513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39393,-0.0131050556315935,0.00617273764470036,-0.0252036214152062,-0.00100648984798085,0.033772017387368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41386,-0.0166537323565987,0.00784598097559052,-0.0320318550687562,-0.0012756096444413,0.0338081193616798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39600,0.00579589548898064,0.00273340469073068,0.000438422295148511,0.0111533686828128,0.0339951334904166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41465,-0.00681322815872676,0.00321339589427503,-0.0131114841115058,-0.000514972205947696,0.0340033843279383
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41534,0.00619171817426287,0.00292048937936051,0.00046755899071627,0.0119158773578095,0.0340169274941339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,41740,-0.0187103930605129,0.00883050967145815,-0.0360181920165709,-0.00140259410445494,0.0341231223272426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,39625,-0.0148705232648894,0.00703484644825623,-0.0286588223034716,-0.00108222422630714,0.0345515325648029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,41740,-0.015477939715576,0.00732267565041672,-0.0298303839903928,-0.00112549544075925,0.0345596896869357
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,41786,-0.0073442951087564,0.00347632970532554,-0.0141579013311945,-0.00053068888631833,0.0346488114515476
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,41925,-0.00956468870512183,0.00452810639382162,-0.0184397772370122,-0.000689600173231454,0.0346798570083231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39589,0.00934452865563346,0.00444142137001124,0.000639342770411425,0.0180497145408555,0.0354054671209398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41521,-0.0126011682832248,0.00599681249758282,-0.0243549207784871,-0.000847415787962423,0.0356329878614201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41502,0.0126734891857319,0.00603307329376292,0.000848665529956567,0.0244983128415072,0.0356894001356685
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,39650,0.00738941180362844,0.00351774131876149,0.000494638818855914,0.014284184788401,0.0356975859571198
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41521,-0.0108127074382349,0.00516072538840735,-0.0209277291995133,-0.000697685676956491,0.03617339806428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,41865,-0.00821396285300332,0.00392391265753723,-0.0159048316617763,-0.000523094044230344,0.0363404958259656
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,41865,-0.00623380639528692,0.00298530380245988,-0.0120850018481083,-0.000382610942465546,0.0368019931294709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,41740,-0.00743335591450137,0.00356124758989662,-0.0144134011906987,-0.000453310638304005,0.0368811616216951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39241,-0.0201621050138457,0.00969463753145885,-0.039163594575505,-0.00116061545218632,0.0375753551786181
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39250,-0.0144142114491155,0.00695443883222018,-0.0280449115602671,-0.000783511337963975,0.0382276061891972
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,39625,-0.0217513322430432,0.0105031088683975,-0.0423374256251023,-0.00116523886098414,0.038387404323764
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39259,0.0102920021930398,0.0049776681800286,0.000535772560183745,0.0200482318258958,0.0386984097654132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39625,0.00842200021100176,0.00408890760421874,0.000407741306733036,0.0164362591152705,0.0394488454628023
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41534,-0.00688637611529275,0.00334471121687743,-0.0134420101003725,-0.000330742130212979,0.0395252243916472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39328,-0.011909113696072,0.00579776753141667,-0.0232727380576487,-0.00054548933449533,0.0399915366787021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,41758,-0.0056832145299329,0.00277151009866405,-0.0111153743233144,-0.000251054736551353,0.0403272324660729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39250,-0.0111157953005754,0.00542354375794006,-0.021745941066138,-0.000485649535012924,0.0404333233513505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",41744,0.020710780916488,0.010107874000507,0.000899347875494168,0.0405222139574818,0.0404843733363258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39250,0.00859269453403502,0.004195229787147,0.000370044151226902,0.0168153449168431,0.0405642914239947
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,41765,-0.00563838835626511,0.00275298427960207,-0.0110342375442852,-0.000242539168245059,0.040569950755874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39408,-0.0208988994700154,0.0102064387153137,-0.0409035193520302,-0.00089427958800049,0.0406214496004223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39589,-0.0113242722841399,0.0055544990084608,-0.0222110903407231,-0.000437454227556753,0.041498194879019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41465,-0.0086964234438531,0.00427218886282318,-0.0170699136149865,-0.000322933272719669,0.0418120266808527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39328,0.0105145316986878,0.0051755675712276,0.000370419259081723,0.0206586441382939,0.0422217268321224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41502,-0.00786174263372072,0.00388035563473056,-0.0154672396777926,-0.000256245589648816,0.0427815677169521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39427,-0.0186753539969378,0.00921773168562564,-0.0367421081007641,-0.000608599893111551,0.0427867044311267
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39600,-0.021301085702244,0.0105322153655306,-0.041944227818684,-0.000657943585804049,0.0431520085747959
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,41925,0.00491228889776793,0.00243032840562028,0.000148845222752179,0.00967573257278368,0.0432743740582496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39328,-0.0109564140492675,0.00543241648145511,-0.0216039503529195,-0.000308877745615435,0.0437351713819362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39318,-0.00778414370389396,0.00386103571677576,-0.0153517737087745,-0.000216513699013468,0.0438168696426801
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41534,0.0103224265754607,0.00512019025455521,0.000286853676532462,0.0203579994743889,0.0438180992014152
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,41758,-0.0261391109024714,0.012966734987048,-0.0515539114770854,-0.000724310327857341,0.0438349969218753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39427,0.00582882726607644,0.00289678757157501,0.000151123625789423,0.0115065309063635,0.0442268049701843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41819,-0.0243040139968312,0.0121113805418004,-0.04804231985876,-0.000565708134902403,0.0448010038597976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39250,0.0097863273017055,0.00487759793488376,0.000226235349333328,0.0193464192540777,0.0448406856775519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39250,0.0118446759535446,0.00592106431264915,0.000239389900752297,0.023449962006337,0.0454791698429748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39408,-0.0177859760439411,0.00890835434157626,-0.0352463505534306,-0.000325601534451658,0.0458991131623417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,41838,-0.00872532717367135,0.00437080042145496,-0.0172920959997231,-0.000158558347619622,0.0459242556255475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,40938,0.010616099957074,0.00531893090536509,0.000190995382558439,0.0210412045315896,0.0459658152900905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39250,0.0109813309675924,0.00550387432204989,0.000193737296374629,0.0217689246388102,0.0460464866767933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,41775,-0.020323555493897,0.0101865520019787,-0.0402891974177752,-0.0003579135700187,0.0460486211026503
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,41765,-0.00977614809987266,0.00490307656585454,-0.0193861781689476,-0.00016611803079777,0.0461857237248934
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39655,-0.00523831778142035,0.00263273503102253,-0.0103984784422245,-7.81571206162008e-05,0.0466500578872045
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,41740,-0.0253838789671423,0.0127665746627908,-0.0504063653062124,-0.000361392628072249,0.0467983793856485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39241,0.0170051922389079,0.00859364795512304,0.000161642246866781,0.0338487422309491,0.0478631989940459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,41911,-0.0166733979656006,0.00842760774034886,-0.0331915091366843,-0.000155286794516801,0.047901255804811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41521,-0.0102388524268602,0.00517616052902571,-0.0203841270637506,-9.35777899698301e-05,0.0479410480303271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41466,-0.00807710626081076,0.00408344746781269,-0.0160806632977236,-7.35492238978855e-05,0.0479487040401421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,41786,-0.0102405436881193,0.00518465364248378,-0.0204024648273875,-7.86225488511021e-05,0.0482703089298559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39334,-0.0103573772897577,0.00524908713776958,-0.0206455880797861,-6.91664997293038e-05,0.0485010290055231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39600,-0.00637038249695174,0.00323148857097044,-0.0127041000960538,-3.66648978496796e-05,0.0487093221395912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39600,0.00966335372924528,0.00490985366560745,4.00405446546754e-05,0.0192866669138359,0.0490752665171872
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39408,-0.0134254113200004,0.00682331766507806,-0.0267991139435534,-5.17086964473591e-05,0.0491421177494612
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39334,0.00964065531263503,0.0048998720496371,3.69060953463209e-05,0.0192444045299237,0.049147612762844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41689,-0.00723936287697052,0.00368687109172591,-0.0144656302167533,-1.3095537187746e-05,0.0496032129103268
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39625,-0.00644837686813141,0.00329145407376463,-0.0128996268527101,2.87311644726115e-06,0.0501230698502486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39241,-0.00756400888073918,0.00386686650970489,-0.0151430672397608,1.5049478282402e-05,0.050478545944399
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,41762,0.00752355095599128,0.00385389043575437,-3.00742980872794e-05,0.0150771762100698,0.0509360663619808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41466,-0.0143252900176992,0.00733825701970719,-0.0287082737763253,5.7693740926899e-05,0.0509434890330093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39427,-0.0136036075805567,0.00697877750993596,-0.0272820115000312,7.47963389177795e-05,0.0512875051739394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,41765,0.00708785464730128,0.00364942284265827,-6.50141243089333e-05,0.0142407234189115,0.0521359965375432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39408,0.00439401459436254,0.00226478713389374,-4.49681880691907e-05,0.00883299737679427,0.0523880926633263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39328,-0.0122854255865425,0.00633221853590557,-0.0246965739169174,0.000125722743832461,0.0523881750379688
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39308,-0.0100744404995894,0.00520196882124781,-0.0202702993892351,0.000121418390056355,0.0528132980575453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39655,-0.0151542077471283,0.00782620263419917,-0.0304935649101587,0.000185149415902114,0.0528512383161513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41534,-0.0148452960169739,0.00768265823595041,-0.0299033061594367,0.000212714125488869,0.0533427650134629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41865,0.0092445492713647,0.00479039371912702,-0.000144622418124272,0.0186337209608537,0.0536516927580298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39334,-0.00911537863830607,0.00472654297600463,-0.0183794028712751,0.000148645594663013,0.0538129806514331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39241,-0.0126672034477678,0.00657245160442881,-0.0255492085924482,0.000214801696912703,0.053966616342173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39328,-0.0103088685414452,0.00535215497908154,-0.020799092300445,0.000181355217554597,0.0541163484037416
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39334,0.0059577411089745,0.00309834953772747,-0.000115023984971343,0.0120305062029203,0.0545220865622498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39427,-0.015229068759285,0.00792151507504608,-0.0307552383063753,0.00029710078780535,0.0545697775443446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,41802,-0.00756023483949617,0.00393426097690334,-0.0152713863542267,0.00015091667523438,0.0546725236674895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39250,0.00536459109943623,0.00279486570245254,-0.000113345677370739,0.0108425278762432,0.0549547249102048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41686,-0.00927394046778761,0.00484092824363102,-0.0187621598253044,0.000214278889729181,0.055420475822426
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,41636,-0.00799563542282988,0.00418656343024857,-0.0162012997461171,0.000210028900457321,0.0561766912895026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,41805,-0.00547019149492466,0.00287030647928806,-0.0110959921943293,0.000155609204479943,0.0566995967204968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,41847,-0.0085274770067797,0.00447556698683865,-0.0172995883009834,0.000244634287424052,0.056757512380849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39250,0.00814257548939064,0.00427588218340438,-0.000238153590081936,0.0165233045688632,0.0568976462234563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39328,0.0120622988916014,0.00635140117548002,-0.000386447412339397,0.0245110451955423,0.057570824529607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,41689,-0.00304042676039228,0.00160538246097969,-0.00618697638391248,0.000106122863127912,0.0582608984060743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,41740,-0.00892091145241659,0.00473107424864658,-0.0181938169797639,0.000351994074930702,0.0593709787686596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39334,0.00594146011747792,0.00315189187476542,-0.000236247957062299,0.0121191681920181,0.0594506609933666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,39604,-0.0064752831859574,0.00343626880453088,-0.0132103700428379,0.000259803670923116,0.0595380804227112
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,41740,0.00857768673616372,0.00456045442254096,-0.000360803932016561,0.017516177404344,0.0600097654767461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39334,-0.0117308105613978,0.00623925444448968,-0.0239597492725976,0.000498128149801921,0.0601130284176146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39250,-0.00701047814885736,0.00372940457896503,-0.0143201111236288,0.000299154825914099,0.0601646848773584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,41765,-0.0134713317551424,0.00717142576218254,-0.0275273262490201,0.000584662738735415,0.0603385276348586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,41765,0.00569290152448898,0.00303224512570144,-0.000250298921885847,0.0116361019708638,0.0604779526808826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41534,-0.0111924454691785,0.00596502942220938,-0.0228839031367088,0.000499012198351925,0.0606305970588477
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39328,0.00723392243249569,0.00385852100588964,-0.000328778739048007,0.0147966236040394,0.0608485586297131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39427,0.00823682014186683,0.00439609992627466,-0.0003795357136315,0.0168531759973652,0.0610034780651587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41465,-0.00960368443453168,0.00514247284322228,-0.0196829312072474,0.000475562338184,0.0618513600302998
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39328,-0.0110069925736695,0.00589395100046621,-0.0225591365345833,0.000545151387244263,0.061858119164899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41534,-0.00746930174703748,0.00400431795613717,-0.0153177649410663,0.000379161446991382,0.0621603294561103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39600,0.00997062906419081,0.00534839179462971,-0.000512218853283427,0.020453476981665,0.0623161175897859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,41877,-0.00738750492962627,0.00396345955689852,-0.0151558856611474,0.000380875801894832,0.0623573557048732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39334,-0.00597988757553779,0.00320866751171471,-0.0122688758984986,0.000309100747423049,0.0623957744060926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,39650,0.00401152539231642,0.00215250223399352,-0.000207378986310868,0.00823042977094371,0.0623964218470198
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41534,-0.0229032963286383,0.0123181808185715,-0.0470469307330385,0.00124033807576188,0.0630061371968517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,39655,-0.00428483370143923,0.00231495116370533,-0.00882213798230167,0.000252470579423208,0.0642049656052565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41466,-0.00989192430048943,0.00535505016022655,-0.0203878226145335,0.000603974013554619,0.0647390566716513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39334,-0.00715045087710734,0.0038709037287899,-0.0147374221855355,0.000436520431320866,0.0647412622038656
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39308,-0.0172125516430924,0.00932186407425409,-0.0354834052286304,0.00105830194244564,0.0648514242576314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,41805,-0.00670411409521221,0.00364277956104498,-0.0138439620348604,0.000435733844435955,0.065734271109866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39250,-0.00832787341569146,0.00452806536634592,-0.0172028815337295,0.000547134702346545,0.0659182849457496
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39334,-0.00926008568348177,0.00504579917247882,-0.0191498520615403,0.000629680694576725,0.0665026855193531
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39328,-0.0098586189244066,0.00539787837993413,-0.0204384605490775,0.000721222700264304,0.0678196532245926
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39241,0.00502416193200137,0.00275764264242877,-0.000380817647159017,0.0104291415111618,0.0684975140678829
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39598,-0.00706847081963229,0.00388352154418799,-0.0146801730462408,0.000543231406976176,0.0687680737410369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41465,-0.00971105015639699,0.00533813219214095,-0.0201737892529932,0.000751688940199271,0.06890644107765
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39589,-0.00699080850384285,0.00384324561192902,-0.0145235699032237,0.000541952895538034,0.0689408274944455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39308,-0.0170936346638997,0.00940504202402036,-0.0355275170309796,0.00134024770318021,0.0691689985896943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39308,0.00769463847586673,0.00423761544339443,-0.000611087793186351,0.0160003647449198,0.0694298687088536
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39643,-0.0220569506980632,0.0121474549989074,-0.0458659624959217,0.00175206109979532,0.0694331937164826
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,39600,-0.00993469764216631,0.00549752137867274,-0.0207098395443649,0.000840444260032248,0.0707704049633631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41293,0.00937659780845146,0.00519410348289036,-0.000803845018013652,0.0195570406349166,0.0710609876141635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,41744,-0.00526900003678187,0.00292041638137519,-0.0109930161442772,0.000455016070713508,0.0712236577972846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39600,-0.00798409965194871,0.004429639390917,-0.016666192858146,0.000697993554248613,0.0715056832686965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39334,0.00819955443771298,0.00455530591743102,-0.000728845160451824,0.0171279540358778,0.0718885744559251
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39328,-0.0201850259037042,0.0112182691180639,-0.0421728333751095,0.00180278156770105,0.0719994096684452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39625,-0.00641479735216008,0.00356737344971065,-0.013406849313593,0.000577254609272799,0.0721750452955022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39241,0.00575364957398738,0.0032012341820383,-0.000520769422807684,0.0120280685707824,0.0723128110321946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41534,0.00555579792599968,0.00310054410753767,-0.000521268524774152,0.0116328643767735,0.0731758182813288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39655,0.00540743544670669,0.00301800305878834,-0.000507850548518452,0.0113227214419318,0.0732041601929523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39308,0.0506983270088422,0.0282979226987028,-0.00476560148061535,0.1061622554983,0.0732266011329984
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,41925,0.00447333388437451,0.00249790902156611,-0.000422567797895075,0.00936923556664409,0.0733430468547068
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39250,-0.00877560401632395,0.00490454511667368,-0.0183885124450044,0.000837304412356465,0.0735981552275706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39328,-0.0133542678961642,0.00746698199116909,-0.0279895525988556,0.00128101680652717,0.073732854452839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41534,-0.0118554204728974,0.00664111437944059,-0.0248720046566009,0.00116116371080621,0.0742595580146019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,39596,0.00909872680092032,0.00509769502072688,-0.000892755439704372,0.019090209041545,0.0743098401282916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41805,-0.0227585202288259,0.0127863942792427,-0.0478198530161416,0.0023028125584898,0.0751150994514795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41614,0.00623351229927599,0.00350268333466909,-0.000631747036675417,0.0130987716352274,0.0751583687892184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,41685,-0.0061159026680597,0.00343867690111507,-0.0128557093942452,0.000623904058125829,0.0753346867503524
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,41744,-0.0567230373617059,0.0319164151831354,-0.119279211120651,0.00583313639723958,0.0755523556975927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41764,-0.00658359207455591,0.00370595151858184,-0.0138472570509763,0.0006800729018645,0.0756750005243695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41281,0.00447030826459423,0.00251830406065985,-0.000465567694299082,0.00940618422348754,0.0759009840700609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39250,-0.0210716703841107,0.0118980361046034,-0.0443918211491335,0.00224848038091205,0.0765858254475969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,41788,-0.0224686711266079,0.0126982284356469,-0.0473571988604759,0.00241985660726008,0.0768446602686508
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39259,-0.00907063935717653,0.00513751037217744,-0.0191401596866443,0.000998880972291246,0.0774964735736034
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39427,-0.0163973315936965,0.00930559271489778,-0.0346362933148961,0.00184163012750319,0.0780815861651262
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,41765,-0.0076016110513311,0.00432301094792583,-0.0160747125092657,0.000871490406603519,0.0787015807858875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39625,-0.00981654598257309,0.00558575882962885,-0.0207646332886456,0.00113154132349946,0.0788733361724825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,41740,-0.00643054785939172,0.00366747762096618,-0.0136188039964854,0.000757708277701984,0.079557031982983
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41454,-0.0159689483619337,0.00912015927598933,-0.0338444605428728,0.00190656381900541,0.0799782718214265
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39410,0.00983884258441341,0.00562524620477659,-0.00118663997694871,0.0208643251457755,0.0803105809288362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41521,-0.00925248789728449,0.00529580348933599,-0.019632262736383,0.00112728694181405,0.080637540857172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39334,-0.00755921753130788,0.00433067932001618,-0.0160473489985396,0.000928913935923825,0.0809258107258584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41466,-0.0109767296600972,0.00628921698607501,-0.0233035949528042,0.00135013563260984,0.0809521287474498
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41740,-0.01537672897051,0.00881448091198058,-0.032653111557992,0.00189965361697191,0.0810979502537125
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39589,-0.00537244490782343,0.00308434995414403,-0.0114177708179457,0.000672881002298871,0.0815643803472859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,41703,0.00530586609472096,0.00304653002145645,-0.000665332747333686,0.0112770649367756,0.0816002381044145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39406,0.0071442886824189,0.00410281884273973,-0.000897236249350965,0.0151858136141888,0.0816573192604666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,39655,-0.0138984930006392,0.00798237360114856,-0.0295439452588904,0.00174695925761197,0.0816854760196063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39334,0.00708754357029837,0.00407137279902428,-0.00089234711578922,0.015067434256386,0.0817430829896649
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,41758,-0.00819511268749664,0.00471037916019498,-0.0174274558414788,0.00103723046648552,0.0819177098037773
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39633,-0.00499197902857013,0.00286944029218357,-0.0106160820012499,0.000632123944109678,0.0819387533470437
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,41744,-0.0104391603131871,0.00601028355800809,-0.0222193160868829,0.00134099546050881,0.082431223063591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,39589,-0.00964628412820243,0.00555705550028086,-0.0205381129087529,0.00124554465234806,0.0826161834788809
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41689,0.00629409650529265,0.00363159738125289,-0.000823834361963025,0.0134120273725483,0.0830928804529353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39583,-0.0129389139017345,0.0074672539172778,-0.027574731579599,0.00169690377612994,0.0831674771026805
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39328,-0.00555149998518878,0.00320487110617753,-0.0118330473532967,0.000730047382919178,0.0832654653399454
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39625,-0.00997855355202219,0.005768445342717,-0.0212847064237475,0.00132759931970312,0.0836848058683546
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39328,0.00696163658668592,0.00402855243020714,-0.000934326176520068,0.0148575993498919,0.0840037399678559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41521,-0.0106817723993665,0.00620088660086906,-0.0228355101370698,0.00147196533833687,0.0849811614841194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41765,-0.00903617403549781,0.00526893765276952,-0.0193632918349261,0.00129094376393045,0.0863706402629444
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41925,-0.00542233352644515,0.00316584706520647,-0.0116273937742498,0.000782726721359528,0.0867801221636871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,41689,-0.034688556901737,0.0202814608420666,-0.0744402201521875,0.00506310634871345,0.0872234077567218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39427,0.00763666296699963,0.00446865839611629,-0.00112190748938829,0.0163952334233876,0.0874909766776562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39250,0.00735717381449299,0.00430623148779062,-0.00108303990157662,0.0157973875305626,0.0875737216260911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,39600,-0.01586568797648,0.00928891144978906,-0.0340719544180666,0.00234057846510651,0.0876600186126407
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39334,0.00773276412254984,0.0045313286842283,-0.00114864009853762,0.0166141683436373,0.087941827918321
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,41765,-0.00603530239875851,0.00355380706198197,-0.0130007642402432,0.000930159442726158,0.0894815873871968
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39600,-0.0152207104794461,0.00898147365804118,-0.0328243988492068,0.00238297789031459,0.090164728091965
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,39600,-0.0111791848536617,0.00660689545163868,-0.0241286999388735,0.00177033023155015,0.0906651263418259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39334,0.00817085862843546,0.00483155812371962,-0.001298995294055,0.0176407125509259,0.0908384085675064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,41736,0.0132438545047463,0.00783260531805344,-0.0021080519186384,0.0285957609281311,0.0908868901844249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39259,-0.0110784085678257,0.00655212502072789,-0.0239205736084524,0.00176375647280093,0.0909020396954416
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39600,-0.00818498431871133,0.00484795701623171,-0.0176869800705255,0.00131701143310282,0.0913749371527875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41534,-0.0247493777135806,0.0146854509146809,-0.0535328615063553,0.00403410607919399,0.091954995669521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41466,-0.0118319324718149,0.00702940413238902,-0.0256095645712974,0.00194569962766758,0.0923595564342418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,39553,-0.00511992079285585,0.00304184687309806,-0.011081940664128,0.000842099078416343,0.0923722511419927
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39600,-0.00532025322558726,0.00316383933633762,-0.011521378324809,0.000880871873634483,0.0926784358680657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39308,0.0069229720203663,0.00411998683100573,-0.00115220216840493,0.0149981462091375,0.0929206646946901
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41465,-0.00927377543299863,0.00552265543606997,-0.0200981800876958,0.00155062922169851,0.0931326836786974
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39328,-0.00494078505268417,0.00294249620139418,-0.0107080776074168,0.000826507502048423,0.0931590495426541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39334,-0.0152589308447481,0.00913862528572537,-0.0331706364047699,0.0026527747152736,0.0950042489417602
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,41734,0.00423238579090586,0.00253569835028862,-0.000737582975659827,0.00920235455747155,0.0951173584608162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39328,0.00736516916730225,0.00443179587022847,-0.00132115073834554,0.0160514890729501,0.0965635090048442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39328,-0.00706423709373684,0.00425837186234481,-0.0154106459439327,0.00128217175645898,0.0971640401289159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39427,-0.0072401238117129,0.00436652648812781,-0.0157985157284434,0.0013182681050176,0.0973268883677794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41415,0.00534973437791785,0.00322881394480959,-0.000978740953908946,0.0116782097097446,0.0975696508085758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39241,-0.00661365013716244,0.00399544517846379,-0.0144447226869515,0.00121742241262658,0.0978936687509976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,41758,0.00634808985953971,0.00383726215332294,-0.00117294396097326,0.0138691236800527,0.0980847578442402
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39600,-0.0104945682601425,0.00634889436122619,-0.0229384012081458,0.00194926468786086,0.0983643413650039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,41925,0.00984530761015929,0.00596191735870192,-0.00184005041289647,0.0215306656332151,0.0986874274896651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39241,-0.0103816695672275,0.00628990019698696,-0.0227098739533219,0.00194653481886693,0.0988640749163258
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39328,-0.0182308043748252,0.0110555695959271,-0.0398997207828423,0.00343811203319183,0.0991737617215857
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39250,-0.00987593416268996,0.00599577840567084,-0.0216276598378048,0.00187579151242488,0.0995571396873595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,41744,-0.00410424231123583,0.00249482269324477,-0.00899409478999558,0.00078561016752391,0.0999723173267648
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39334,-0.00589357186289662,0.00359740529660263,-0.0129444862442378,0.00115734251844453,0.101391754105467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41447,0.015998900430873,0.00977051529148944,-0.00315130954044626,0.0351491104021923,0.10155733310366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39334,0.00749417851497501,0.00458020503536516,-0.00148302335434071,0.0164713803842907,0.101824905308951
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,39625,0.00484485677726411,0.00296159928288521,-0.000959877817190892,0.0106495913717191,0.101890723068748
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39241,0.00745504347040056,0.00456367313685562,-0.00148975587783645,0.0163998428186376,0.102380415493159
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39334,0.0079320834054086,0.00485579676804658,-0.00158527825996269,0.0174494450707799,0.102387176522438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,41758,0.00496487287659131,0.00304507933239024,-0.00100348261489356,0.0109332283680762,0.103028744447039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41689,-0.0161750891733613,0.00995360988309376,-0.0356841645442251,0.00333398619750244,0.10417650774767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41911,-0.00482112368058455,0.00297419158817113,-0.0106505391934,0.00100829183223085,0.105044272630779
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,41877,-0.00756374165941563,0.00467100390703987,-0.0167189093172138,0.00159142599838251,0.105407170651106
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41689,0.0143696364007246,0.00887569093971685,-0.00302671784112039,0.0317659906425697,0.105473955365058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39650,0.00313745276538928,0.00194319361844682,-0.000671206726766493,0.00694611225754505,0.106428980460677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41534,0.00831072726425642,0.0051478409978443,-0.00177904109151842,0.0184004956200313,0.106462863279442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39250,0.00605698789181579,0.00375825441207497,-0.00130919075585116,0.0134231665394827,0.107067920079468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39259,0.00711986193702476,0.00441836973873937,-0.0015401427509044,0.0157798666249539,0.10711719907193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39250,0.00871482330264175,0.0054091223027395,-0.00188705641072766,0.0193167030160112,0.107180054204382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41534,0.0104084072147884,0.00646395006407827,-0.00226093491080505,0.0230777493403818,0.107373377224758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39334,0.00980741356658477,0.00612100883753642,-0.0021897637549866,0.0218045908881561,0.109128781312176
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,38782,-0.00964269915737897,0.00602117656156126,-0.021444205218039,0.00215880690328109,0.109305148181859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39250,-0.00988473426357164,0.00618200279629835,-0.0220014597443164,0.00223199121717311,0.109860626072957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39328,-0.0092149847408485,0.00577017707793185,-0.0205245318135949,0.00209456233189792,0.110294698362624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,41689,-0.00324027130838279,0.00202941282925052,-0.00721792045371381,0.000737377836948224,0.110366863825854
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39259,-0.0075624678026184,0.00474125437656879,-0.0168553263806932,0.00173039077545644,0.110734003463949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39334,-0.0146419858493492,0.00918770051010643,-0.0326498788491578,0.00336590715045941,0.111043722821103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39259,0.0104297969714399,0.00654645779177229,-0.00240126030043374,0.0232608542433136,0.111145653088517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,41865,-0.00463614621804514,0.00291025115362679,-0.0103402384791536,0.00106794604306336,0.111175065670969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,41829,-0.014161918069068,0.00889075899016699,-0.0315878056897953,0.00326396955165929,0.111210856425389
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39600,-0.0156749044443223,0.00986449908100938,-0.0350093226431007,0.00365951375445609,0.112084202084544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39195,-0.00741250246560537,0.00466926184956028,-0.0165642556907435,0.00173925075953278,0.11242689889264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39427,-0.0118056616050288,0.00745474046147292,-0.0264169529095157,0.0028056296994581,0.11330376029008
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41689,-0.00895053986460474,0.00566778124305995,-0.0200593911010022,0.00215831137179276,0.114315174573754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,41794,-0.00856037908670321,0.00542793123519297,-0.0191991243076814,0.002078366134275,0.114796968744744
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41466,-0.0114803522445508,0.00728768592489689,-0.0257642166573487,0.00280351216824713,0.11520988219376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39408,-0.00615822042998127,0.00391816721670791,-0.0138378281747288,0.00152138731476624,0.116047222192971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39598,-0.00934200259204477,0.00594911667320685,-0.0210022712715302,0.00231826608744066,0.116370009978572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,41740,-0.0085318532392628,0.00543681434844739,-0.0191880093622197,0.0021243028836941,0.116608107706798
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41740,-0.0202497562714004,0.012914058026795,-0.0455613100039185,0.0050617974611177,0.11689593617601
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39427,-0.00755569719247023,0.00481975815100874,-0.0170024231684473,0.0018910287835069,0.116991898959418
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39493,-0.00524153932289181,0.00334767121797101,-0.011802974910115,0.00131989626433138,0.117441582661206
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,39598,-0.00635656405395252,0.00406484590125193,-0.0143236620204063,0.00161053391250127,0.117895741167521
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41521,0.00540560121425351,0.00346085456237113,-0.00137767372799391,0.0121888761565009,0.118329743308351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,41790,-0.00447970430574491,0.00287031838971416,-0.0101055283495847,0.00114611973809485,0.118618674448344
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39241,0.006623804405875,0.00425018507220629,-0.00170655833564933,0.0149541671473993,0.119150583127721
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,39600,-0.0108600021853501,0.0069719353699918,-0.024524995510534,0.00280499113983384,0.119339324374969
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39589,-0.0089215051695668,0.00573489815597843,-0.0201619055552845,0.00231889521615092,0.119819689304043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,41764,-0.00843950367051623,0.00542549891009353,-0.0190734815342995,0.00219447419326709,0.119844928281037
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,41786,-0.00948489171344801,0.0061019053647115,-0.0214446262282826,0.00247484280138653,0.120109516053527
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39598,-0.00722526836759316,0.00465674008266951,-0.0163524789296254,0.00190194219443908,0.120793397529001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,39655,-0.00376103884089508,0.00242520802178388,-0.00851444656359148,0.00099236888180133,0.120975652186406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,41728,0.0114637264972415,0.00741026129512421,-0.0030603856412019,0.025987838635685,0.121885649127977
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39250,0.00634691712368673,0.00410696616851836,-0.00170273656660926,0.0143965708139827,0.122278569497647
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39250,0.00583525233013108,0.00379158277111565,-0.0015962499012556,0.0132667545615178,0.123833589924015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39308,0.00385037639761495,0.00250229526159748,-0.00105412231511611,0.00875487511034602,0.123897858820156
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39334,-0.0149936813295808,0.00974420536143024,-0.034092323837984,0.00410496117882249,0.123900197134757
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39107,-0.0177227788432079,0.0115455079674564,-0.0403519744594223,0.00490641677300657,0.124804914763499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,41683,0.00594788268595714,0.00387772250128296,-0.00165245341655745,0.0135482187884717,0.125088326285208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41877,-0.00547294194807684,0.00357306365496308,-0.0124761467118045,0.00153026281565079,0.12561475610666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39221,-0.0140045981968338,0.00914765657031801,-0.0319340050746571,0.0039248086809895,0.125811711895368
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41666,-0.00542466845231529,0.0035461607285866,-0.012375143480345,0.00152580657571445,0.126107782723449
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39250,-0.00632949114448447,0.00414097842020086,-0.0144458088480782,0.00178682655910922,0.126417804567786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39427,0.00985545142551929,0.00644799730439868,-0.00278262329110212,0.0224935261421407,0.126429678740595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39259,-0.0189660314564554,0.0124481793520462,-0.0433644629864659,0.0054324000735551,0.127638622931631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39259,0.00491810377064081,0.00323671440122487,-0.00142585645575993,0.0112620639970415,0.12867285711291
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39328,-0.0112990262340298,0.00744715429203317,-0.0258954486464148,0.00329739617835522,0.129238756464955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39250,-0.0111275328109103,0.00735075021131357,-0.0255350032250849,0.00327993760326425,0.130107381293092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39589,-0.00772862061577828,0.00511439828027811,-0.0177528412451234,0.00229560001356682,0.130779108809073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39598,-0.00443995060573447,0.00293862970539144,-0.0101996648283017,0.00131976361683276,0.130844829974298
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39328,-0.00547725028260284,0.00363527256162781,-0.0126023845033933,0.00164788393818767,0.131918065287971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39250,0.00698278103663018,0.00463526158307515,-0.00210233166619713,0.0160678937394575,0.131981837784099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39600,-0.00898540911588715,0.00596955657323105,-0.02068573999942,0.0027149217676457,0.132299975401992
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,41802,0.00616747800443758,0.00410294556972771,-0.00187429531222874,0.0142092513211039,0.132815780967929
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,39633,-0.00414329638222097,0.00276193768972687,-0.00955669425408563,0.00127010148964369,0.133606457504913
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,41732,0.00679027456530418,0.0045559600405168,-0.00213940711410876,0.0157199562447171,0.136138973381957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,39579,-0.00963861376645079,0.00648582925673291,-0.0223508391096473,0.00307361157674571,0.137280451985043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39600,-0.0189734987246861,0.0127753424812253,-0.0440131699878877,0.00606617253851544,0.137528627461805
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39259,-0.00754611267266303,0.00509886890713032,-0.0175398957306385,0.0024476703853124,0.138913965756318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41466,-0.00611667066929317,0.00413400472025997,-0.0142193199210027,0.00198597858241638,0.139004685478626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39250,-0.00746805641254894,0.00506842588312076,-0.0174021711434656,0.00246605831836774,0.140660125934504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41666,0.00620166716064197,0.0042335559602964,-0.00209610252153897,0.0144994368428229,0.142976708424611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39589,0.00684069387517943,0.00467205095293733,-0.00231652599257774,0.0159979137429366,0.143175114040971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,41744,0.00558188565010455,0.00381465179088488,-0.00189483186002982,0.0130586031602389,0.143415982151933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,41865,-0.0101340920688273,0.00693528342820744,-0.0237272475881139,0.00345906345045931,0.143974125614119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39328,-0.00747444890358867,0.00512452664978167,-0.0175185211371607,0.00256962332998341,0.144714487094064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39241,-0.00979653677654935,0.00672364148782557,-0.0229748740926875,0.00338180053958877,0.145138040976805
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39241,0.00657097659618,0.00451026429686678,-0.00226914142567889,0.0154110946180389,0.145175173511257
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,41720,-0.0067585378651118,0.00466577523071955,-0.0159034573173221,0.00238638158709851,0.147491433912528
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39334,0.00429411308173721,0.00297096307534236,-0.00152897454593382,0.0101172007094082,0.14838580695171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39334,-0.00262297852436637,0.0018172100532699,-0.00618471022877536,0.000938753180042627,0.148934290165469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39250,-0.00960177672155246,0.00665935994960709,-0.0226541222227824,0.00345056877967743,0.149375005752598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39328,0.00549613032923451,0.00381704925474047,-0.00198528621005682,0.0129775468685258,0.149927755656867
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41534,-0.00649976818569595,0.00451905647259198,-0.0153571188719762,0.00235758250058434,0.150372565954837
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39334,-0.00668175250259496,0.00465604614591496,-0.0158076029485883,0.00244409794339837,0.151296264894514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41899,-0.0058559392585646,0.004083755095215,-0.013860099245186,0.00214822072805679,0.151607342558097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39328,-0.0118444490041648,0.00826707994715844,-0.0280479257005954,0.00435902769226573,0.151965687809525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39241,0.0120402094917092,0.00843740089234419,-0.00449709625728545,0.0285775152407038,0.153607923391339
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,39598,-0.00739403007596356,0.00519918919872529,-0.0175844409054651,0.002796380753538,0.155010892841923
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39466,-0.00493158026898982,0.00347138014263875,-0.0117354853485618,0.00187232481058212,0.155450239185012
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39259,0.00498341704993058,0.00351118064177357,-0.00189849700794561,0.0118653311078068,0.155840949811165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,41765,-0.0115454305292609,0.00813897803638773,-0.0274978274805808,0.00440696642205909,0.156058108689026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39408,-0.0134594356332551,0.00951727546832231,-0.0321132955511668,0.00519442428465665,0.157328764840956
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,39598,-0.0135336378243291,0.00957009695029901,-0.0322910278469152,0.00522375219825693,0.157343557941131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,41708,-0.0129876190189155,0.00920616881949927,-0.0310317099051341,0.00505647186730307,0.158341549301367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,39598,-0.0142378697609139,0.0101023990200996,-0.0340385718403092,0.00556283231848138,0.158758404220202
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39598,-0.00574114947102739,0.00408810255030839,-0.0137538304696318,0.00227153152757705,0.16024124197043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39334,-0.00569812955339209,0.00405995560237319,-0.0136556425340435,0.00225938342725935,0.160498050472577
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41447,-0.00721804844615901,0.00515752546131343,-0.0173267983503333,0.00289070145801531,0.161681923352643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,41740,0.0066055153840525,0.00472317277358613,-0.00265190325217633,0.0158629340202813,0.161976518438808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39259,-0.0121836889780283,0.00872048175711639,-0.0292758332219764,0.00490845526591982,0.162402106366386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39334,0.00458413275639687,0.00328736951443015,-0.00185911149188622,0.01102737700468,0.163205078438556
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39328,-0.00531318397603595,0.00381271996339041,-0.0127861151042812,0.00215974715220924,0.163484934716425
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39250,-0.00873456983119213,0.00627304386655772,-0.0210297358096453,0.003560596147261,0.163831168442912
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39655,0.0089795193804633,0.00645256115847565,-0.00366750049014898,0.0216265392510756,0.164065206570942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39250,0.0122322270486093,0.00880421936068485,-0.00502404289833301,0.0294884969955516,0.164752462419802
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39427,0.00785088001426989,0.00565715899438441,-0.00323715161472354,0.0189389116432633,0.165233256497289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41350,-0.00390088546483249,0.00281098346608678,-0.00941041305836257,0.0016086421286976,0.165243595466103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41466,-0.00434189148865466,0.00313610306918892,-0.0104886535042649,0.00180487052695561,0.166233634356295
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41802,0.00515396094358832,0.00372837570352533,-0.00215365543532132,0.012461577322498,0.166884287721001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39598,-0.00413002286237488,0.00299388484600079,-0.00999803716053642,0.00173799143578666,0.167772942088455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,39598,0.00583692061914495,0.00423330279619713,-0.00246035286140142,0.0141341940996913,0.167981355890972
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,41805,-0.00418894924961567,0.00305110428420803,-0.0101691136466634,0.00179121514743206,0.169797764680092
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,41765,-0.00997456622249049,0.00726593066309268,-0.0242157903221521,0.00426665787717117,0.169842339110052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41636,-0.00896938458447963,0.00653914629603621,-0.0217861113247106,0.00384734215575134,0.170197714695654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39427,-0.00542888388354905,0.00396145932785481,-0.0131933441661445,0.00233557639904637,0.170582606977766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39250,0.00502822200946522,0.00366922069774608,-0.00216345055811709,0.0122198945770475,0.170597591101517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39241,0.00486646367826138,0.0035559210152497,-0.00210314151162803,0.0118360688681508,0.171168172806529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39328,-0.00886452687114045,0.00648549583171419,-0.0215760987013003,0.00384704495901937,0.171709336617208
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39250,0.0091614517824399,0.00670730052701441,-0.00398485725050835,0.0223077608153882,0.172001536076733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,41758,0.00895070003933255,0.00656306001747705,-0.00391289759492246,0.0218142976735876,0.172653908103704
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39250,-0.00735623376595161,0.00540439062735795,-0.0179488393955732,0.00323637186366997,0.173492315270541
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39427,-0.0115191176365403,0.00851584170787013,-0.0282101673839657,0.00517193211088516,0.176189549936218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39334,-0.00383176167531736,0.00284433651518013,-0.00940666124507041,0.0017431378944357,0.17795880976126
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39408,0.00599668635058994,0.0044548505541462,-0.00273482073553661,0.0147281934367165,0.178297631032195
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39241,0.00444561167009504,0.00330269110421143,-0.00202766289415936,0.0109188862343494,0.178312693502193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41465,-0.00675684179137411,0.00502967223770021,-0.0166149993772665,0.0031013157945183,0.179167462376955
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,41765,0.00403964449928536,0.00301357141652543,-0.00186695547710448,0.0099462444756752,0.180111148754483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,41636,0.00173451468498917,0.00129416543722715,-0.00080204957197604,0.00427107894195437,0.180185064057565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39259,-0.00691032918251926,0.00516147898854829,-0.0170268280000739,0.00320616963503538,0.180655440327781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,41706,-0.0113908582680888,0.00855223558312523,-0.0281532400110143,0.00537152347483659,0.182910998028845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39408,0.00643452508810889,0.00484138125924766,-0.00305458218001654,0.0159236323562343,0.183853579566716
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39427,-0.00824573884105338,0.00622982574114411,-0.0204561972936958,0.00396471961158909,0.185666992569697
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39241,0.00561192078670987,0.00424267572503204,-0.00270372363435293,0.0139275652077727,0.185953112635991
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39427,-0.00722517680297119,0.00548359292777859,-0.0179730189414172,0.00352266533547484,0.187665785365288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39328,-0.00757740889514744,0.00575122483064786,-0.0188498095632172,0.00369499177292236,0.18768930544911
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,41753,0.0268863542953527,0.0204142896072461,-0.0131256533348496,0.066898361925555,0.187849502601105
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,41740,-0.00696437247708367,0.00529883283043178,-0.01735008482473,0.00342133987056263,0.188760813906065
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,39650,0.00411317010496549,0.00313238694655009,-0.00202630831027269,0.0102526485202037,0.189172992439263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,39600,-0.00315406743208649,0.00241185108701071,-0.00788129556262749,0.00157316069845451,0.190989784612511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39241,-0.0116518355152384,0.008913831516965,-0.0291229452884898,0.00581927425801296,0.191185421898018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41598,-0.00901531423899827,0.00690945133404251,-0.0225578388537216,0.00452721037572504,0.191990854878858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39427,0.00463302426063649,0.00355677975468176,-0.00233826405853976,0.0116043125798127,0.192742621221514
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39427,-0.00877272200786377,0.00675678021939593,-0.0220160112378798,0.00447056722215226,0.194191879240194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39241,0.00926133094090382,0.00713530378118041,-0.00472386447020978,0.0232465263520174,0.194329596582534
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41521,-0.00536628303062112,0.00413570108727043,-0.0134722571616712,0.00273969110042892,0.194464838151155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39600,-0.00748599296455566,0.00578109493998539,-0.018816939046927,0.0038449531178157,0.195378736125314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41465,-0.0116127703487139,0.00896894256770552,-0.0291918977814167,0.00596635708398887,0.195420797894669
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39250,0.0053924359930626,0.00418047530287463,-0.00280129560057168,0.0135861675866969,0.197109991823262
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39589,0.00644506535127956,0.00503132535244685,-0.00341633233951627,0.0163064630420754,0.200225056859551
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,39600,-0.00475174202750663,0.00371033932020959,-0.0120240070951174,0.00252052304010417,0.200334541338631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41466,0.00995880600230325,0.00780963392305979,-0.00534807648689394,0.0252656884915004,0.20226326203194
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39600,-0.0224812613374742,0.0176494187238987,-0.0570741220363157,0.0121115993613673,0.202772631425007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39241,0.00566528548041865,0.00445802699949527,-0.00307244743859208,0.0144030183994294,0.203825612601459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,41765,-0.0112354834283718,0.00885312196985917,-0.0285876024892957,0.00611663563255219,0.204428386830299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41465,0.0118610489455489,0.00937360463256068,-0.00651121613427006,0.0302333140253678,0.205762755340057
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39334,-0.00546524595271608,0.00432085335350839,-0.0139341185255925,0.00300362662016035,0.205951352798582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39427,-0.00848861806985212,0.00672859515401173,-0.0216766645717151,0.00469942843201087,0.207129436513274
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39301,-0.00892628945945227,0.00709525735052319,-0.0228329938664777,0.00498041494757318,0.208395979043277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41636,-0.00402753361209504,0.00320585601173612,-0.0103110113950978,0.00225594417090776,0.209027846386165
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39416,-0.00289757006172757,0.0023257888611346,-0.00745611622955138,0.00166097610609625,0.212848663540684
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39241,-0.00752307850362292,0.00603967956986671,-0.0193608504605617,0.00431469345331582,0.212935446391868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41465,-0.0130597552196016,0.0104911037657504,-0.0336223186004724,0.00750280816126921,0.213212908176166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41593,0.00456455037508293,0.00366967958726056,-0.00262802161594775,0.0117571223661136,0.213575266367588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41911,-0.003687134671123,0.00296676861946828,-0.00950200116528083,0.00212773182303482,0.213959131793366
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39400,0.00819209937415344,0.00659798117441583,-0.00473994372770159,0.0211241424760085,0.214408575045231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,41717,0.00507821989229161,0.00409226856164875,-0.00294262648853995,0.0130990662731232,0.214653705836886
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,41764,0.00502054700465237,0.00406705739050359,-0.00295088548073466,0.0129919794900394,0.21706023200709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,41925,-0.00211309844500633,0.00171515620291534,-0.00547480460272039,0.00124860771270773,0.217965160534052
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,39650,0.00337178998845667,0.00274150215223206,-0.00200155422991818,0.00874513420683152,0.218758485746362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,39625,-0.00698486714814122,0.00567981022732489,-0.018117295193698,0.00414756089741557,0.218809030419554
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,41740,-0.00864220679223593,0.00703441721396513,-0.0224296645316076,0.00514525094713572,0.219258653925997
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41865,-0.00610320893828426,0.00497212305625709,-0.0158485701285481,0.00364215225197963,0.21966195213406
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39259,-0.00652875942190578,0.0053204534652413,-0.0169568482137787,0.00389932936996716,0.219809921995782
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39250,-0.00784560994971061,0.00639883308197361,-0.0203873227903789,0.00469610289095766,0.220188113637935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39334,0.0056374154218437,0.00460213125497762,-0.00338276183791243,0.0146575926815998,0.220618095229714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39427,0.00801683783942927,0.00654867068694888,-0.00481855670699054,0.0208522323858491,0.220906007399894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39629,-0.00256727403816996,0.00210072267315529,-0.00668469047755433,0.0015501424012144,0.221699376134562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,39589,-0.00552387886109531,0.00453146533996917,-0.0144055509274349,0.00335779320524427,0.222868464623502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39328,-0.00658534609176871,0.00540288518824624,-0.0171750010607313,0.00400430887719392,0.222925156405131
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39427,-0.00517955373367941,0.00425959692776274,-0.0135283637120944,0.00316925624473555,0.224021818287053
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39361,-0.0110634327781356,0.00909970760217719,-0.0288988596784029,0.00677199412213165,0.224087442706615
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,41758,0.015282074557949,0.0126093345184228,-0.00943222109815975,0.0399963702140577,0.22554746682438
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39589,-0.00509435172031243,0.00420652702679711,-0.0133391446928348,0.0031504412522099,0.225898900452488
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41498,0.00551398368336581,0.00455827185515098,-0.00342022915273011,0.0144481965194617,0.226429487784149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39427,-0.00455095851179663,0.0037732639977787,-0.0119465559474429,0.00284463892384962,0.227802755424689
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41534,-0.00570105562669712,0.00472867104426341,-0.0149692508734534,0.00356713962005917,0.227979961321017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",41805,-0.00357258729862354,0.00297140434692413,-0.00939653981859483,0.00225136522134775,0.229260032179753
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39250,0.00544321436379797,0.0045312166185703,-0.00343797020859981,0.0143243989361958,0.22967321673618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,41697,-0.00752420496546169,0.00627758958188794,-0.0198282805459621,0.00477987061503867,0.230712264070074
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39241,0.0148525585970958,0.0124082125468794,-0.00946753799478795,0.0391726551889795,0.231335476768461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39414,0.00681044708041048,0.00572139716497561,-0.00440349136294172,0.0180243855237627,0.233936224697636
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39259,0.00660751320698777,0.00556268461648719,-0.00429534864132711,0.0175103750553027,0.234927600948844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39241,-0.00530131241560639,0.00446782997193138,-0.0140582591605919,0.00345563432937912,0.235430884601706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39259,-0.00540693667321791,0.00458996633595831,-0.0144032706916962,0.00358939734526037,0.238826698356502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39427,0.0102815644618935,0.00875062991142775,-0.00686967016450489,0.0274327990882919,0.240040017514341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41466,-0.00364509612232434,0.00310332963747134,-0.00972762221176816,0.00243742996711949,0.240186178828095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39308,0.00978868874188387,0.00833853677412138,-0.00655484333539404,0.0261322208191618,0.240457327057308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41740,-0.0187013339399553,0.0159445226185101,-0.0499525982722351,0.0125499303923245,0.240857086795163
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,39633,0.00315470633248586,0.00270939779146733,-0.00215571333879012,0.00846512600376183,0.244304535129224
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39334,0.0067772473888817,0.00582936230286471,-0.00464830272473314,0.0182027975024965,0.245015534533823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39250,0.00756842214017301,0.0065270014039448,-0.0052245006115588,0.0203613448919048,0.246255713543472
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,41736,-0.0108096428941847,0.00936720977692109,-0.02916937405695,0.00755008826858067,0.248526292585259
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41534,0.00866702254301963,0.00752019158274445,-0.0060725529591595,0.0234065980451988,0.249136874671155
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39600,0.0126902082198984,0.0110650534145434,-0.0089972964726066,0.0343777129124033,0.25145916221486
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39250,-0.00609012549175678,0.00531267693430204,-0.0165029722829888,0.00432272129947523,0.251680921653505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41865,0.00854157205235423,0.00747052628464148,-0.00610065946554306,0.0231838035702515,0.252905835711266
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41465,-0.00439489098694289,0.00384637509146235,-0.0119337861662091,0.00314400419232332,0.253223506069328
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41443,0.0142919001855554,0.0125318692385883,-0.0102705635220778,0.0388543638931885,0.254122467621586
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,39589,-0.00640639276867586,0.00563305349529247,-0.0174471776194491,0.00463439208209739,0.255443550622501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,41877,0.00565216348900513,0.00497289053547286,-0.00409470196052166,0.0153990289385319,0.25572806318029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39259,-0.00658425109250713,0.00581652622240197,-0.017984642488415,0.00481614030340073,0.25766398989856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39308,0.00258046856712861,0.00228001884499804,-0.00188836836906755,0.00704930550332476,0.257754341152999
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39259,0.00851144815629262,0.0075236983414443,-0.00623500059293822,0.0232578969055235,0.257960547069784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39259,0.00646088337682202,0.00571739845570912,-0.00474521759636785,0.0176669843500119,0.258485208824393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41534,0.00764672880634891,0.00677201853502642,-0.00562642752230286,0.0209198851350007,0.258849021628303
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39250,0.00702898811842986,0.00622573874072467,-0.0051734598133905,0.0192314360502502,0.25891451760862
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,41808,0.00327599045320125,0.00290598629467709,-0.00241974268436584,0.00897172359076834,0.259625654655153
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,41740,-0.00288256499257024,0.00255716408080868,-0.00789460659095526,0.00212947660581478,0.259657085110358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,41740,0.00447309095456197,0.00397411321814659,-0.00331617095300535,0.0122623528621293,0.260373634912818
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39589,-0.00527370687650418,0.00469544354176731,-0.0144767762183681,0.00392936246535975,0.261396570399469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39250,0.0042320886567123,0.00376959428621186,-0.00315631614426294,0.0116204934576875,0.261594164410284
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41534,-0.00512411186639095,0.00457092314037833,-0.0140831212215325,0.00383489748875057,0.262298709047566
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39221,0.00430462443992011,0.00384051147069889,-0.00322277804264971,0.0118320269224899,0.262378482750545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39241,0.00573974552924784,0.00512760599963491,-0.00431036223003659,0.0157898532885323,0.26300283299609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41465,-0.0036276717697793,0.00324705532031516,-0.00999190019759702,0.00273655665803841,0.263921579274252
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39598,0.00449103115262669,0.00402767905483445,-0.00340321979484883,0.0123852821001022,0.2648568050071
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39589,-0.0118457329182008,0.0106398555980447,-0.0326998498903683,0.00900838405396676,0.265588557189386
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,39600,-0.00518227140499341,0.00466044769202474,-0.0143167488813619,0.00395220607137508,0.266175961347341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41465,-0.00869173624563579,0.00781750513102695,-0.0240140463024486,0.00663057381117704,0.266232053627848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39589,0.0105191426957141,0.00947466014914556,-0.00805119119661115,0.0290894765880394,0.266920094769246
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39259,0.00652605120355591,0.00589125481638415,-0.00502080823655703,0.0180729106436688,0.267993792139811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39334,-0.0117894566966206,0.0106516731858941,-0.032666736140973,0.00908782274773185,0.268397708215821
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39250,0.00464257905041563,0.00419619876324482,-0.0035819705255442,0.0128671286263755,0.2685882374172
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41534,-0.00499050854345325,0.00453283140704061,-0.0138748581012529,0.00389384101434634,0.270930476514506
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39334,-0.00704216534420295,0.00640027165753434,-0.0195866977929703,0.00550236710456435,0.271229751545539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41758,0.00341600263348364,0.00310571203020081,-0.00267119294570996,0.00950319821267723,0.271391612269899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39308,0.00553859542892309,0.00503905696752395,-0.00433795622742385,0.01541514708527,0.271734628141228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39259,0.00572441862694555,0.00521006367264029,-0.00448730617142942,0.0159361434253205,0.271913569851417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39476,0.0041725489904852,0.00379955157704382,-0.00327457210052069,0.0116196700814911,0.272155098608286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,41925,-0.00294818847103809,0.00269050608506549,-0.00822158039776645,0.00232520345569028,0.273197191542149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39259,-0.00684513240688885,0.00625598590491674,-0.0191068647805257,0.00541659996674797,0.273903727921587
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39250,-0.00552923662429705,0.00505676379436078,-0.0154404936612442,0.00438202041265008,0.274228096175523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41534,-0.00757492391058572,0.00693794787368711,-0.0211733017430124,0.006023453921841,0.274936766856391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,39600,-0.0300741865224342,0.0276084206757115,-0.0841866910468287,0.0240383180019604,0.276040144944828
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41534,0.00402030368685143,0.00369515104432495,-0.00322219236002546,0.0112627997337283,0.276617847640173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39308,0.00883998687982722,0.00813869821888502,-0.00711186162918742,0.0247918353888419,0.277429485786517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,41783,-0.00591593605511971,0.00546739428514577,-0.0166320288540054,0.00480015674376599,0.279254810963387
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39334,0.00640005890705327,0.00592539158987767,-0.00521370860910696,0.0180138264232135,0.280118654541232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41447,-0.0053720836570122,0.00497839914446984,-0.0151297459801731,0.0043855786661487,0.280572977837351
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39406,0.00580571108312203,0.00538022061351264,-0.00473952131936274,0.0163509434856068,0.280574277042875
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39328,0.00468199890713666,0.00434552081733395,-0.00383522189483789,0.0131992197091112,0.281311980577871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39600,-0.0101270374482068,0.00940998091447723,-0.0285706000405821,0.0083165251441686,0.281860662794711
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39427,-0.00742431969557569,0.00690616280826784,-0.0209603987997807,0.00611175940862928,0.282386063942781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,39600,-0.00535282602677418,0.00499781491434478,-0.01514854325889,0.00444289120534159,0.284177971216548
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41764,-0.00395550595356561,0.00369538658045317,-0.0111984636512538,0.0032874517441226,0.284463288187217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39328,-0.00413130509252798,0.00386338306063916,-0.0117035358913807,0.00344092570632477,0.284936465615279
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41758,0.00406247889193633,0.0038016013667319,-0.0033886597868582,0.0115136175707309,0.285259156570067
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39589,0.00547001367974583,0.00512312227432813,-0.00457130597793731,0.015511333337429,0.285674378535311
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,41802,-0.00902408272236012,0.00846342464544989,-0.0256123950274419,0.00756422958272165,0.286332482754504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39328,-0.00874455556502204,0.00821965425320219,-0.0248550779012983,0.00736596677125425,0.287416390932442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39589,-0.00604329243128034,0.00568144497654384,-0.0171789245853063,0.00509233972274558,0.287492830001248
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39625,-0.012091127252719,0.0113805004915362,-0.0343969082161299,0.010214653710692,0.288058125158447
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39259,-0.00395353526823157,0.00372336009532301,-0.0112513210550647,0.00334425051860152,0.288341824946606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41466,-0.00624506848228751,0.005889864093673,-0.0177892021058866,0.00529906514131158,0.289024523314709
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41521,-0.00942005914956264,0.00889575274703095,-0.0268557345337433,0.00801561623461801,0.289647375427451
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39334,-0.00290690079776503,0.0027490579503484,-0.00829505438044788,0.00248125278491783,0.290345081501558
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39259,-0.00439198132384046,0.0041569765163226,-0.0125396552958328,0.00375569264815183,0.290748887060103
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39498,0.0122651775698439,0.0116918839056221,-0.0106509148851755,0.0351812700248633,0.294185976165672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,39598,-0.00767744067470099,0.00737126721471057,-0.0221251244155337,0.00677024306613172,0.297649717074695
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41617,0.00395557786061171,0.00379872089733592,-0.00348991509816669,0.0114010708193901,0.297759365779953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,39655,-0.00591452613414987,0.00568194378486133,-0.0170511359524781,0.00522208368417834,0.297929135545049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39562,-0.00298339596044997,0.00289237736645332,-0.00865245559869847,0.00268566367779854,0.302343958560559
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39221,0.00587806743761502,0.00570295310662005,-0.00529972065136028,0.0170558555265903,0.302702225342081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39634,0.00281815000714867,0.00273585057168453,-0.00254411711335302,0.00818041712765035,0.302994164847943
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39250,0.00757089064739745,0.00735885538972833,-0.00685246591647006,0.021994247211265,0.303590630172432
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,41765,0.0034705050666483,0.00338349001813014,-0.00316113536888678,0.0101021455021834,0.305043588889976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39241,-0.0058688228009582,0.00572304795700591,-0.0170859967966898,0.00534835119477338,0.305164058028198
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41609,-0.00302856202832097,0.00295600464243498,-0.00882233112749353,0.00276520707085158,0.305596618421691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39334,-0.00451525207667203,0.00440757764726997,-0.0131541042653212,0.00412360011197711,0.305655592197448
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39241,0.00843810473462611,0.00823930662053091,-0.00771093624161446,0.0245871457108667,0.305798094388369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41465,-0.00503345212219481,0.00492153774129244,-0.014679666095128,0.00461276185073838,0.30645015755607
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,39600,-0.00754693739256607,0.00738672537791412,-0.0220249191332777,0.00693104434814561,0.306950502485658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39334,0.00320496831660741,0.00315083358481606,-0.00297066550963208,0.0093806021428469,0.309090219453077
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41534,-0.00427119404961102,0.00420215688142433,-0.0125074215372027,0.00396503343798068,0.309444161810707
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41521,0.00469426082751201,0.004623536746882,-0.00436787119637672,0.0137563928514007,0.309983507545623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39427,0.00924581256984969,0.00910998690109632,-0.0086097617562991,0.0271013868959985,0.310171631563138
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,39589,0.00421131956502493,0.00415098721960665,-0.0039246153854041,0.012347254515454,0.310350132803342
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,41802,-0.00452762987129194,0.00448436708547878,-0.0133169893588303,0.00426172961624646,0.312682723139745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41466,-0.00324723300945316,0.00321764483654941,-0.00955381688909002,0.00305935087018369,0.312899815449485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41466,0.00579821799490459,0.00576165394683643,-0.00549462374089481,0.017091059730704,0.314268036108745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39250,-0.00456731269215908,0.00454276770864424,-0.0134711374011018,0.00433651201678363,0.314725634633654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39259,-0.0080263001523608,0.00799405339721916,-0.0236946448109104,0.00764204450618875,0.315385093341288
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39241,0.00357197203397027,0.00356069943984637,-0.00340699886812861,0.0105509429360692,0.315803664068905
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39328,0.00682093666754708,0.00686216785973382,-0.00662891233753121,0.0202707856726254,0.320249414095706
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39334,-0.00316793401721407,0.00318937568954995,-0.00941911036873198,0.00308324233430383,0.320597296351594
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39334,-0.00429086734986869,0.00434025488886484,-0.0127977669320438,0.00421603223230639,0.322870866729435
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41328,0.00885869566242188,0.00897159699733454,-0.00872563445235381,0.0264430257771976,0.32345766428895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39250,0.0110420724710726,0.0112448700113562,-0.0109978727511855,0.0330820176933307,0.326139236004051
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,41925,0.00425530414107791,0.00433796516847758,-0.00424710758913815,0.012757715871294,0.326637799483966
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41663,0.00225842089091054,0.00230994196015278,-0.00226906535098891,0.00678590713280999,0.328242832626238
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,41779,0.00321139202602451,0.00328641997165657,-0.00322999111842236,0.00965277517047139,0.328502779647652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41534,0.0059156236114483,0.00606598655940109,-0.00597371004497783,0.0178049572678744,0.329473289936624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39334,-0.00375497545763517,0.00385547868940617,-0.0113117136888713,0.00380176277360092,0.330112072112485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39241,0.00519957446200715,0.00534233073667833,-0.00527139378188238,0.0156705427058967,0.330437138656787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39259,0.00325101567079893,0.0033450877342239,-0.0033053562882799,0.00980738762987777,0.331133523265411
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39427,0.00461979923817785,0.00475352410131768,-0.0046971080004048,0.0139367064767605,0.331137798680318
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39308,0.00732452632949226,0.00758026723950052,-0.00753279745992877,0.0221818501189133,0.333934776093261
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39259,-0.0108758355298533,0.0112666658751059,-0.032958500645061,0.0112068295853543,0.334411007130529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39334,-0.00586047684614445,0.00607572033692878,-0.0177688887065249,0.00604793501423597,0.334780371358555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,41911,-0.000943150899150382,0.000980392305208896,-0.00286471981735982,0.000978418019059054,0.336060161177672
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41466,-0.00671779224924896,0.00700281830138875,-0.0204433161199709,0.00700773162147299,0.337426477898553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39250,-0.00503795448320464,0.00529425758807451,-0.0154146993558307,0.0053387903894214,0.341327325719667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41466,0.004973246038288,0.00522838843131932,-0.00527439528709787,0.0152208873636739,0.341520438830645
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39600,0.00304442006063423,0.00320373653229998,-0.00323490354267374,0.00932374366394219,0.341995108245256
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39259,-0.00493664123255147,0.00520335623700904,-0.0151352194570892,0.00526193699198625,0.342773490330858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39427,0.00565403036598996,0.0059597832692246,-0.00602714484169027,0.0173352055736702,0.342795756096609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41465,-0.00486665922794338,0.00513395066675879,-0.0149292025347906,0.00519588407890385,0.343179586972946
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39250,-0.00468735204296374,0.00495222539083407,-0.0143937138089985,0.00501900972307103,0.343907817404204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,41636,0.00337613796203885,0.00361345230200315,-0.00370622854988733,0.010458504473965,0.350153700836589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,41840,-0.0070670934672045,0.00759996122269157,-0.02196301746368,0.00782883052927096,0.352447343325314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41466,-0.00807514120843586,0.00869057531214956,-0.025108668820249,0.00895838640337728,0.352811308466898
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39259,0.00331098783659569,0.00356704564116112,-0.00368042162008011,0.0103023972932715,0.353316700068699
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41465,0.00313694282033321,0.00337977068584896,-0.00348740772393074,0.00976129336459716,0.353345850689428
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39334,-0.00873357525933096,0.00943349117226452,-0.0272232179569694,0.00975606743830751,0.354568033635629
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,41925,-0.00169673827383717,0.00183694188514386,-0.00529714436871915,0.0019036678210448,0.355672000194755
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,41758,-0.00581371823375107,0.00629629707709104,-0.0181544605048495,0.00652702403734736,0.355839095797316
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39655,0.00258937911492449,0.00281530459307369,-0.00292861788749993,0.00810737611734892,0.357722981357679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39427,-0.00437181044831251,0.00476920214589711,-0.0137194466542708,0.00497582575764583,0.359333159856935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39259,0.00336480966995106,0.00368248720499938,-0.00385286525184773,0.0105824845917498,0.360877885785459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,41765,-0.00288440920929091,0.00315747392000723,-0.00907305809250508,0.00330423967392326,0.36098690894293
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39241,-0.00747716745491407,0.00821914063004404,-0.0235866830898004,0.00863234817997224,0.36298753572419
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41521,-0.00498696822750611,0.00550010566478101,-0.0157671753304769,0.00579323887546468,0.364580215331814
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39420,-0.00955967507654846,0.0105494638496575,-0.0302366242218771,0.0111172740687802,0.364862675739382
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,41896,-0.00501133014337989,0.00555094739812834,-0.0158911870437114,0.00586852675695164,0.366654637667717
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39334,0.00448819633163555,0.00497713003788404,-0.00526697854261717,0.0142433712058883,0.36720251874658
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39600,-0.0109821589850502,0.012197334309351,-0.0348889342313782,0.0129246162612777,0.367941124508434
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,39598,-0.00274108371005413,0.00305928553764421,-0.00873728336383678,0.00325511594372851,0.370278681238741
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41689,-0.00199108016483166,0.00222350136316007,-0.00634914283662539,0.00236698250696207,0.370552026601299
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39250,-0.00385938002602685,0.00431403599606728,-0.0123148905783187,0.00459613052626501,0.371015786195871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39308,-0.00244116632552212,0.0027301780553751,-0.00779231531405732,0.00290998266301307,0.371266122096032
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,39633,0.00409459655446162,0.00458074402529502,-0.00488366173511663,0.0130728548440399,0.371410143233933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,41765,-0.00334558779085875,0.00374625935560079,-0.0106882561278363,0.0039970805461188,0.371848025604866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,41744,0.0122242178345867,0.0137150226281099,-0.0146572265165087,0.0391056621856821,0.372783853303547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,39600,-0.00572561515349471,0.00642625405312189,-0.0183210730976136,0.00686984279062418,0.372963451131381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,41765,-0.00448617506605012,0.00503586812777606,-0.0143564765964912,0.00538412646439095,0.373028916218517
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41805,-0.00261320793604808,0.00294714354994325,-0.00838960929393684,0.00316319342184068,0.375261017431283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39241,0.00575062640314138,0.00649516621188927,-0.00697989937216158,0.0184811521784443,0.375977022417393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41521,0.00489274858270765,0.00552884383841522,-0.00594378534058618,0.0157292825060015,0.376200239318397
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39259,0.00713099854201771,0.00806551175344431,-0.00867740449473314,0.0229394015787686,0.376643463376978
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39241,0.00561239991970888,0.00636225024383607,-0.00685761055820981,0.0180824103976276,0.377720648079016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41744,-0.00372114340274955,0.00422300093250649,-0.0119982252304623,0.00455593842496316,0.378246837976591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41534,0.0057006094552332,0.00649484671004542,-0.00702929009645583,0.0184305090069222,0.380115952753347
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,41925,-0.00304715417904457,0.0034801845606973,-0.00986831591801128,0.00377400755992214,0.381278218915681
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,39633,0.00445099044085739,0.00508490766448546,-0.0055154285815341,0.0144174094632489,0.381411481992393
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41287,-0.00579635153472788,0.00662773501875231,-0.0187867121714824,0.00719400910202664,0.381829948180481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39427,0.0154255065124419,0.0176605593328501,-0.0191891897799444,0.0500402028048282,0.382440583481595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39520,0.00630222795848465,0.00723128491789794,-0.0078710904805953,0.0204755463975646,0.383488052135678
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41521,-0.00440551166365647,0.00507114841657767,-0.0143449625601487,0.00553393923283576,0.38500525719314
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39334,0.00304621408999758,0.00352235456568928,-0.00385760085875341,0.00995002903874857,0.387155139489572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41877,-0.00572780650469982,0.00662964714505224,-0.0187219149090022,0.00726630189960257,0.387620785595091
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39241,0.00356944043062417,0.00414263447085129,-0.00455012313224436,0.0116890039934927,0.388907610430662
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,39633,0.00292822422606008,0.00340507759316348,-0.00374572785654033,0.00960217630866049,0.389830797713619
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,41866,0.00382060274299453,0.0044462105447772,-0.00489396992476879,0.0125351754107579,0.390193773690442
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,41827,0.00219109602339339,0.00255091073168872,-0.00280868901071651,0.00719088105750329,0.390385560162178
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,41765,-0.00799692156731062,0.00932009264898771,-0.0262643031593265,0.0102704600247053,0.390891372030662
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,39589,-0.0036505127155155,0.00425880468337208,-0.0119977698949248,0.00469674446389379,0.391370526689007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41466,-0.00777927636970018,0.00907885834922252,-0.0255738387341763,0.010015285994776,0.391540302260737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41534,-0.00858898515220355,0.0100270941334835,-0.0282420896538312,0.0110641193494241,0.391694188055128
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39224,0.00242149254836774,0.00282800813252965,-0.00312140339139037,0.00796438848812584,0.391876753197778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,41758,-0.00483781016642981,0.00566934040554065,-0.0159497173612895,0.00627409702842987,0.393492651684831
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,39650,-0.00275975600834448,0.00324647036997344,-0.00912283793349242,0.00360332591680346,0.395299631631286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39241,0.00236178156401332,0.00279012460556883,-0.00310686266290158,0.00783042579092821,0.397304683858395
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39328,-0.0045584814744545,0.00538634196810932,-0.0151157117319488,0.00599874878303975,0.397402186110409
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39250,-0.00342211013135367,0.00407280144417381,-0.0114048009619343,0.004560580699227,0.400795526421252
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,41925,-0.00409130834546364,0.00487186632659663,-0.013640166345593,0.00545754965466575,0.401045383713685
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39328,-0.0068970245764001,0.00823978025184518,-0.0230469938700167,0.00925294471721645,0.402588803753101
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41534,0.00426098838332612,0.00509692586346407,-0.00572898630906346,0.0142509630757157,0.403174942369017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39259,-0.0052300665999262,0.00627716662888138,-0.0175333131925337,0.0070731799926813,0.40475677716468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41636,-0.00253909023847494,0.00304771011059296,-0.00851260205523715,0.00343442157828727,0.404795650572885
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39259,0.00613635280136384,0.00738575012538404,-0.00833971744438887,0.0206124230471165,0.406084455270158
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39334,-0.00545187754390287,0.00656519526167254,-0.018319660256781,0.00741590516897531,0.4063191339839
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39334,-0.00934539671426134,0.0113078928814846,-0.0315088667619712,0.0128180733334485,0.408567809288021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39250,-0.00418166059979167,0.00506565808633138,-0.0141103504490012,0.00574702924941783,0.409110770970642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39241,0.00600466898789876,0.00728254532133498,-0.00826911984191779,0.0202784578177153,0.409657590664817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41636,-0.00353774264416949,0.00429518336527037,-0.0119563020400994,0.00488081675176043,0.410151558066957
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39250,0.00286536773622265,0.0034857966660889,-0.00396679372931159,0.00969752920175688,0.411088298535403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39633,0.00237461962380544,0.00288913770834968,-0.00328809028455994,0.00803732953217082,0.411144217458606
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39600,-0.00580627738135445,0.00717728047473152,-0.0198737471118282,0.00826119234911934,0.418544065244201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41689,-0.0073080027043885,0.00906791636397652,-0.0250811187777825,0.0104651133690055,0.420304411348958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,41925,-0.00297539032839077,0.00369799332359621,-0.0102234572426393,0.00427267658585781,0.421067254101771
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41866,0.00295720626898057,0.00367954606240553,-0.00425470401333426,0.0101691165512954,0.421591703635935
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41585,-0.00583555033032494,0.00728014543699119,-0.0201046353868277,0.00843353472617778,0.42281607471873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,41865,-0.0024873578017778,0.00311756408372705,-0.00859778340588283,0.00362306780232722,0.4249700930637
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39241,-0.00473306641070661,0.00594563082673984,-0.0163865028311167,0.00692037000970348,0.426016138886523
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39427,0.00621118300695486,0.00782430510151872,-0.00912445499202184,0.0215468210059316,0.427310694831433
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39334,-0.0062376078264644,0.00787822044551011,-0.0216789198996642,0.00920370424673542,0.428521974321416
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41636,-0.00883739670425773,0.0111864476196967,-0.0307628340388632,0.0130880406303478,0.42953675650468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,41769,-0.00790708009489521,0.0100402071042028,-0.0275858860191327,0.0117717258293423,0.430979099216157
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,41765,0.00325790726901047,0.00414530961036273,-0.00486689956730049,0.0113827141053214,0.431924891831876
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41911,-0.00332254466722987,0.00423156731036522,-0.0116164165955457,0.00497132726108596,0.432361647850271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39308,-0.00341956045713733,0.00435972772121559,-0.0119646267907199,0.00512550587644522,0.432851039893187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39625,-0.00249670536093432,0.00320273621964455,-0.00877406835143765,0.00378065762956901,0.435670260737452
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41798,0.00478492148176959,0.00615152293800987,-0.00727206347672975,0.0168419064402689,0.436675285435286
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39328,-0.00310350754588679,0.00399161606932474,-0.0109270750417633,0.0047200599499897,0.436877130099059
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39250,-0.00281680261639354,0.00362764176337924,-0.00992698047261684,0.00429337523982977,0.437481024412358
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39328,-0.0046500812369212,0.00599109305613215,-0.0163926236269402,0.00709246115309781,0.437668236605327
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41740,-0.00703484316325858,0.00907246245580948,-0.0248168695766452,0.010747183250128,0.438113657816544
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41466,-0.0122538434660577,0.0158488908970553,-0.0433176696242862,0.0188099826921708,0.439437606742535
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39259,-0.00889465158081868,0.0115356904880856,-0.0315046049374665,0.0137153017758292,0.440691435955924
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39259,-0.0067730074926218,0.00878541758048957,-0.0239924259503814,0.0104464109651378,0.44076109166578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41465,-0.00646010978020475,0.00838914583963084,-0.0229028356258812,0.00998261606547169,0.441280977452836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,39625,-0.00245599486285177,0.0031989109721792,-0.00872586036832301,0.00381387064261947,0.442646415592423
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39308,0.00333295587459865,0.00434842970464773,-0.00518996634651091,0.0118558780957082,0.443411546121899
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39408,0.00241643733847488,0.00315437722216893,-0.00376614201697623,0.00859901669392599,0.443658251738231
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39241,0.00356689666711414,0.0046709565203344,-0.00558817811274129,0.0127219714469696,0.445102892163403
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41689,0.00266245317107814,0.00348724665330495,-0.00417255026939956,0.00949745661155585,0.445189220332505
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39334,-0.00239280054202501,0.00313889624448973,-0.00854503718122488,0.00375943609717486,0.445893934359042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39408,-0.00266596220575778,0.00350272762380671,-0.00953130834841893,0.00419938393690338,0.446607771401391
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39250,-0.00380600119181351,0.00501544240911127,-0.0136362683136716,0.00602426593004458,0.447955182753922
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39259,0.0058234599649598,0.00767765341911225,-0.0092247407365002,0.0208716606664198,0.448171613291502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39334,-0.00236482586366961,0.00312903135406432,-0.00849772731763568,0.00376807559029646,0.449804105213743
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41534,-0.00459541097407743,0.00615435785852424,-0.0166579523767849,0.00746713042863007,0.455262954864638
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39259,0.00481952637926789,0.00645919017174573,-0.00784048635735374,0.0174795391158895,0.455593110709021
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39250,-0.00310096892248313,0.00416032740901025,-0.0112552106441432,0.00505327279917697,0.456066603664621
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,41758,0.00269722955505718,0.00362397578450678,-0.00440576298257611,0.00980022209269046,0.456724251922563
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39600,-0.0135488977268116,0.0182781839312418,-0.0493741382320455,0.0222763427784224,0.458551265564562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39427,0.00274737316139417,0.00371167633132912,-0.00452751244801092,0.0100222587707993,0.459196276556565
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39308,-0.00723203117271797,0.00978703228394335,-0.0264146144492469,0.011950552103811,0.459959532994856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41802,-0.00357572822618805,0.00486159246501675,-0.0131044494576209,0.00595299300524478,0.462044728916149
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41689,0.00201135545479266,0.00274986640003652,-0.00337838268927893,0.00740109359886424,0.464525050109917
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39250,0.00785677534478774,0.0107429355878189,-0.0131993784073374,0.0289129290969128,0.464585500741939
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,41636,-0.00283978890645743,0.0038859448349801,-0.0104562407830184,0.00477666297010356,0.464923823639618
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39408,-0.0026852218826891,0.00368502875175598,-0.00990787823613083,0.00453743447075262,0.466210705466792
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,41689,-0.00576049347895241,0.00791034063188812,-0.0212647611174531,0.0097437741595483,0.466490000484264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39250,0.00521732623665651,0.00722031076401388,-0.0089344828608107,0.0193691353341237,0.469947520338803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39241,-0.00560573885392461,0.00776121334529769,-0.0208177170107081,0.00960623930285886,0.470140620208694
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39250,0.00438105478852139,0.00607269701838176,-0.00752143136750685,0.0162835409445496,0.470657896503482
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,41740,-0.00519721066164153,0.00722536362555402,-0.0193589233677274,0.00896450204444436,0.471968324672596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39328,-0.00593667420884312,0.0082676859141227,-0.0221413386005236,0.0102679901828374,0.472737445451421
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39625,-0.00585605030319309,0.00817043974134675,-0.0218701121962327,0.0101580115898465,0.473552039428575
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39082,0.00537813929820056,0.00751349027768336,-0.00934830164605882,0.0201045802424599,0.474132197919784
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39655,0.00217044633201999,0.00303669578385946,-0.00378147740434456,0.00812237006838454,0.474785136608481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39221,0.00311383594178082,0.00437317839339413,-0.00545759370927167,0.0116852655928333,0.476461593571679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39250,0.00241399533914005,0.00339181967533897,-0.00423397122452432,0.00906196190280443,0.476659349588971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,41802,0.00322704680478925,0.00454993453300625,-0.00569082487990299,0.0121449184894815,0.478181092855868
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39259,0.00391499348842752,0.00556615368959496,-0.00699466774317861,0.0148246547200336,0.481848622669891
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41466,-0.00352976569884435,0.00502171130137946,-0.0133723198495481,0.00631278845185939,0.482130190044201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39250,0.00492507069107178,0.00701914825809223,-0.00883245989478899,0.0186826012769325,0.482905212176353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39427,-0.00395634975871443,0.00565577786736252,-0.015041674378745,0.00712897486131611,0.484239934693971
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39250,0.00538601365231468,0.00772474435480177,-0.00975448528309679,0.0205265125877262,0.485666784862184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,41925,0.00423898221293467,0.00608054603583146,-0.007678888017295,0.0161568524431643,0.485728338894097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39259,0.00482223838544324,0.00692847089931222,-0.00875756457720871,0.0184020413480952,0.486441958568657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39259,-0.00546293997554082,0.00786121992180672,-0.020870931022282,0.00994505107120036,0.487118909388388
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39328,-0.00296492087986233,0.00426932320520352,-0.0113327943620612,0.00540295260233657,0.487401960602644
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,39633,-0.00318515025808431,0.00458805897648161,-0.0121777458519883,0.00580744533581966,0.487555048451936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39600,-0.00352616703413229,0.0051069442936799,-0.0135357778497449,0.0064834437814803,0.489916289544643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39241,0.00341847433350422,0.00496724035591771,-0.0063173167640945,0.0131542654311029,0.491339371478026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39241,-0.00228231567858961,0.00331798745170885,-0.00878557108393896,0.00422093972675974,0.491555024305624
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41466,-0.00290838356160101,0.00425027202263934,-0.0112389167259741,0.00542214960277211,0.493809596184459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39259,0.00337384477240953,0.00496232540576063,-0.0063523130228813,0.0131000025677004,0.496587685796725
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39625,-0.00254744902784599,0.0037709542273718,-0.00993851931349471,0.00484362125780274,0.499343781160869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39241,0.00217530776155263,0.00322168028573992,-0.00413918559849762,0.00848980112160288,0.499557613711061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39241,-0.00371998440498738,0.00552008380111165,-0.0145393486551662,0.00709937984519145,0.500389537854478
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39241,-0.00557113034241956,0.00829656908959039,-0.0218324057580167,0.0106901450731776,0.501917849127499
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39633,0.00185392569991007,0.00276253713821693,-0.0035606470909951,0.00726849849081525,0.502173867499714
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39600,-0.00241362750566816,0.00359795633414659,-0.00946562192059548,0.00463836690925915,0.502341066504069
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41465,-0.00404540653539643,0.00605054966805749,-0.0159044838847891,0.00781367081399625,0.503761716617405
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,41640,0.00909360649362948,0.0136071133183189,-0.0175763356102755,0.0357635485975345,0.503955224253817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41490,0.00353412920709654,0.00530462781182404,-0.00686294130407858,0.0139311997182717,0.505272768181022
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39334,-0.00462170480421064,0.0069730298691857,-0.0182888433478146,0.00904543373939334,0.507474666574794
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39241,-0.00441700463595798,0.00669355257312263,-0.0175363676792783,0.00870235840736236,0.50933906568515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41585,0.00819296933414928,0.0124711625858793,-0.0162505093341742,0.0326364480024728,0.511222695223735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,41740,-0.00316166551469888,0.00482303412874675,-0.0126148124070425,0.00629148137764474,0.512135124845525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41534,0.00508443476286106,0.00777852125535915,-0.0101614668976429,0.020330336423365,0.513348583461884
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,41787,0.00256322247630831,0.00393825956193348,-0.0051557662650813,0.0102822112176979,0.515153637395893
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39241,-0.00252356303073151,0.00388294690268179,-0.0101341389599878,0.00508701289852479,0.515764885331084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,41765,0.00295610708061989,0.00457754108784376,-0.00601587345155388,0.0119280876127937,0.518429900261511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39328,0.00215501184172126,0.00333991136608682,-0.00439121443580891,0.00870123811925143,0.518791784868845
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39427,-0.00243745486251709,0.00378320924894205,-0.00985254499044351,0.00497763526540933,0.519406021645081
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39334,-0.00287186878300503,0.00446147171296896,-0.0116163533404242,0.00587261577441413,0.519780916113162
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41799,0.00332630183032479,0.00517140269737561,-0.00680964745653141,0.013462251117181,0.520098530053705
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39625,0.00272603423287127,0.00424496764305408,-0.00559410234751474,0.0110461708132573,0.520769530140169
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41534,-0.00218565848429403,0.00340572828848555,-0.0088608859297257,0.00448956896113764,0.521040722424143
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39328,-0.00425624117265992,0.00664503268084808,-0.0172805052271222,0.00876802288180232,0.521851709977735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,41758,0.00241076806282082,0.00376936589549129,-0.00497718909234211,0.00979872521798374,0.522464237401859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39589,-0.00276448041692724,0.00432324478321739,-0.0112380401920333,0.00570907935817884,0.522546336997529
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41708,-0.00433773257192032,0.00678658310192318,-0.0176394354516897,0.0089639703078491,0.522728091380873
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,39589,-0.00313248734703595,0.00492046593830585,-0.0127766005861154,0.00651162589204351,0.524382964145007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39589,0.00241728910184416,0.00379900289293298,-0.00502875656830448,0.0098633347719928,0.524596977187361
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39259,-0.00649467881569918,0.0103437670790145,-0.0267684622905677,0.0137791046591693,0.530093829893018
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41408,-0.00422537531478218,0.00676992898299923,-0.0174944361214607,0.00904368549189632,0.532547554440307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39308,0.00120733534834022,0.00193462324406412,-0.00258452621002546,0.00499919690670589,0.532596599646264
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39427,-0.00459791212723603,0.00737073014580789,-0.0190445432130195,0.00984871895854743,0.532767567043362
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,41758,0.0035675755403475,0.00572402333535792,-0.00765151019695401,0.014786661277649,0.533122099152367
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,41849,0.00276463331644006,0.0044461581689179,-0.00594983669463902,0.0114791033275191,0.53408228587302
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41614,-0.00170399378548039,0.00274355310158281,-0.0070813578645827,0.00367337029362192,0.53455119278282
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41466,-0.002152265678841,0.0034756501753906,-0.00896454002260659,0.00466000866492458,0.535768458715659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39250,0.00450792651926364,0.00728600636713822,-0.00977264596032728,0.0187884989988546,0.536120516233582
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41466,-0.0025357512264923,0.00410827050137797,-0.0105879614091931,0.00551645895620851,0.537093403693952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,41865,0.00484364473199098,0.00784989542260173,-0.0105421502963084,0.0202294397602904,0.537223532169824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,41819,0.00148183423313828,0.00240303996082496,-0.00322812409007864,0.00619179255635521,0.537476325318729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,41911,0.00317436370846209,0.00515870966211322,-0.00693670722927983,0.013285434646204,0.5383403034756
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,39596,-0.00202400924437722,0.00329719802880613,-0.00848651738083724,0.0044384988920828,0.539322294498294
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39250,0.00258673939065088,0.00421488542115574,-0.00567443603481436,0.0108479148161161,0.53941662774306
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39328,-0.00384799028652645,0.00627089456792314,-0.0161389436396558,0.0084429630666029,0.53947484071221
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39427,0.00515728891561426,0.0084181432435541,-0.0113422718417518,0.0216568496729803,0.540127455900933
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39259,-0.00601421034711142,0.00984128017061984,-0.0253031194815263,0.0132746987873035,0.541132687095538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,41732,-0.00184617105361388,0.00305455766568818,-0.00783310407836271,0.00414076197113495,0.545588960742844
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39427,0.00257265797991623,0.00426311588791095,-0.00578304916038924,0.0109283651202217,0.546209421107055
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39427,-0.00438801521197807,0.00727309037914627,-0.0186432723551048,0.00986724193114862,0.546307158778455
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41465,-0.00190794309735238,0.00317372777928004,-0.00812844954474126,0.0043125633500365,0.547738789103249
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39259,0.00294385690001027,0.00490725836404178,-0.00667436949351162,0.0125620832935322,0.548586638739685
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39427,0.00236335533744838,0.00395762459660185,-0.00539358887189123,0.010120299546788,0.550409636747271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,39589,0.00362546387608076,0.00607202524000001,-0.00827570559431927,0.0155266333464808,0.550468575365123
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39427,0.00328832421308482,0.00553037424615755,-0.00755120930938398,0.0141278577355536,0.55212769498846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39334,-0.00453689727008839,0.00763761557610707,-0.0195066237992582,0.0104328292590815,0.552511178674234
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39241,0.00318116031639878,0.00535903559089275,-0.00732254944175102,0.0136848700745486,0.552787705751388
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39250,0.00269188733361617,0.00454698799593237,-0.00622020913841128,0.0116039838056436,0.553852781968642
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39334,-0.0043605488772372,0.00739029804048282,-0.0188455330365835,0.0101244352821091,0.555178301183114
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39655,0.00165939097958761,0.00281723018929437,-0.00386238019142935,0.00718116215060456,0.555863213244817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,41888,0.00298101249518652,0.00506719736286608,-0.00695069433603099,0.012912719326404,0.556343554889651
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,41877,-0.00138043429486247,0.00235636515277234,-0.00599890999429626,0.00323804140457133,0.557998322381859
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39250,0.00317673096698836,0.0054244903262827,-0.00745527007252572,0.0138087320065025,0.558138240993909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41521,-0.00203798242851015,0.00351496989698111,-0.00892732342659313,0.00485135856957283,0.562059053847623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39598,0.00365330362498874,0.00631908268529397,-0.00873209843818745,0.0160387056881649,0.563182598346735
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39259,0.00510996647476833,0.00889858332797344,-0.0123312568480596,0.0225511897975963,0.565814178148646
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39250,-0.00379607047258953,0.00669664951577325,-0.0169215035235051,0.00932936257832605,0.570820464540823
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,41740,-0.00292575838212471,0.00516771344553955,-0.0130544767353822,0.0072029599711328,0.571293932769849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39241,0.00240077014613162,0.00424765466648533,-0.00592463300017964,0.0107261732924429,0.571950336228469
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39250,-0.00445725875217957,0.00793932361412644,-0.0200183330358674,0.0111038155315083,0.574526182940062
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39241,-0.00158007171180095,0.00282410304106297,-0.00711531367228437,0.00395517024868248,0.575835674706312
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39427,0.00235008962658188,0.00420157515614859,-0.00588499767946936,0.0105851769326331,0.575944424978151
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,39589,0.00623022493700954,0.0111400490152574,-0.015604271132895,0.0280647210069141,0.575993168318439
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39250,0.0028547648259454,0.00513536591943456,-0.00721055237614634,0.0129200820280371,0.578288911113907
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39250,0.0023822552639287,0.00431422064243175,-0.00607361719523753,0.0108381277230949,0.580832032220652
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41689,0.00185756010609405,0.00336665549186507,-0.0047410846579615,0.00845620487014959,0.581127451901356
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39334,-0.00319229946477026,0.00578645484141822,-0.01453375095395,0.00814915202440946,0.581175776669726
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,41819,-0.00166111655068011,0.00301332495008172,-0.00756723345284029,0.00424500035148007,0.5814668101359
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41466,-0.00298801919129582,0.0054344703541674,-0.0136395810854639,0.00766354270287228,0.582447498402061
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39259,0.00331680938402481,0.00608022941682807,-0.0086004402729582,0.0152340590410078,0.585416092914013
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39259,0.00487598178744143,0.00894786486229002,-0.012661833342647,0.0224137969175299,0.58581138846108
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41466,-0.00241467044839404,0.00444665385792369,-0.0111301120099245,0.0063007711131364,0.58711793419073
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,41758,-0.00217162814572826,0.00402830157765689,-0.0100670992379358,0.00572384294647924,0.589831983906297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,39650,-0.000857572224356096,0.00159550363794263,-0.00398475935472365,0.00226961490601145,0.590937861292453
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39241,-0.00524533065352271,0.00976200116432755,-0.0243788529356047,0.0138881916285593,0.591056965859042
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39250,-0.00315601106485912,0.00587754621186925,-0.0146760016401228,0.00836397951040461,0.591306008968989
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39328,0.0016105673552855,0.00300769351211721,-0.00428451192846424,0.00750564663903523,0.592327329359878
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,39655,-0.00137322946991384,0.00256999768562282,-0.00641042493373456,0.00366396599390689,0.593123283202247
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39589,0.00347736625954422,0.00650925573165514,-0.00928077497449984,0.0162355074935883,0.593201026351064
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,41750,-0.00290602879202669,0.00544550479289975,-0.0135792181861102,0.00776716060205682,0.59358826026611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39655,-0.00209904385511361,0.00393570705469095,-0.00981302968230787,0.00561494197208065,0.593813562600631
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41559,-0.00951897371167955,0.0179284083096929,-0.0446586539986776,0.0256207065753185,0.595466959720787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",41877,-0.00408271676369582,0.00773951857097439,-0.0192521731628056,0.011086739635414,0.597844402541986
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39259,-0.00416432694382882,0.00793180754400451,-0.0197106697300777,0.01138201584242,0.599582893689263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41466,0.00253058234379508,0.00484079514878065,-0.00695737614781499,0.0120185408354051,0.601149090899789
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39250,-0.00268893995430618,0.00515728322527374,-0.0127972150758427,0.00741933516723036,0.602108111272909
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,41785,-0.00296720490174378,0.0056978650086543,-0.0141350203187062,0.00820061051521864,0.602544584420189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39600,0.00119096935220323,0.00228883261306243,-0.00329514256939913,0.0056770812738056,0.602837644258063
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39250,0.00269678431864995,0.00521037687949409,-0.00751555436515846,0.0129091230024584,0.604762430076953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,39633,-0.00627271070098798,0.0121221217340962,-0.0300320692998166,0.0174866478978407,0.604845597758384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39600,-0.00386292076428603,0.0074685154117371,-0.0185012109712907,0.0107753694427187,0.605007830985948
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39408,0.00255911021216889,0.00498634897906691,-0.00721413378680226,0.01233235421114,0.607805656527197
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,41815,0.00160525576526714,0.0031487000653086,-0.00456619636273772,0.00777670789327199,0.610189313417369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,41689,0.00242645744013679,0.00480400589736313,-0.00698939411869493,0.0118423089989685,0.613503821463167
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41534,0.00168872899954585,0.00334593845234934,-0.00486931036705887,0.00824676836615056,0.613771050173736
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39241,0.00277011222203603,0.00553574860146784,-0.00807995503684093,0.013620179480913,0.616800798092613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39241,0.00212879397699777,0.00426463375570706,-0.00622988818418805,0.0104874761381836,0.617667180690223
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,41758,0.00228969703931342,0.00460969105762299,-0.00674529743362764,0.0113246915122545,0.61939920649863
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41521,0.00144015739837763,0.0029062507075044,-0.00425609398833099,0.00713640878508624,0.62022889705667
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39328,-0.00365937414763775,0.0073873587665202,-0.0181385973300173,0.0108198490347418,0.620358835279985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,39600,-0.00197508916985568,0.00399831821534448,-0.00981179287193085,0.0058616145322195,0.621330178664097
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,41877,0.00154775255256274,0.00314325891067925,-0.00461303491236859,0.00770854001749407,0.622442073324381
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41466,-0.00391660206403836,0.00803204946941929,-0.0196594190241002,0.0118262148960234,0.625826091247526
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39241,-0.00303603051325949,0.00623793363410722,-0.0152623804361096,0.00919031940959067,0.626477763689235
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41534,0.00397221926158649,0.0081959218753177,-0.0120917876140362,0.0200362261372092,0.62792715758866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39259,-0.00379135035033507,0.00785743115356706,-0.0191919154113265,0.0116092147106564,0.629448069314778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41636,-0.0031251986377334,0.00650140607322745,-0.0158679545412592,0.0096175572657924,0.630740778692384
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39259,-0.00383743335626219,0.00798945934580886,-0.0194967736740475,0.0118219069615232,0.631015400031936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39334,-0.00288495258372603,0.00606093428180641,-0.0147643837760666,0.00899447860861454,0.634090193336283
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,39600,-0.00184939222174155,0.00389731239970423,-0.00948812452516184,0.00578934008167874,0.63513132600036
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41173,-0.00142835959903418,0.00301509283784461,-0.00733794156120962,0.00448122236314126,0.635696030529733
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,41747,0.00111834560016621,0.00237053306997107,-0.00352789921697709,0.00576459041730952,0.637099032468758
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39328,-0.00300011964964802,0.00639096727927526,-0.0155264155170275,0.0095261762177315,0.638770968224609
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39250,-0.00221942002308024,0.00476217081717241,-0.0115532748247382,0.00711443477857769,0.64118769271793
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39328,0.00203062930693897,0.00436078662820597,-0.00651651248434474,0.0105777710982227,0.641470737100588
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,41861,0.00215447067170347,0.00465839650958393,-0.00697598648708104,0.011284927830488,0.643736194917277
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41662,-0.00139805123150381,0.00303296042307338,-0.00734265366072763,0.00454655119772001,0.644840230735975
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39259,-0.00301902194600917,0.00655420260426178,-0.0158652590503623,0.00982721515834392,0.645077904493555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,41740,-0.00155893040177852,0.00339352765240565,-0.00821024460049359,0.00509238379693656,0.645966438587973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39308,-0.0021307701875188,0.00464481408965746,-0.0112346058032474,0.00697306542820982,0.646428933034263
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39250,-0.00195328172984674,0.00428692311994238,-0.0103556510449338,0.00644908758524033,0.648660163594883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41765,0.0015635427437802,0.00343363507526685,-0.00516638200374282,0.00829346749130323,0.648857216324936
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39334,0.00492088963562155,0.0108632848511141,-0.0163711486725621,0.0262129279438052,0.650569722783599
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39600,0.00237708264933623,0.0052515301057807,-0.00791591635799394,0.0126700816566664,0.650812794768013
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39427,-0.00267373146919022,0.00592842917744327,-0.014293452656979,0.00894598971859859,0.651997376247808
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39259,0.00278869761937003,0.0061985907336506,-0.00936054021858514,0.0149379354573252,0.652797321202016
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39427,0.00330292022532276,0.00738567923802548,-0.0111730110812072,0.0177788515318527,0.654735260302545
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,39589,-0.00366735611854131,0.00824273125924164,-0.0198231093866549,0.0124883971495723,0.656386320577538
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39250,0.00165904476647854,0.0038346089942052,-0.00585678886216365,0.00917487839512073,0.665277595270141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41465,-0.00742410753906285,0.0171909819686468,-0.0411184321976105,0.0262702171194848,0.665849980048229
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39565,0.00175366927363965,0.00407928620634054,-0.0062417316907878,0.0097490702380671,0.66727966280747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41070,-0.00192139681102073,0.00447005095024755,-0.0106826966735059,0.00683990305146447,0.667321070172184
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39427,0.0030416989211367,0.00708265800734074,-0.0108403107732512,0.0169237086155246,0.667599034747895
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39259,-0.00183943142495456,0.00429102458239717,-0.010249839606453,0.00657097675654389,0.668172411513732
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41595,0.00185939532290137,0.00434609945551527,-0.00665895960990856,0.0103777502557113,0.668781381382953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,39583,0.00111508215027235,0.00261423293844841,-0.00400881440908653,0.00623897870963124,0.669720751941289
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39250,0.00225042036947782,0.00527876241355344,-0.00809595396108692,0.0125967947000426,0.669886286881786
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39598,0.00183165927704721,0.00430462107500814,-0.00660539802996875,0.0102687165840632,0.670473265322113
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,41911,-0.00332291976494656,0.00781987241009457,-0.0186498696887319,0.0120040301588388,0.670892579621335
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39241,-0.00385884441477632,0.00908489059057548,-0.0216652299723043,0.0139475411427516,0.671024538075665
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,39600,-0.00135605559322924,0.00320785626808723,-0.00764345387868021,0.00493134269222173,0.67250086624148
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39259,-0.00325061787377105,0.00775338429579295,-0.0184472510935252,0.0119460153459831,0.675040797996056
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39259,-0.00249241068455951,0.00594937548983913,-0.0141531866446442,0.00916836527552518,0.675270965151497
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41534,-0.00125759537842105,0.00301263577622748,-0.00716236149982692,0.00464717074298482,0.676363361201375
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39328,0.00185971307857703,0.00445506206509461,-0.00687220856900841,0.0105916347261625,0.676366273958598
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,41636,0.00187824441386907,0.00451142732395186,-0.00696415314107657,0.0107206419688147,0.677175092874093
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,41636,0.00462508740182881,0.0111220848606891,-0.0171741989251218,0.0264243737287794,0.677528692342666
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39250,-0.00145534959833544,0.00350217673292251,-0.00831961599486356,0.00540891679819268,0.677743501198147
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39328,0.00252397546826532,0.00614169131267761,-0.00951373950458279,0.0145616904411134,0.68111174444099
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41534,0.00276489263838408,0.00677194090670896,-0.0105081115387655,0.0160378968155336,0.683070044421976
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",41911,-0.00285295882121909,0.00702094405923493,-0.0166140091773196,0.0109080915348814,0.684492172742132
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39334,0.00378087109052235,0.00931970367792292,-0.0144857481182066,0.0220474902992513,0.684981590934145
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39625,-0.00147338377897502,0.00363705791785236,-0.00860201729796566,0.00565524974001561,0.685409518805579
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41466,-0.00228380086257591,0.00564389764122707,-0.013345840239381,0.00877823851422915,0.685741828768562
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41521,0.000985503578327954,0.00244043237195187,-0.00379774387069771,0.00576875102735362,0.686349306795742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39589,-0.00229373470888335,0.00569020248810652,-0.0134465315855721,0.00885906216780543,0.686880681776477
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,41863,-0.00121482661339158,0.0030195145374122,-0.00713307510671948,0.00470342187993632,0.687451237750232
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39241,-0.0030396685090638,0.00755656262067569,-0.0178505312455881,0.0117711942274605,0.687504116060119
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,39655,0.00113304290816115,0.00286467697209483,-0.00448172395714473,0.00674780977346702,0.692465283998446
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39427,-0.00286643504579637,0.00729515637401267,-0.0171649415388612,0.0114320714472685,0.694384057013555
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39427,0.00115420882693651,0.00293929175067034,-0.00460680300437735,0.00691522065825037,0.694561628929584
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39420,0.00419066335962574,0.0106875941281016,-0.0167570211314534,0.0251383478507049,0.694988061299785
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41507,0.00220687744580034,0.00570734446543822,-0.00897951770645857,0.0133932725980592,0.699004494877236
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39334,0.00122581926792314,0.0031879176041286,-0.00502249923616892,0.00747413777201519,0.70060041602952
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41521,-0.00244644595924299,0.00646514879936365,-0.0151181376059957,0.0102252456875098,0.705135818577173
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39589,0.00302330331170475,0.00804492694187225,-0.0127447534943649,0.0187913601177744,0.707071015063871
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39334,-0.00170816044532033,0.00454975735803422,-0.0106256848670674,0.00720936397642673,0.707340754357094
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41534,-0.0020486978084675,0.00546239516618602,-0.0127549923341921,0.0086575967172571,0.707625823028519
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39334,0.00179602456440532,0.00479230259546469,-0.00759688852270548,0.0111889376515161,0.70783686385894
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41614,0.00134193608378234,0.00358309316269347,-0.00568092651509686,0.00836479868266153,0.708024405501468
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,41765,0.00321968892734401,0.00864518347743809,-0.0137248706884346,0.0201642485431227,0.709581880938938
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39328,0.00265276316645436,0.00718034108458118,-0.0114207053593247,0.0167262316922335,0.711801064267363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39259,-0.00221704402739587,0.00602128628230535,-0.0140187651407144,0.00958467708592261,0.712730627291171
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,41740,0.00175049760869117,0.00475482686615707,-0.00756896304897669,0.011069958266359,0.71276605073075
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39241,-0.00255473238279695,0.00694122259863248,-0.0161595286761166,0.0110500639105227,0.712841618142525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39655,-0.00205263617383369,0.00565552163075946,-0.0131374585701222,0.00903218622245484,0.716653850312271
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41465,-0.00343118482443531,0.00947496039282327,-0.0220021071943689,0.0151397375454983,0.717259460519747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41925,-0.000935149648750682,0.00260664610542716,-0.00604417601538792,0.00417387671788656,0.719783395848659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41466,0.00194854718058635,0.00543218279056933,-0.00869853108892954,0.0125956254501022,0.719822216850925
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39259,-0.00254501702145011,0.00710917730094966,-0.0164790045313114,0.0113889704884112,0.720357608049445
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39625,0.00106974141849458,0.00302416141558057,-0.00485761495604334,0.00699709779303251,0.72354681168611
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41466,-0.00209252399356816,0.00592496402933619,-0.0137054534910671,0.00952040550393077,0.72396622043763
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39241,0.00239947384150255,0.0068009960080334,-0.0109304783342429,0.015729426017248,0.724236282560752
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39598,-0.00137769459218171,0.00392306492013466,-0.00906690183564566,0.00631151265128223,0.725461445165481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41534,-0.00164947379711366,0.00472004975847997,-0.0109007713237344,0.00760182372950707,0.726748856558595
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41577,-0.00220982857801329,0.00637079990695046,-0.0146965963956362,0.0102769392396096,0.728695881916596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,41732,0.00108816684259191,0.00314264422590563,-0.00507141584018313,0.00724774952536695,0.729154104867776
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41465,-0.00117773735638144,0.00343124354511327,-0.00790297470480344,0.00554749999204056,0.731424110465817
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41466,0.00214154702387472,0.00624426487293466,-0.0100972121270772,0.0143803061748267,0.731632475768166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39589,0.00145598272444127,0.00424840627489062,-0.00687089357434435,0.00978285902322689,0.731821173240363
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41534,-0.00205683941390678,0.00602160561554982,-0.0138591864203844,0.00974550759257086,0.732675118543942
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41466,0.00167477561365319,0.0049163950311775,-0.0079613586474547,0.0113109098747611,0.733371780967811
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39250,0.00198452500508491,0.00586524483172072,-0.0095113548650877,0.0134804048752575,0.735103623980547
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39576,-0.00130980108102196,0.0038733084880183,-0.00890148571753783,0.00628188355549391,0.735248485318691
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41593,-0.00375942281434212,0.0112207267815111,-0.0257520473061039,0.0182332016774196,0.737598269963007
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41925,-0.00249518522690975,0.00745746286981137,-0.01711181245174,0.0121214419979205,0.737940391535874
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39600,-0.00107657718760063,0.00322744973785113,-0.00740237867378883,0.00524922429858758,0.738711170720398
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39250,-0.00177592737525873,0.00534322514186168,-0.0122486486533076,0.00869679390279016,0.739616481599307
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39427,0.00137316052992439,0.00413378802388052,-0.00672906399688143,0.0094753850567302,0.739759989979349
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41465,-0.00185140184492145,0.00573516917107124,-0.0130923334202211,0.00938952973037818,0.746840174753591
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41447,0.00192475629191961,0.00599763759134387,-0.00983061338711438,0.0136801259709536,0.748276940239404
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39328,0.00105641634509906,0.00333811019137406,-0.00548627962999411,0.00759911232019222,0.751650901110797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39598,-0.000842799883709545,0.00270014507395889,-0.00613508422866896,0.00444948446124987,0.754946631468017
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39427,0.00251908644497673,0.00811869360074646,-0.0133935530124863,0.0184317259024398,0.756352307002083
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41534,0.00148542209104428,0.00481224296365981,-0.00794657411772894,0.0109174182998175,0.757573260928982
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,41722,-0.000570388955875983,0.00184974968412455,-0.0041958983367601,0.00305512042500813,0.757813251176475
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39193,-0.00112260826531552,0.00364808992958014,-0.0082728645272926,0.00602764799666156,0.758297688321483
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39427,-0.000757864833721124,0.0024715316068472,-0.00560206678314163,0.00408633711569938,0.759125030855539
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,39598,0.000710707819236058,0.00232023992202493,-0.0038369624279328,0.00525837806640492,0.759376022590791
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41447,-0.00175052765377451,0.00572952744722906,-0.0129804014503435,0.00947934614279445,0.759969450919461
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41521,-0.00227643115342217,0.00748124386975756,-0.016939669138147,0.0123868068313026,0.760915584308915
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39259,0.00229671382553096,0.00755043664184873,-0.0125021419924926,0.0170955696435545,0.760994478446412
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,41740,0.0019080105915209,0.00636313582518144,-0.0105637356258347,0.0143797568088765,0.764293402794525
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39241,-0.00208419482391871,0.00703102517208929,-0.0158650041612137,0.0116966145133763,0.766908802383781
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,41709,-0.00228014938727134,0.00772379061110217,-0.0174187789850316,0.0128584802104889,0.767837232588504
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41245,-0.00100400267108788,0.00344517052588026,-0.00775653690181318,0.00574853155963743,0.770732441764304
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39266,-0.00106255286919968,0.00366140650536627,-0.00823890961971757,0.00611380388131821,0.771666224127058
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,41689,-0.00411108025019759,0.0141922943028156,-0.0319279770837163,0.0237058165833211,0.772073385958348
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39224,-0.00149166138826005,0.00515512518247735,-0.0115957067459157,0.00861238396939556,0.772315352775574
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39334,-0.000755896825025237,0.00261913744505847,-0.00588940621733983,0.00437761256728935,0.772889048000417
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39241,-0.00142400367116359,0.0049681182499566,-0.0111615154410785,0.00831350809875135,0.77440246427806
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39250,0.00255960923107864,0.00894526748894265,-0.014973115047249,0.0200923335094062,0.774775571932752
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39427,0.00215316421676091,0.00767400148789462,-0.0128878786995125,0.0171942071330344,0.779038630425916
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39589,-0.00176608441406103,0.00638419377146492,-0.0142791042061323,0.0107469353780102,0.782066435273552
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,41740,0.00165317517201774,0.0060116917162024,-0.010129740591739,0.0134360909357745,0.783325680139489
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39328,-0.00185970576450829,0.00687984828642244,-0.0153442084058963,0.0116247968768797,0.786925409978458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39241,-0.00095219953712162,0.00357256934020558,-0.00795443544392456,0.00605003636968132,0.789835655378834
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39589,0.00163465562918519,0.00629439630080771,-0.0107023611203979,0.0139716723787683,0.795099946194813
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39600,0.00204920868431428,0.00791964947817647,-0.0134733042929116,0.0175717216615402,0.795833040072824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39259,0.00260731865229338,0.0102473952762169,-0.0174775760890917,0.0226922133936785,0.799162716264204
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39308,-0.00151726349525296,0.00600906781863043,-0.0132950364197686,0.0102605094292627,0.800662821039095
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,41736,-0.000908088464777124,0.00363227306452199,-0.00802734367124022,0.00621116674168597,0.802586957693981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39259,-0.002438007716485,0.00977566239707651,-0.021598306014755,0.016722290581785,0.80305955218623
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39259,0.00138757660977825,0.00557441353098574,-0.0095382739109538,0.0123134271305103,0.803428349254824
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39250,0.00102525022760149,0.00417117792485252,-0.00715025850510946,0.00920075896031244,0.805846490197154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39241,0.00161674304377219,0.00662599295490347,-0.0113702031478386,0.014603689235383,0.807235434789549
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39250,-0.00123818201251037,0.00515193519851162,-0.0113359750015931,0.0088596109765724,0.810076443550853
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39221,0.00195357941193571,0.00818187539227743,-0.0140828963569281,0.0179900551807995,0.811289201785866
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39259,0.000817853251867327,0.00343745949570627,-0.00591956735971697,0.00755527386345162,0.811944808119747
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",41716,0.00166046528442408,0.00722124886903993,-0.0124931824988942,0.0158141130677423,0.818140761200679
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39259,-0.00181546925481,0.00797838413826533,-0.0174531021658101,0.01382216365619,0.820001633497847
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,39630,0.000348113853977292,0.00154186361783562,-0.00267393883698052,0.00337016654493511,0.821380809233657
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39250,-0.000940946568757994,0.00417254404911998,-0.00911913290503315,0.00723723976751716,0.82158758967205
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39241,0.000607413554853441,0.00269844966266567,-0.00468154778397128,0.00589637489367816,0.821907955213322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39259,0.0021625335217036,0.00972209102128909,-0.016892764880023,0.0212178319234302,0.82397951346331
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39334,0.000617892937316669,0.00278582011162923,-0.00484231448147662,0.00607810035610996,0.824474347507783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41686,-0.000698231831666987,0.00316071883669245,-0.00689324075158418,0.00549677708825021,0.825166589676729
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,41765,0.00128005248454086,0.00580792762395547,-0.0101034856584119,0.0126635906274936,0.825565042505902
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39427,0.000704277611486582,0.00322137105040527,-0.00560960964730775,0.00701816487028091,0.826944999768675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41465,0.00125841228187305,0.00576353428044755,-0.0100381149078042,0.0125549394715502,0.827167375510846
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,41805,0.000501965001069475,0.00230146133917895,-0.00400889922372127,0.00501282922586022,0.82734905523745
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,39589,-0.000920449692647725,0.00423570594329252,-0.00922243334150106,0.00738153395620561,0.827972926639001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39427,-0.00133095238849774,0.0061573064316259,-0.0133992729944845,0.010737368217489,0.82886849264465
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,41925,0.000444120583818253,0.00208738935302105,-0.003647162548103,0.00453540371573951,0.831514570018166
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,41758,0.000941309320525643,0.00449177884725884,-0.00786257722010168,0.00974519586115297,0.83401223556515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39250,0.000730390023017918,0.00350602595765387,-0.00614142085398367,0.00760220090001951,0.834979827646635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41617,0.000721840695341991,0.00348115716727942,-0.00610122735252567,0.00754490874320965,0.835734666856139
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39408,-0.000541266590759034,0.00261873335291781,-0.00567398396247794,0.00459145078095987,0.83625568394958
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41521,0.000509130244708405,0.00247100891134395,-0.00433404722152574,0.00535230771094255,0.836761784176719
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39250,-0.00106409844898874,0.00520093525929383,-0.0112579315572046,0.00912973465922716,0.837890503898203
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39259,-0.00075100232952024,0.00367818643307321,-0.00796024773834373,0.00645824307930325,0.838218814886693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41865,0.000606100899199645,0.00297334450943723,-0.00522165433929733,0.00643385613769662,0.838477887794869
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39589,-0.000831755068516471,0.00408741975731669,-0.00884309779285718,0.00717958765582423,0.838754677406848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41534,-0.000884336850448141,0.00439218829886639,-0.00949302591622626,0.00772435221532998,0.840433462220278
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,39589,-0.000567106771780753,0.0028214239744105,-0.00609709776162533,0.00496288421806382,0.840702140814501
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41521,0.000581566767099994,0.00292972243135616,-0.00516068919835807,0.00632382273255806,0.842652504521677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41640,0.00123236872524886,0.00623761135422026,-0.0109933495290229,0.0134580869795206,0.843384105135341
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41521,0.00061660700961022,0.00314145789714386,-0.00554065046879174,0.00677386448801218,0.844393689432766
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41465,0.00256612805061503,0.0131522050134581,-0.0232121937757628,0.0283444498769929,0.845309836061708
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41465,0.000735122953107888,0.00378479760399819,-0.00668308035072857,0.00815332625694434,0.845998505575675
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39328,-0.00138584865799931,0.00715881416254102,-0.0154171244165797,0.0126454271005811,0.846503457138038
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,41667,-0.00118835897330412,0.00618220874738435,-0.0133054881181775,0.0109287701715692,0.847570991156849
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41689,-0.00115646689966135,0.00602858854190213,-0.0129725004417895,0.0106595666424668,0.847877987876481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39250,0.00102178018438881,0.00536207125562752,-0.00948787947664114,0.0115314398454188,0.848876317950217
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41465,-0.00159205112596353,0.00836741327333515,-0.0179921811417004,0.0148080788897734,0.849102117053799
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39250,-0.000949078289183148,0.00500345537345381,-0.0107558508211526,0.00885769424278632,0.849559926266033
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41466,-0.00121785396791355,0.00642576795378607,-0.0138123591573343,0.0113766512215071,0.849683096942427
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39578,0.00113995971315914,0.00605933899192326,-0.0107363447110105,0.0130162641373287,0.850776116960767
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,39600,0.00311954835617288,0.016636155966757,-0.0294873173386709,0.0357264140510166,0.851259400288104
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39328,0.000952386547433896,0.00514058971043978,-0.00912316928502807,0.0110279423798959,0.853022372802485
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,41758,-0.000676822745728529,0.00367351353698811,-0.00787690927822522,0.00652326378676816,0.853824900114654
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,39633,0.0018149153234802,0.00985064569394389,-0.0174923502366498,0.0211221808836102,0.853825990127373
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39241,0.00107418323003438,0.00584079107177708,-0.0103737672706487,0.0125221337307175,0.854087114898742
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39334,0.00106260216720447,0.00578725979798878,-0.0102804270368535,0.0124056313712625,0.854322425388084
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39328,0.00133096894905427,0.00726435062940718,-0.0129071582845838,0.0155690961826923,0.854629445011889
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,41746,-0.00115012208698033,0.00635636726625701,-0.0136086019288441,0.0113083577548834,0.856417338143858
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39259,-0.000866342609718253,0.00481517340343126,-0.0103040824804435,0.00857139726100703,0.85721934637086
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41521,0.0019887481390244,0.0113806225749446,-0.020317272107867,0.0242947683859158,0.861279896829098
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39241,0.000893928592195323,0.00513988637217606,-0.00918024869726976,0.0109681058816604,0.861931710960953
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41805,0.000797915025980581,0.00466567408246828,-0.00834680617565725,0.00994263622761841,0.864212101694816
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39598,0.00435777936223197,0.0256611754920618,-0.0459381246022091,0.0546536833266731,0.865154865854819
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,41711,0.000469860706880025,0.00276784349241538,-0.00495511253825412,0.00589483395201417,0.865203892773218
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41636,-0.000775613762905994,0.00457251163904804,-0.00973773657544015,0.00818650904962816,0.865307438451865
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41758,-0.000554316457435926,0.0033042914674303,-0.00703072773359932,0.00592209481872746,0.86677740309141
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39250,0.00119736965689716,0.00717577255910577,-0.0128671445589501,0.0152618838727445,0.867481154819596
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41465,-0.00232054487075043,0.0141653645642424,-0.0300846594166655,0.0254435696751646,0.869876817877308
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41689,-0.000667754710288802,0.00417928304911122,-0.00885914948654679,0.00752364006596919,0.873058943676677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39334,-0.000524152016580339,0.00330939185359483,-0.0070105600496262,0.00596225601646553,0.874157843741825
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39334,0.000472447399080128,0.00298311105241877,-0.00537445026366066,0.00631934506182092,0.874165034752643
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41465,-0.00123203564719244,0.0083188054943518,-0.017536894416122,0.0150728231217371,0.882264220664622
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,41878,0.00054323955423873,0.0036788678932453,-0.00666734151652206,0.00775382062499952,0.882609498329225
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39241,-0.000612286433702515,0.00424088564300645,-0.00892442229399516,0.00769984942659013,0.885205495772635
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,39600,0.000674156454518923,0.0046991673440413,-0.00853621153980202,0.00988452444883987,0.885927190463313
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,41750,0.000705380250888697,0.0050626010082315,-0.00921731772524505,0.0106280782270224,0.889190261384117
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39259,0.000798821899664398,0.00574477457625783,-0.0104609362698009,0.0120585800691297,0.889411753095376
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41689,0.000692857030074022,0.00501670809453526,-0.00913989083521509,0.0105256048953631,0.890155689851146
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39250,-0.00101341681133312,0.0074093125373635,-0.0155356693845656,0.0135088357618993,0.891210367413142
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39328,-0.000681272843559755,0.00504559092365582,-0.0105706310539252,0.00920808536680566,0.892595906007043
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39408,0.000520047872906577,0.0038808707244238,-0.00708645874696407,0.00812655449277723,0.893402788229026
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,41865,-0.000456229979580737,0.00341981382354374,-0.00715906507372646,0.00624660511456499,0.893872868145467
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39427,0.000600056447333001,0.00449795258866295,-0.00821593062644638,0.00941604352111238,0.893874325515201
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39328,0.000517730482242215,0.00391087118089382,-0.00714757703230968,0.00818303799679411,0.894684323850005
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,41765,-0.000375406196007004,0.0028788744101888,-0.00601800003997705,0.00526718764796304,0.896251691570589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,39600,0.00157563732505156,0.0123097694029335,-0.0225515107046981,0.0257027853548012,0.898152158835459
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39334,-0.000831759736432385,0.0066777853709885,-0.0139202190635699,0.0122566995907051,0.900877218261297
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41466,0.000646096238930882,0.00522976642638041,-0.00960424595677473,0.0108964384346365,0.901679781735985
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39633,0.00177679637731928,0.014737991576931,-0.0271096671134654,0.030663259868104,0.904042602210015
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39334,-0.000359481031270297,0.00302733668257578,-0.00629306092911882,0.00557409886657822,0.905479622426613
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,41743,-0.000818579133104231,0.00693796272469287,-0.0144169860735022,0.0127798278072938,0.906080934853883
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39259,-0.000948080904304788,0.00805816617028764,-0.0167420865980686,0.014845924789459,0.906343499920211
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39334,-0.000726386320466929,0.00626610798057346,-0.0130079579623909,0.0115551853214571,0.907715699681502
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39334,-0.000325034162580318,0.00284900912475946,-0.00590909204710885,0.00525902372194822,0.909171167454608
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39230,0.000981468189471735,0.00874181437620634,-0.0161524879878927,0.0181154243668362,0.910609208536693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39625,-0.000569497691095005,0.00514385415167675,-0.0106514518283814,0.00951245644619142,0.911845001449028
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41636,-0.000802978000236675,0.00739548180076267,-0.0152981223297315,0.0136921663292581,0.913539806936219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39241,-0.000624697093304142,0.00576661688530967,-0.0119272661885111,0.0106778720019028,0.913736039256578
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39259,-0.000681762453100985,0.00632948491370546,-0.0130875528839637,0.0117240279777617,0.914226055473187
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41534,-0.000550391529396391,0.00516073247852245,-0.0106654271873004,0.0095646441285076,0.915068395143001
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,41818,-0.000417298988685561,0.00399277155515129,-0.0082431312367821,0.00740853325941098,0.916763350054511
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39408,0.000313439180818209,0.00301454283227067,-0.00559506477043231,0.00622194313206873,0.917190567205765
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41465,0.000577738782806199,0.00575814622337905,-0.0107082278150167,0.0118637053806291,0.92008059946219
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,41802,0.0002764392141044,0.0029416198218531,-0.00548913563672768,0.00604201406493648,0.925130309358049
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39600,-0.000769599968808477,0.00832077147835847,-0.0170783120663911,0.0155391121287741,0.926309292242481
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,41758,-0.000731647898293303,0.00809310841470613,-0.0165941403911173,0.0151308445945307,0.927967699025189
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39328,-0.0003172878115882,0.00363932558131753,-0.00745036595097056,0.00681579032779416,0.930527572184949
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39328,0.000565598877408147,0.00655917032257146,-0.0122903749548319,0.0134215727096482,0.931284995807228
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39241,0.000269393106744958,0.00323626197526212,-0.00607368036476879,0.00661246657825871,0.933660637166589
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41429,0.000409143959078205,0.00511664400499783,-0.00961947829071754,0.010437766208874,0.93626765795322
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39328,0.000380766218196872,0.00486369457600311,-0.00915207515076922,0.00991360758716296,0.937600864869513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39633,-0.00025126356439948,0.00321639992541251,-0.00655540741820799,0.00605288028940903,0.93773440989458
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41534,0.000420356582026454,0.00542874197416662,-0.0102199776873401,0.011060690851393,0.938281341450803
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,39600,-0.000428053366302967,0.00558956435069897,-0.0113835994936729,0.010527492761067,0.93895841814029
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41521,0.000476881889514549,0.00638743025250424,-0.0120424814053938,0.0129962451844229,0.940486845005553
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41447,-0.000279167694433603,0.00376205012007669,-0.00765278592978392,0.00709445054091671,0.940847414844778
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41534,0.000238338288669228,0.00330156427650697,-0.00623272769328443,0.00670940427062289,0.942452213906682
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39589,-0.000363010376168895,0.00512290076691161,-0.0104038958793157,0.00967787512697786,0.943510215244572
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39241,-0.000391468313755029,0.00553948151108641,-0.0112488520754844,0.0104659154479743,0.943662709070255
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39241,0.00039178039617001,0.00557270972407989,-0.0105307306630266,0.0113142914553666,0.943953503876571
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41636,-0.00037894822450824,0.00544006553413893,-0.0110414766714205,0.0102835802224041,0.944466334470394
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39259,-0.000317551482740823,0.00464296710771521,-0.00941776701386263,0.00878266404838099,0.945473213911856
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39241,0.000444509266686211,0.00684896458592506,-0.0129794613217269,0.0138684798550993,0.948253506915354
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41534,0.000253510657416718,0.00391884992371745,-0.00742743519306948,0.00793445650790292,0.948421772743292
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,41704,-0.000180539503914783,0.00283255926648146,-0.00573235566621845,0.00537127665838888,0.949180425608154
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,41836,0.000179178543149355,0.00290251505583213,-0.00550975096628161,0.00586810805258032,0.950777055608039
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39600,-0.000152391630447571,0.00256807664125823,-0.00518582184731371,0.00488103858641857,0.952681771104487
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,39600,-0.000205797450341367,0.00349222005291845,-0.00705054875406154,0.0066389538533788,0.953008723056193
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39570,-0.000323661108851942,0.0055943264929448,-0.0112885410350237,0.0106412188173199,0.953864989423908
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39328,-0.00022608932677971,0.00391721836115098,-0.00790383731463563,0.00745165866107621,0.953975282791981
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41124,0.000181643782596683,0.00315961037848797,-0.00601119255923974,0.00637448012443311,0.954156348111787
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39533,-0.000185793658074889,0.00325947687924345,-0.00657436834139204,0.00620278102524226,0.954545387297509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41465,-0.000225417982398755,0.00401814719214513,-0.0081009864790032,0.00765015051420569,0.955263030009783
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39334,-0.000122115768160552,0.00217687772250569,-0.00438879610427171,0.0041445645679506,0.955265776046795
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39328,-0.000229485576416998,0.00432485276075993,-0.00870619698750646,0.00824722583467247,0.957683452295655
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39314,-0.000234675896666144,0.00475687335332581,-0.00955814766918474,0.00908879587585245,0.960653992637843
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39250,-0.000165542270524138,0.00341392162499008,-0.00685682865550469,0.00652574411445642,0.96132636049693
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39427,-0.000214970290593079,0.00507169676207084,-0.0101554959442519,0.00972555536306576,0.96619155784626
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41465,-0.000561127649095949,0.0134400945053453,-0.0269037128795728,0.0257814575813809,0.966698422669568
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,41824,0.000489169081901126,0.0118807277891957,-0.0227970573849224,0.0237753955487246,0.967158339746369
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,39598,0.00011515784453601,0.00283176802269801,-0.00543510747995209,0.00566542316902411,0.967562577102254
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39334,-0.000144200549072249,0.00361515606757434,-0.00722990644151796,0.00694150534337346,0.968183335497713
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41521,0.000315184646433487,0.00809413919403502,-0.0155493281738752,0.0161796974667421,0.968938938622677
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39385,0.000107642574958301,0.00308991089185898,-0.00594858277308529,0.00616386792300189,0.972210529435973
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39334,-0.000137070429424655,0.0041624732455596,-0.00829551799072147,0.00802137713187216,0.973730985961836
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,41764,7.94126424072172e-05,0.00253514438911541,-0.00488947036025898,0.00504829564507341,0.975011065643179
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,41838,0.000205068672086697,0.00676948263789435,-0.0130631172981862,0.0134732546423596,0.975833749330513
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39259,0.000130634604310643,0.00436999011011934,-0.00843454601152327,0.00869581522014456,0.9761524937962
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39328,-0.000114515874709417,0.00386811612658114,-0.00769602348280844,0.00746699173338961,0.976382567145353
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39655,-7.01664673252727e-05,0.00281253739316932,-0.00558273975793714,0.00544240682328659,0.980097093883014
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39650,4.75827956378842e-05,0.00195262054669422,-0.00377955347588279,0.00387471906715856,0.980558966426464
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,41758,-0.000112546632583712,0.00475495876092672,-0.00943226580400009,0.00920717253883267,0.981116738484436
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,39589,-8.5239610054113e-05,0.00372847432409068,-0.00739304928527184,0.00722257006516361,0.981760931885509
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39313,-9.23514714963878e-05,0.00417133321768293,-0.00826816457815494,0.00808346163516216,0.982337044228048
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39334,-8.68442982758307e-05,0.00393961246385832,-0.00780848472743813,0.00763479613088647,0.982413371930317
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39334,7.01972606661039e-05,0.0036689021317116,-0.00712085091748863,0.00726124543882084,0.984735327704659
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,41826,0.000304205987083872,0.0165691673231642,-0.032171361966318,0.0327797739404858,0.985352128350777
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41466,-8.42213854582699e-05,0.00479682806526292,-0.0094860043933736,0.00931756162245706,0.985991954715515
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39259,8.52499951762463e-05,0.0058348091524489,-0.0113509759436236,0.0115214759339761,0.988343125244848
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41521,-4.49963823347214e-05,0.00335830320041448,-0.0066272706551471,0.00653727789047766,0.989310033146737
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,41911,-5.63994122196773e-05,0.00485336720563573,-0.00956899913526571,0.00945620031082636,0.990728424135754
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39259,-4.40377870351342e-05,0.00516145377799265,-0.0101604871919007,0.0100724116178305,0.99319265047413
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39328,-3.13618816686468e-05,0.00427299215482794,-0.00840642650513141,0.00834370274179412,0.99414406755797
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,41637,-3.69923279297789e-05,0.00509851374199291,-0.0100300792622359,0.00995609460637632,0.994211100754019
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41466,6.35200370856292e-05,0.00915082187541488,-0.0178720908387275,0.0179991309128988,0.994461670681961
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39334,1.05812379548048e-05,0.00661704287877635,-0.0129588228044468,0.0129799852803564,0.998724142139532
NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41689,-3.09020005672153e-06,0.00391442655415935,-0.00767536624620905,0.0076691858460956,0.999370131095359
